BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: de Franchis R, Baveno VI Faculty. Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. J Hepatol. 2015;63:743-752. [PMID: 26047908 DOI: 10.1016/j.jhep.2015.05.022] [Cited by in Crossref: 1489] [Cited by in F6Publishing: 1184] [Article Influence: 212.7] [Reference Citation Analysis]
Number Citing Articles
1 Agarwal S, Sharma S, Anand A, Gunjan D, Saraya A. Liver stiffness assessment as an alternative to hepatic venous pressure gradient for predicting rebleed after acute variceal bleed: A proof-of-concept study. JGH Open 2021;5:73-80. [PMID: 33490616 DOI: 10.1002/jgh3.12449] [Reference Citation Analysis]
2 Hernández-Gea V, De Gottardi A, Leebeek FWG, Rautou PE, Salem R, Garcia-Pagan JC. Current knowledge in pathophysiology and management of Budd-Chiari syndrome and non-cirrhotic non-tumoral splanchnic vein thrombosis. J Hepatol 2019;71:175-99. [PMID: 30822449 DOI: 10.1016/j.jhep.2019.02.015] [Cited by in Crossref: 31] [Cited by in F6Publishing: 22] [Article Influence: 10.3] [Reference Citation Analysis]
3 Zhang YR, Wu DM, Liu XC, Zhou N, Cao CC, Liu WH, Wang CX, Wang H. Multimodal therapy and twenty years of valid management of a patient with chronic hepatitis B in a less developed Western Region in China---case report and review of the literature. BMC Infect Dis 2019;19:49. [PMID: 30642253 DOI: 10.1186/s12879-019-3673-4] [Reference Citation Analysis]
4 Abraldes JG, Trebicka J, Chalasani N, D’amico G, Rockey DC, Shah VH, Bosch J, Garcia-tsao G. Prioritization of Therapeutic Targets and Trial Design in Cirrhotic Portal Hypertension: Hepatology. Hepatology 2019;69:1287-99. [DOI: 10.1002/hep.30314] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 7.3] [Reference Citation Analysis]
5 Danielsen KV, Hove JD, Nabilou P, Yin M, Chen J, Zhao M, Kallemose T, Teisner AS, Siebner HR, Ehman RL, Møller S, Bendtsen F. Using MR elastography to assess portal hypertension and response to beta-blockers in patients with cirrhosis. Liver Int 2021;41:2149-58. [PMID: 34060714 DOI: 10.1111/liv.14981] [Reference Citation Analysis]
6 Bazarbashi AN, Ryou M. Gastric variceal bleeding. Curr Opin Gastroenterol 2019;35:524-34. [PMID: 31577562 DOI: 10.1097/MOG.0000000000000581] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
7 Colecchia A, Ravaioli F, Marasco G, Colli A, Dajti E, Di Biase AR, Bacchi Reggiani ML, Berzigotti A, Pinzani M, Festi D. A combined model based on spleen stiffness measurement and Baveno VI criteria to rule out high-risk varices in advanced chronic liver disease. J Hepatol. 2018;69:308-317. [PMID: 29729368 DOI: 10.1016/j.jhep.2018.04.023] [Cited by in Crossref: 72] [Cited by in F6Publishing: 51] [Article Influence: 18.0] [Reference Citation Analysis]
8 Powell EE, Wong VW, Rinella M. Non-alcoholic fatty liver disease. Lancet 2021;397:2212-24. [PMID: 33894145 DOI: 10.1016/S0140-6736(20)32511-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 12.0] [Reference Citation Analysis]
9 Wöran K, Semmler G, Jachs M, Simbrunner B, Maria Bauer DJ, Binter T, Pomej K, Stättermayer AF, Schwabl P, Bucsics T, Paternostro R, Lampichler K, Pinter M, Trauner M, Mandorfer M, Stift J, Reiberger T, Scheiner B. Clinical Course of Porto-Sinusoidal Vascular Disease Is Distinct From Idiopathic Noncirrhotic Portal Hypertension. Clin Gastroenterol Hepatol 2020:S1542-3565(20)31629-3. [PMID: 33279774 DOI: 10.1016/j.cgh.2020.11.039] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Nguyen TH, Wardell R, Chitturi S, Teoh N, Farrell G. When the liver gets stiff, the tough get moving. J Gastroenterol Hepatol 2020;35:953-9. [PMID: 31867782 DOI: 10.1111/jgh.14963] [Reference Citation Analysis]
11 Marciano S, Díaz JM, Dirchwolf M, Gadano A. Spontaneous bacterial peritonitis in patients with cirrhosis: incidence, outcomes, and treatment strategies. Hepat Med 2019;11:13-22. [PMID: 30666172 DOI: 10.2147/HMER.S164250] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 5.3] [Reference Citation Analysis]
12 Sigal SH, Sherman Z, Jesudian A. Clinical Implications of Thrombocytopenia for the Cirrhotic Patient. Hepat Med. 2020;12:49-60. [PMID: 32341665 DOI: 10.2147/hmer.s244596] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
13 Praktiknjo M, Meyer C, Strassburg CP, Trebicka J. [Recent thrombosis of splanchnic veins : Two case reports of catheter-assisted local thrombolysis and thrombus aspiration]. Internist (Berl) 2017;58:82-9. [PMID: 27573529 DOI: 10.1007/s00108-016-0120-0] [Reference Citation Analysis]
14 Tseng YJ, Zeng XQ, Chen J, Li N, Xu PJ, Chen SY. Computed tomography in evaluating gastroesophageal varices in patients with portal hypertension: A meta-analysis. Dig Liver Dis 2016;48:695-702. [PMID: 27103357 DOI: 10.1016/j.dld.2016.02.007] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
15 Berger A, Ravaioli F, Farcau O, Festi D, Stefanescu H, Buisson F, Nahon P, Bureau C, Ganne-Carriè N, Berzigotti A, de Ledinghen V, Petta S, Calès P; multicenter groups Varices œsophagiennes - Vidéo-capsule œsophagienne, Agence Nationale de Recherches sur le Sida et les Hépatites Virales, Cohort 12 Cirrhoses Virales, M116, and Validation of Expanded Baveno VI Criteria. Including Ratio of Platelets to Liver Stiffness Improves Accuracy of Screening for Esophageal Varices That Require Treatment. Clin Gastroenterol Hepatol 2021;19:777-787.e17. [PMID: 32562889 DOI: 10.1016/j.cgh.2020.06.022] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
16 Jakab SS, Garcia-Tsao G. Screening and Surveillance of Varices in Patients With Cirrhosis. Clin Gastroenterol Hepatol 2019;17:26-9. [PMID: 29551741 DOI: 10.1016/j.cgh.2018.03.012] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
17 Li B, Chen J, Zhang CQ, Wang GC, Hu JH, Luo JJ, Zhang W, Wei YC, Zeng XQ, Chen SY. The pharmacodynamic effect of terlipressin versus high-dose octreotide in reducing hepatic venous pressure gradient: a randomized controlled trial. Ann Transl Med 2021;9:793. [PMID: 34268406 DOI: 10.21037/atm-20-6774] [Reference Citation Analysis]
18 Chazouillères O, Potier P, Bouzbib C, Hanslik B, Heurgue A, NGuyen-Khac E, Gournay J, Tanne F, Bureau C, Bourlière M, Ganne-Carrié N, de Lédinghen V. NON-INVASIVE DIAGNOSIS AND FOLLOW-UP OF PRIMARY SCLEROSING CHOLANGITIS. Clin Res Hepatol Gastroenterol 2021;:101775. [PMID: 34332142 DOI: 10.1016/j.clinre.2021.101775] [Reference Citation Analysis]
19 Zou Z, Yan X, Li C, Li X, Ma X, Zhang C, Ju S, Tian J, Qi X. von Willebrand factor as a biomarker of clinically significant portal hypertension and severe portal hypertension: a systematic review and meta-analysis. BMJ Open 2019;9:e025656. [PMID: 31473610 DOI: 10.1136/bmjopen-2018-025656] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
20 Kamath PS, Mookerjee RP. Individualized care for portal hypertension: Not quite yet. Journal of Hepatology 2015;63:543-5. [DOI: 10.1016/j.jhep.2015.07.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
21 Schultheiss M, Bettinger D, Sturm L, Schmidt A, Backhus J, Waidmann O, Radecke K, Grandt D, Thimme R, Rössle M. Comparison of the Covered Self-Expandable Viatorr CX Stent with the Covered Balloon-Expandable BeGraft Peripheral Stent for Transjugular Intrahepatic Portosystemic Shunt (TIPS) Creation: a Single-Centre Retrospective Study in Patients with Variceal Bleeding. Cardiovasc Intervent Radiol 2022. [PMID: 35020042 DOI: 10.1007/s00270-021-03040-8] [Reference Citation Analysis]
22 Benmassaoud A, Nitulescu R, Pembroke T, Halme AS, Ghali P, Deschenes M, Wong P, Klein MB, Sebastiani G. Liver-related Events in Human Immunodeficiency Virus-infected Persons With Occult Cirrhosis. Clin Infect Dis 2019;69:1422-30. [PMID: 30561558 DOI: 10.1093/cid/ciy1082] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
23 Trebicka J, Amoros A, Pitarch C, Titos E, Alcaraz-Quiles J, Schierwagen R, Deulofeu C, Fernandez-Gomez J, Piano S, Caraceni P, Oettl K, Sola E, Laleman W, McNaughtan J, Mookerjee RP, Coenraad MJ, Welzel T, Steib C, Garcia R, Gustot T, Rodriguez Gandia MA, Bañares R, Albillos A, Zeuzem S, Vargas V, Saliba F, Nevens F, Alessandria C, de Gottardi A, Zoller H, Ginès P, Sauerbruch T, Gerbes A, Stauber RE, Bernardi M, Angeli P, Pavesi M, Moreau R, Clària J, Jalan R, Arroyo V. Addressing Profiles of Systemic Inflammation Across the Different Clinical Phenotypes of Acutely Decompensated Cirrhosis. Front Immunol 2019;10:476. [PMID: 30941129 DOI: 10.3389/fimmu.2019.00476] [Cited by in Crossref: 55] [Cited by in F6Publishing: 52] [Article Influence: 18.3] [Reference Citation Analysis]
24 Forns X, Sarrazin C. Treatment of chronic hepatitis C. J Hepatol 2018;69:544-6. [PMID: 29891100 DOI: 10.1016/j.jhep.2018.04.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
25 Ma X, Wang L, Wu H, Feng Y, Han X, Bu H, Zhu Q. Spleen Stiffness Is Superior to Liver Stiffness for Predicting Esophageal Varices in Chronic Liver Disease: A Meta-Analysis. PLoS One. 2016;11:e0165786. [PMID: 27829057 DOI: 10.1371/journal.pone.0165786] [Cited by in Crossref: 56] [Cited by in F6Publishing: 49] [Article Influence: 9.3] [Reference Citation Analysis]
26 Kumar R, Kerbert AJC, Sheikh MF, Roth N, Calvao JAF, Mesquita MD, Barreira AI, Gurm HS, Ramsahye K, Mookerjee RP, Yu D, Davies NH, Mehta G, Agarwal B, Patch D, Jalan R. Determinants of mortality in patients with cirrhosis and uncontrolled variceal bleeding. J Hepatol 2021;74:66-79. [PMID: 32561318 DOI: 10.1016/j.jhep.2020.06.010] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 6.5] [Reference Citation Analysis]
27 Al-Khazraji A, Curry MP. The current knowledge about the therapeutic use of endoscopic sclerotherapy and endoscopic tissue adhesives in variceal bleeding. Expert Rev Gastroenterol Hepatol. 2019;13:893-897. [PMID: 31389265 DOI: 10.1080/17474124.2019.1652092] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
28 Vonghia L, Magrone T, Verrijken A, Michielsen P, Van Gaal L, Jirillo E, Francque S. Peripheral and Hepatic Vein Cytokine Levels in Correlation with Non-Alcoholic Fatty Liver Disease (NAFLD)-Related Metabolic, Histological, and Haemodynamic Features. PLoS One 2015;10:e0143380. [PMID: 26599575 DOI: 10.1371/journal.pone.0143380] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 4.6] [Reference Citation Analysis]
29 Vuille-Lessard É, Rodrigues SG, Berzigotti A. Noninvasive Detection of Clinically Significant Portal Hypertension in Compensated Advanced Chronic Liver Disease. Clin Liver Dis 2021;25:253-89. [PMID: 33838850 DOI: 10.1016/j.cld.2021.01.005] [Reference Citation Analysis]
30 Nardelli S, Riggio O, Gioia S, Puzzono M, Pelle G, Ridola L. Spontaneous porto-systemic shunts in liver cirrhosis: Clinical and therapeutical aspects. World J Gastroenterol 2020; 26(15): 1726-1732 [PMID: 32351289 DOI: 10.3748/wjg.v26.i15.1726] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
31 Innes H, Irving WL. A new tool for estimating liver cancer risk after a hepatitis C virus cure. Hepatobiliary Surg Nutr 2020;9:791-3. [PMID: 33299837 DOI: 10.21037/hbsn.2020.03.08] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
32 Li M, Luo J, Chen J, Wu C, Pan T, Huang M, Jiang Z. Application of percutaneous transluminal sharp recanalization in transjugular intrahepatic portosystemic shunt for patients with chronic portal vein occlusion. Diagn Interv Radiol 2021;27:257-62. [PMID: 33044172 DOI: 10.5152/dir.2020.20461] [Reference Citation Analysis]
33 Serper M, Shaked A, Olthoff KM, Hoteit M, Appolo B, Reddy KR. A local response to COVID-19 for advanced liver disease: Current model of care, challenges and opportunities. J Hepatol 2020;73:708-9. [PMID: 32450089 DOI: 10.1016/j.jhep.2020.05.022] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
34 Kang SH, Kim MY, Baik SK. Novelties in the pathophysiology and management of portal hypertension: new treatments on the horizon. Hepatol Int 2018;12:112-21. [DOI: 10.1007/s12072-017-9806-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
35 Robertson M, Ng J, Abu Shawish W, Swaine A, Skardoon G, Huynh A, Deshpande S, Low ZY, Sievert W, Angus P. Risk stratification in acute variceal bleeding: Comparison of the AIMS65 score to established upper gastrointestinal bleeding and liver disease severity risk stratification scoring systems in predicting mortality and rebleeding. Dig Endosc. 2019;. [PMID: 31863515 DOI: 10.1111/den.13577] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
36 Ravaioli F, Colecchia A, Dajti E, Marasco G, Alemanni LV, Tamè M, Azzaroli F, Brillanti S, Mazzella G, Festi D. Spleen stiffness mirrors changes in portal hypertension after successful interferon-free therapy in chronic-hepatitis C virus patients. World J Hepatol 2018; 10(10): 731-742 [PMID: 30386466 DOI: 10.4254/wjh.v10.i10.731] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
37 Pinter M, Scheiner B, Peck-Radosavljevic M. Immunotherapy for advanced hepatocellular carcinoma: a focus on special subgroups. Gut 2021;70:204-14. [PMID: 32747413 DOI: 10.1136/gutjnl-2020-321702] [Cited by in Crossref: 25] [Cited by in F6Publishing: 32] [Article Influence: 12.5] [Reference Citation Analysis]
38 Zampino R, Lebano R, Coppola N, Macera M, Grandone A, Rinaldi L, De Sio I, Tufano A, Stornaiuolo G, Adinolfi LE, Durante-Mangoni E, Battista GG, Niglio A. The use of nonselective beta blockers is a risk factor for portal vein thrombosis in cirrhotic patients. Saudi J Gastroenterol 2018;24:25-9. [PMID: 29451181 DOI: 10.4103/sjg.SJG_100_17] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
39 Fortea JI, Puente Á, Ezcurra I, Cuadrado A, Arias-Loste MT, Cabezas J, Llerena S, Iruzubieta P, Rodríguez-Lope C, Huelin P, Casafont F, Fábrega E, Crespo J. Management of haemostatic alterations and associated disorders in cirrhosis in Spain: A national survey. Dig Liver Dis 2019;51:95-103. [PMID: 29960901 DOI: 10.1016/j.dld.2018.06.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
40 Ferraioli G, Wong VW, Castera L, Berzigotti A, Sporea I, Dietrich CF, Choi BI, Wilson SR, Kudo M, Barr RG. Liver Ultrasound Elastography: An Update to the World Federation for Ultrasound in Medicine and Biology Guidelines and Recommendations. Ultrasound Med Biol. 2018;44:2419-2440. [PMID: 30209008 DOI: 10.1016/j.ultrasmedbio.2018.07.008] [Cited by in Crossref: 152] [Cited by in F6Publishing: 110] [Article Influence: 38.0] [Reference Citation Analysis]
41 Yan Y, Xing X, Lu Q, Wang X, Luo X, Yang L. Two-Dimensional Shear Wave Elastography for Sparing Endoscopy Screening in Patients with HBV-Related Compensated Advanced Chronic Liver Disease. Expert Rev Gastroenterol Hepatol 2021. [PMID: 34939906 DOI: 10.1080/17474124.2022.2020644] [Reference Citation Analysis]
42 Tsauo J, Noh SY, Shin JH, Gwon DI, Han K, Lee JM, Jeon UB, Kim YH. Retrograde transvenous obliteration for the prevention of variceal rebleeding in patients with hepatocellular carcinoma: a multicentre retrospective study. Clin Radiol 2021;76:681-7. [PMID: 34140137 DOI: 10.1016/j.crad.2021.05.011] [Reference Citation Analysis]
43 Dell’era A, Seijo S. Portal vein thrombosis in cirrhotic and non cirrhotic patients: from diagnosis to treatment. Expert Opinion on Orphan Drugs 2016;4:927-40. [DOI: 10.1080/21678707.2016.1215907] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
44 Calame P, Ronot M, Bouveresse S, Cervoni J, Vilgrain V, Delabrousse É. Predictive value of CT for first esophageal variceal bleeding in patients with cirrhosis: Value of para-umbilical vein patency. European Journal of Radiology 2017;87:45-52. [DOI: 10.1016/j.ejrad.2016.12.006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 2.2] [Reference Citation Analysis]
45 Roberts D, Best LM, Freeman SC, Sutton AJ, Cooper NJ, Arunan S, Begum T, Williams NR, Walshaw D, Milne EJ, Tapp M, Csenar M, Pavlov CS, Davidson BR, Tsochatzis E, Gurusamy KS. Treatment for bleeding oesophageal varices in people with decompensated liver cirrhosis: a network meta-analysis. Cochrane Database Syst Rev 2021;4:CD013155. [PMID: 33837526 DOI: 10.1002/14651858.CD013155.pub2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
46 Perazzo H, Fernandes FF, Castro Filho EC, Perez RM. Points to be considered when using transient elastography for diagnosis of portal hypertension according to the Baveno's VI consensus. J Hepatol 2015;63:1048-9. [PMID: 26206072 DOI: 10.1016/j.jhep.2015.06.036] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 3.4] [Reference Citation Analysis]
47 Men C, Zhang G. Endoscopic ultrasonography predicts early esophageal variceal bleeding in liver cirrhosis: A case report. Medicine (Baltimore). 2017;96:e6749. [PMID: 28445299 DOI: 10.1097/md.0000000000006749] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
48 Lattanzi B, Gioia S, Di Cola S, D'Ambrosio D, Nardelli S, Tavano D, Farcomeni A, Merli M, Riggio O. Prevalence and impact of sarcopenia in non-cirrhotic portal hypertension. Liver Int 2019;39:1937-42. [PMID: 31152475 DOI: 10.1111/liv.14160] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
49 Reiberger T, Mandorfer M. Beta adrenergic blockade and decompensated cirrhosis. J Hepatol. 2017;66:849-859. [PMID: 27864004 DOI: 10.1016/j.jhep.2016.11.001] [Cited by in Crossref: 74] [Cited by in F6Publishing: 53] [Article Influence: 12.3] [Reference Citation Analysis]
50 Mandorfer M, Kozbial K, Schwabl P, Chromy D, Semmler G, Stättermayer AF, Pinter M, Hernández-Gea V, Fritzer-Szekeres M, Steindl-Munda P, Trauner M, Peck-Radosavljevic M, García-Pagán JC, Ferenci P, Reiberger T. Changes in Hepatic Venous Pressure Gradient Predict Hepatic Decompensation in Patients Who Achieved Sustained Virologic Response to Interferon-Free Therapy. Hepatology 2020;71:1023-36. [PMID: 31365764 DOI: 10.1002/hep.30885] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 15.7] [Reference Citation Analysis]
51 Yeh JH, Lo GH, Huang RY, Lin CW, Wang WL, Perng DS. Short-course vasoconstrictors are adequate for esophageal variceal bleeding after endoscopic variceal ligation: A systematic review and meta-analysis. Sci Prog 2021;104:368504211031711. [PMID: 34260315 DOI: 10.1177/00368504211031711] [Reference Citation Analysis]
52 Singh SP, Wadhawan M, Acharya SK, Bopanna S, Madan K, Sahoo MK, Bhat N, Misra SP, Duseja A, Mukund A, Anand AC, Goel A, Satyaprakash BS, Varghese J, Panigrahi MK, Tandan M, Mohapatra MK, Puri P, Rathi PM, Wadhwa RP, Taneja S, Thomas V, Bhatia V; Indian Society of Gastroenterology Task Force on Upper Gastrointestinal Bleeding. Management of portal hypertensive upper gastrointestinal bleeding: Report of the Coorg Consensus workshop of the Indian Society of Gastroenterology Task Force on Upper Gastrointestinal Bleeding. Indian J Gastroenterol 2021. [PMID: 34890020 DOI: 10.1007/s12664-021-01169-5] [Reference Citation Analysis]
53 Sun X, Zhang A, Zhou T, Wang M, Chen Y, Zhou T, Chen X, Xiu A, Peng Z, Cheng B, Liu X, Gao Y. Partial splenic embolization combined with endoscopic therapies and NSBB decreases the variceal rebleeding rate in cirrhosis patients with hypersplenism: a multicenter randomized controlled trial. Hepatol Int 2021;15:741-52. [PMID: 33638769 DOI: 10.1007/s12072-021-10155-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
54 Calès P, Boursier J, Lebigot J, de Ledinghen V, Aubé C, Hubert I, Oberti F. Liver fibrosis diagnosis by blood test and elastography in chronic hepatitis C: agreement or combination? Aliment Pharmacol Ther 2017;45:991-1003. [DOI: 10.1111/apt.13954] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
55 Ardevol A, Alvarado-Tapias E, Garcia-Guix M, Brujats A, Gonzalez L, Hernández-Gea V, Aracil C, Pavel O, Cuyas B, Graupera I, Colomo A, Poca M, Torras X, Concepción M, Villanueva C. Early rebleeding increases mortality of variecal bleeders on secondary prophylaxis with β-blockers and ligation. Dig Liver Dis 2020;52:1017-25. [PMID: 32653417 DOI: 10.1016/j.dld.2020.06.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
56 Buechter M, Kahraman A, Manka P, Gerken G, Dechêne A, Canbay A, Wetter A, Umutlu L, Theysohn JM. Partial spleen embolization reduces the risk of portal hypertension-induced upper gastrointestinal bleeding in patients not eligible for TIPS implantation. PLoS One 2017;12:e0177401. [PMID: 28494001 DOI: 10.1371/journal.pone.0177401] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 2.6] [Reference Citation Analysis]
57 Romano J, Abdelfattah T, Manka PP, Fuchs M, Syn WK. Non-Invasive Risk Stratification in NAFLD/NASH Patients for Screening EGD. Clin Exp Gastroenterol 2022;15:1-3. [PMID: 35046690 DOI: 10.2147/CEG.S339850] [Reference Citation Analysis]
58 Ozdil K, Ozturk O, Calık ES, Akbas ES, Kanat E, Calıskan Z, Demirdag H, Kahraman R, Bulur A, Bilgic NM, Doganay L, Sokmen HM. Relationship between size of varices and platelet count/spleen size ratio in cirrhotic patients. North Clin Istanb 2016;3:46-52. [PMID: 28058385 DOI: 10.14744/nci.2016.60362] [Reference Citation Analysis]
59 Lee DU, Fan GH, Hastie DJ, Addonizio EA, Prakasam VN, Ahern RR, Suh J, Seog KJ, Karagozian R. The clinical impact of cirrhosis on the postoperative outcomes of patients undergoing bariatric surgery: propensity score-matched analysis of 2011-2017 US hospitals. Expert Rev Gastroenterol Hepatol 2021;:1-10. [PMID: 33706616 DOI: 10.1080/17474124.2021.1902803] [Reference Citation Analysis]
60 Abby Philips C, Sahney A. Oesophageal and gastric varices: historical aspects, classification and grading: everything in one place.Gastroenterol Rep (Oxf). 2016;4:186-195. [PMID: 27324725 DOI: 10.1093/gastro/gow018] [Cited by in Crossref: 41] [Cited by in F6Publishing: 22] [Article Influence: 6.8] [Reference Citation Analysis]
61 Fujita K, Masaki T. Serum Biomarkers of Liver Fibrosis Staging in the Era of the Concept "Compensated Advanced Chronic Liver Disease". J Clin Med 2021;10:3340. [PMID: 34362121 DOI: 10.3390/jcm10153340] [Reference Citation Analysis]
62 Fortune BE, Garcia-Tsao G, Ciarleglio M, Deng Y, Fallon MB, Sigal S, Chalasani NP, Lim JK, Reuben A, Vargas HE, Abrams G, Lewis MD, Hassanein T, Trotter JF, Sanyal AJ, Beavers KL, Ganger D, Thuluvath PJ, Grace ND, Groszmann RJ; Vapreotide Study Group. Child-Turcotte-Pugh Class is Best at Stratifying Risk in Variceal Hemorrhage: Analysis of a US Multicenter Prospective Study. J Clin Gastroenterol. 2017;51:446-453. [PMID: 27779613 DOI: 10.1097/mcg.0000000000000733] [Cited by in Crossref: 30] [Cited by in F6Publishing: 12] [Article Influence: 10.0] [Reference Citation Analysis]
63 Abadía M, Montes ML, Ponce D, Froilán C, Romero M, Poza J, Hernández T, Fernández-Martos R, Olveira A, on behalf of the “La Paz Portal Hypertension” Study Group Investigators. Management of betablocked patients after sustained virological response in hepatitis C cirrhosis. World J Gastroenterol 2019; 25(21): 2665-2674 [PMID: 31210717 DOI: 10.3748/wjg.v25.i21.2665] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
64 Chang TS, Tsai YH, Lin YH, Chen CH, Lu CK, Huang WS, Yang YH, Chen WM, Hsieh YY, Wu YC, Tung SY, Huang YH. Limited effects of antibiotic prophylaxis in patients with Child-Pugh class A/B cirrhosis and upper gastrointestinal bleeding. PLoS One 2020;15:e0229101. [PMID: 32084186 DOI: 10.1371/journal.pone.0229101] [Reference Citation Analysis]
65 Intagliata NM, Ferreira CN, Caldwell SH. Anticoagulation for portal vein thrombosis in cirrhosis. Clin Liver Dis (Hoboken) 2016;7:126-31. [PMID: 31041046 DOI: 10.1002/cld.552] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
66 Vidal-González J, Simón-Talero M, Genescà J. Should prophylactic embolization of spontaneous portosystemic shunts be routinely performed during transjugular intrahepatic portosystemic shunt placement? Dig Liver Dis 2018;50:1324-6. [PMID: 30005961 DOI: 10.1016/j.dld.2018.06.013] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
67 Lv Y, Li K, He C, Luo B, Zhang B, Liu H, Wang Z, Guo W, Wang Q, Chen H, Bai W, Yuan X, Yu T, Li X, Yuan J, Han N, Zhu Y, Niu J, Xie H, Wang J, Chen L, Yin Z, Fan D, Li Z, Han G. TIPSS for variceal bleeding in patients with idiopathic non-cirrhotic portal hypertension: comparison with patients who have cirrhosis. Aliment Pharmacol Ther. 2019;49:926-939. [PMID: 30820990 DOI: 10.1111/apt.15186] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
68 Benamouzig R, Guenoun M, Deutsch D, Fauchier L. Review Article: Gastrointestinal Bleeding Risk with Direct Oral Anticoagulants. Cardiovasc Drugs Ther 2021. [PMID: 34143317 DOI: 10.1007/s10557-021-07211-0] [Reference Citation Analysis]
69 Couto I, Victoria M, Veloso VG, Rodrigues L, Grinsztejn B, Lacerda M, Victoria F, Perazzo H. Prevalence and predictors for compensated Advanced Chronic Liver Disease (c-ACLD) in patients with chronic Hepatitis Delta Virus (HDV) infection. PLoS One. 2017;12:e0174453. [PMID: 28329027 DOI: 10.1371/journal.pone.0174453] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
70 Balakrishnan M, Falker C, Conley S, Ciarleglio M, Deng Y, Redeker NS, Garcia-Tsao G. Sleep Disturbance Is Associated With the Presence of Portosystemic Collaterals in Patients With Compensated Cirrhosis. Hepatol Commun 2021;5:491-501. [PMID: 33681681 DOI: 10.1002/hep4.1636] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
71 Drolz A, Ferlitsch A, Fuhrmann V. Management of Coagulopathy during Bleeding and Invasive Procedures in Patients with Liver Failure. Visc Med 2018;34:254-8. [PMID: 30345282 DOI: 10.1159/000491106] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
72 Staugaard B, Christensen PB, Mössner B, Hansen JF, Madsen BS, Søholm J, Krag A, Thiele M. Feasibility of transient elastography versus real-time two-dimensional shear wave elastography in difficult-to-scan patients. Scand J Gastroenterol 2016;51:1354-9. [PMID: 27310486 DOI: 10.1080/00365521.2016.1193217] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
73 Rodrigues S. Baveno VI Recommendation on Avoidance of Screening Endoscopy in Cirrhotic Patients: Not Quite There Yet! GE Port J Gastroenterol 2017;24:58-60. [PMID: 28848784 DOI: 10.1159/000456092] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
74 Maimone S, Saffioti F, Filomia R, Alibrandi A, Isgrò G, Calvaruso V, Xirouchakis E, Guerrini GP, Burroughs AK, Tsochatzis E, Patch D. Predictors of Re-bleeding and Mortality Among Patients with Refractory Variceal Bleeding Undergoing Salvage Transjugular Intrahepatic Portosystemic Shunt (TIPS). Dig Dis Sci 2019;64:1335-45. [PMID: 30560334 DOI: 10.1007/s10620-018-5412-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
75 Yoshiji H, Nagoshi S, Akahane T, Asaoka Y, Ueno Y, Ogawa K, Kawaguchi T, Kurosaki M, Sakaida I, Shimizu M, Taniai M, Terai S, Nishikawa H, Hiasa Y, Hidaka H, Miwa H, Chayama K, Enomoto N, Shimosegawa T, Takehara T, Koike K. Evidence-based clinical practice guidelines for liver cirrhosis 2020. Hepatol Res 2021;51:725-49. [PMID: 34228859 DOI: 10.1111/hepr.13678] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
76 Trivedi PS, Jensen AM, Brown MA, Morgan RL, Lindrooth RC, Ryu RK, Ho PM, Kriss MS. High Prevalence of Transjugular Intrahepatic Portosystemic Shunt Creation Without Prior Endoscopy During Acute Variceal Bleeding Hospitalization in the United States. Hepatol Commun 2021;5:1784-90. [PMID: 34558832 DOI: 10.1002/hep4.1756] [Reference Citation Analysis]
77 Schwabl P, Laleman W. Novel treatment options for portal hypertension. Gastroenterol Rep (Oxf). 2017;5:90-103. [PMID: 28533907 DOI: 10.1093/gastro/gox011] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 3.4] [Reference Citation Analysis]
78 Wang AJ, Zheng XL, Hong JB, Zhong JW, Yu HQ, Zeng HY, Gong Y, Gan N, Wang J, You Y, Guo GH, Xie BS, Li BM, Zhu X. Cap-Assisted Endoscopic Sclerotherapy vs Ligation in the Long-Term Management of Medium Esophageal Varices: A Randomized Trial. Clin Transl Gastroenterol 2020;11:e00285. [PMID: 33512812 DOI: 10.14309/ctg.0000000000000285] [Reference Citation Analysis]
79 Agbim U, Asrani SK. Non-invasive assessment of liver fibrosis and prognosis: an update on serum and elastography markers. Expert Review of Gastroenterology & Hepatology 2019;13:361-74. [DOI: 10.1080/17474124.2019.1579641] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 9.3] [Reference Citation Analysis]
80 Garteiser P, Pagé G, d'Assignies G, Leitao HS, Vilgrain V, Sinkus R, Van Beers BE. Necro-inflammatory activity grading in chronic viral hepatitis with three-dimensional multifrequency MR elastography. Sci Rep 2021;11:19386. [PMID: 34588519 DOI: 10.1038/s41598-021-98726-x] [Reference Citation Analysis]
81 Grgurevic I, Tjesic Drinkovic I, Pinzani M. Multiparametric ultrasound in liver diseases: an overview for the practising clinician. Postgrad Med J 2019;95:425-32. [PMID: 30665903 DOI: 10.1136/postgradmedj-2018-136111] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
82 Eslam M, Sarin SK, Wong VW, Fan JG, Kawaguchi T, Ahn SH, Zheng MH, Shiha G, Yilmaz Y, Gani R, Alam S, Dan YY, Kao JH, Hamid S, Cua IH, Chan WK, Payawal D, Tan SS, Tanwandee T, Adams LA, Kumar M, Omata M, George J. The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease. Hepatol Int. 2020;14:889-919. [PMID: 33006093 DOI: 10.1007/s12072-020-10094-2] [Cited by in Crossref: 61] [Cited by in F6Publishing: 67] [Article Influence: 30.5] [Reference Citation Analysis]
83 Steib CJ, Gerbes AL. Secondary prophylaxis for variceal bleeding: carvedilol vs. propranolol. Hepatol Int 2017;11:141-2. [PMID: 28233256 DOI: 10.1007/s12072-017-9791-4] [Reference Citation Analysis]
84 Kim DH, Cho E, Jun CH, Son DJ, Lee MJ, Park CH, Cho SB, Park SY, Kim HS, Choi SK, Rew JS. Risk Factors and On-site Rescue Treatments for Endoscopic Variceal Ligation Failure. Korean J Gastroenterol. 2018;7:188-196. [PMID: 30419643 DOI: 10.4166/kjg.2018.72.4.188] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
85 Zuckerman MJ, Elhanafi S, Mendoza Ladd A. Endoscopic Treatment of Esophageal Varices. Clin Liver Dis 2022;26:21-37. [PMID: 34802661 DOI: 10.1016/j.cld.2021.08.003] [Reference Citation Analysis]
86 Bangaru S, Benhammou JN, Tabibian JH. Noninvasive scores for the prediction of esophageal varices and risk stratification in patients with cirrhosis. World J Hepatol 2020; 12(11): 908-918 [PMID: 33312418 DOI: 10.4254/wjh.v12.i11.908] [Reference Citation Analysis]
87 Serrao A, Merli M, Lucani B, Aprile F, Fiori L, Gioia S, Breccia M, Riggio O, Chistolini A. Outcomes of long-term anticoagulant treatment for the secondary prophylaxis of splanchnic venous thrombosis. Eur J Clin Invest 2021;51:e13356. [PMID: 33180323 DOI: 10.1111/eci.13356] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
88 Peck-Radosavljevic M, Singal AK. DAAs prevent HCC - the plot thickens. Dig Liver Dis 2019;51:460-1. [PMID: 30827865 DOI: 10.1016/j.dld.2019.01.027] [Reference Citation Analysis]
89 Hussain I, Wong YJ, Lohan R, Lin S, Kumar R. Does preemptive transjugular intrahepatic portosystemic shunt improve survival after acute variceal bleeding? Systematic review, meta-analysis, and trial sequential analysis of randomized trials. J Gastroenterol Hepatol 2021. [PMID: 34665473 DOI: 10.1111/jgh.15714] [Reference Citation Analysis]
90 Sheibani S, Khemichian S, Kim JJ, Hou L, Yan AW, Buxbaum J, Dara L, Laine L. Randomized trial of 1-week versus 2-week intervals for endoscopic ligation in the treatment of patients with esophageal variceal bleeding. Hepatology 2016;64:549-55. [PMID: 27082942 DOI: 10.1002/hep.28597] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
91 Sinha R, Lockman KA, Mallawaarachchi N, Robertson M, Plevris JN, Hayes PC. Carvedilol use is associated with improved survival in patients with liver cirrhosis and ascites. J Hepatol. 2017;67:40-46. [PMID: 28213164 DOI: 10.1016/j.jhep.2017.02.005] [Cited by in Crossref: 44] [Cited by in F6Publishing: 36] [Article Influence: 8.8] [Reference Citation Analysis]
92 Karatzas A, Konstantakis C, Aggeletopoulou I, Kalogeropoulou C, Thomopoulos K, Triantos C. Νon-invasive screening for esophageal varices in patients with liver cirrhosis. Ann Gastroenterol 2018;31:305-14. [PMID: 29720856 DOI: 10.20524/aog.2018.0241] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
93 Kabbani AR, Tergast TL, Manns MP, Maasoumy B. [Treatment strategies for acute-on-chronic liver failure]. Med Klin Intensivmed Notfmed 2021;116:3-16. [PMID: 31463674 DOI: 10.1007/s00063-019-00613-x] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
94 Dajti E, Colecchia A, Brandi N, Golfieri R, Renzulli M. Reply to: Triple-phase CT scan for disease progression prediction in cirrhosis: A valid repurpose? Eur J Radiol 2022;146:110076. [PMID: 34883410 DOI: 10.1016/j.ejrad.2021.110076] [Reference Citation Analysis]
95 Simbrunner B, Marculescu R, Scheiner B, Schwabl P, Bucsics T, Stadlmann A, Bauer DJM, Paternostro R, Eigenbauer E, Pinter M, Stättermayer AF, Trauner M, Mandorfer M, Reiberger T. Non-invasive detection of portal hypertension by enhanced liver fibrosis score in patients with different aetiologies of advanced chronic liver disease. Liver Int 2020;40:1713-24. [PMID: 32358998 DOI: 10.1111/liv.14498] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
96 Intagliata NM, Davitkov P, Allen AM, Falck-Ytter YT, Stine JG. AGA Technical Review on Coagulation in Cirrhosis. Gastroenterology 2021;161:1630-56. [PMID: 34579937 DOI: 10.1053/j.gastro.2021.09.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
97 Chuah YY, Hsu PI, Tsai WL, Yu HC, Tsay FW, Chen WC, Lin KH, Lee YY, Wang HM. Short-term vasoactive agent treatment driven by physicians' preference in acute esophageal variceal bleeding in a tertiary center. PeerJ 2019;7:e7913. [PMID: 31720102 DOI: 10.7717/peerj.7913] [Reference Citation Analysis]
98 Bonifazi F, Barbato F, Ravaioli F, Sessa M, Defrancesco I, Arpinati M, Cavo M, Colecchia A. Diagnosis and Treatment of VOD/SOS After Allogeneic Hematopoietic Stem Cell Transplantation. Front Immunol 2020;11:489. [PMID: 32318059 DOI: 10.3389/fimmu.2020.00489] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
99 Kreisel W, Lazaro A, Trebicka J, Grosse Perdekamp M, Schmitt-Graeff A, Deibert P. Cyclic GMP in Liver Cirrhosis-Role in Pathophysiology of Portal Hypertension and Therapeutic Implications. Int J Mol Sci 2021;22:10372. [PMID: 34638713 DOI: 10.3390/ijms221910372] [Reference Citation Analysis]
100 Xu X, Jin Y, Lin Y, Hu D, Zhou Y, Li D, Wang H, Jin C. Multimodal Ultrasound Model Based on the Left Gastric Vein in B-Viral Cirrhosis: Noninvasive Prediction of Esophageal Varices. Clin Transl Gastroenterol 2020;11:e00262. [PMID: 33259161 DOI: 10.14309/ctg.0000000000000262] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
101 Giuffrè M, Colecchia A, Crocè LS. Elastography: where are we now? Minerva Gastroenterol (Torino) 2021;67:109-11. [PMID: 33103405 DOI: 10.23736/S2724-5985.20.02773-7] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
102 Singh GK, Chauhan SG, Sethiya P, Pandey V. Thrombin or glue - you decide. Endoscopy 2021;53:210. [PMID: 33503671 DOI: 10.1055/a-1233-8902] [Reference Citation Analysis]
103 Vilar-Gomez E, Calzadilla-Bertot L, Wong VW, Castellanos M, Aller-de la Fuente R, Eslam M, Wong GL, George J, Romero-Gomez M, Adams LA. Type 2 Diabetes and Metformin Use Associate With Outcomes of Patients With Nonalcoholic Steatohepatitis-Related, Child-Pugh A Cirrhosis. Clin Gastroenterol Hepatol 2021;19:136-145.e6. [PMID: 32389886 DOI: 10.1016/j.cgh.2020.04.083] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 8.5] [Reference Citation Analysis]
104 Tripathi D, Stanley AJ, Hayes PC, Travis S, Armstrong MJ, Tsochatzis EA, Rowe IA, Roslund N, Ireland H, Lomax M, Leithead JA, Mehrzad H, Aspinall RJ, McDonagh J, Patch D. Transjugular intrahepatic portosystemic stent-shunt in the management of portal hypertension. Gut 2020;69:1173-92. [PMID: 32114503 DOI: 10.1136/gutjnl-2019-320221] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 11.0] [Reference Citation Analysis]
105 Mandorfer M, Reiberger T. Nonselective beta blockers in patients with ascites: implications of a nationwide study. Liver Int 2016;36:1255-7. [DOI: 10.1111/liv.13147] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
106 Fang KC, Su CW, Chiou YY, Lee PC, Chiu NC, Liu CA, Chen PH, Kao WY, Huang YH, Huo TI, Hou MC, Lin HC, Wu JC. The impact of clinically significant portal hypertension on the prognosis of patients with hepatocellular carcinoma after radiofrequency ablation: a propensity score matching analysis. Eur Radiol. 2017;27:2600-2609. [PMID: 27678133 DOI: 10.1007/s00330-016-4604-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
107 Scheiner B, Parada-Rodriguez D, Bucsics T, Schwabl P, Mandorfer M, Pfisterer N, Riedl F, Sieghart W, Ferlitsch A, Trauner M, Peck-Radosavljevic M, Reiberger T. Non-selective beta-blocker treatment does not impact on kidney function in cirrhotic patients with varices. Scand J Gastroenterol 2017;52:1008-15. [PMID: 28532189 DOI: 10.1080/00365521.2017.1329456] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
108 Dajti E, Renzulli M, Colecchia A, Bacchi-Reggiani ML, Milandri M, Rossini B, Ravaioli F, Marasco G, Alemanni LV, Ierardi AM, Carrafiello G, Pinzani M, Azzaroli F, Mazzella G, Golfieri R, Festi D. Size and location of spontaneous portosystemic shunts predict the risk of decompensation in cirrhotic patients. Dig Liver Dis 2022;54:103-10. [PMID: 33414086 DOI: 10.1016/j.dld.2020.12.114] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
109 Hasbaoui BE, Rifai Z, Saghir S, Ayad A, Lamalmi N, Abilkassem R, Agadr A. Congenital hepatic fibrosis: case report and review of literature. Pan Afr Med J 2021;38:188. [PMID: 33995794 DOI: 10.11604/pamj.2021.38.188.27941] [Reference Citation Analysis]
110 Pons M, Augustin S, Scheiner B, Guillaume M, Rosselli M, Rodrigues SG, Stefanescu H, Ma MM, Mandorfer M, Mergeay-Fabre M, Procopet B, Schwabl P, Ferlitsch A, Semmler G, Berzigotti A, Tsochatzis E, Bureau C, Reiberger T, Bosch J, Abraldes JG, Genescà J. Noninvasive Diagnosis of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease. Am J Gastroenterol 2021;116:723-32. [PMID: 33982942 DOI: 10.14309/ajg.0000000000000994] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
111 Masetti C, Lleo A, Colombo M, Colombo M, Aghemo A. Postsustained Virological Response Management in Hepatitis C Patients. Semin Liver Dis 2020;40:233-9. [PMID: 32107758 DOI: 10.1055/s-0040-1702944] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
112 Petrisor A, Peagu R, Badiu DC, Stanescu AMA, Moldoveanu AC, Fierbinteanu -Braticevici C. Can Non-Invasive Methods Be Clinically Useful for Diagnosis and Severity of Portal Hypertension? Hepat Mon 2020;20. [DOI: 10.5812/hepatmon.99974] [Reference Citation Analysis]
113 Laine L. Treatment of thrombocytopenic patients with GI bleeding. Gastrointestinal Endoscopy 2018;88:62-5. [DOI: 10.1016/j.gie.2018.03.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
114 Thiele M, Hugger MB, Kim Y, Rautou PE, Elkrief L, Jansen C, Verlinden W, Allegretti G, Israelsen M, Stefanescu H, Piscaglia F, García-Pagán JC, Franque S, Berzigotti A, Castera L, Jeong WK, Trebicka J, Krag A. 2D shear wave liver elastography by Aixplorer to detect portal hypertension in cirrhosis: An individual patient data meta-analysis. Liver Int 2020;40:1435-46. [PMID: 32180327 DOI: 10.1111/liv.14439] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
115 Hu Y, Wen Z. Validation and comparison of non-invasive prediction models based on liver stiffness measurement to identify patients who could avoid gastroscopy. Sci Rep 2021;11:150. [PMID: 33420233 DOI: 10.1038/s41598-020-80136-0] [Reference Citation Analysis]
116 Giri S. The need of HVPG-guided beta-blocker therapy for NASH cirrhosis with varices - Answer is still up in the air. Dig Liver Dis 2021:S1590-8658(21)00885-9. [PMID: 34916144 DOI: 10.1016/j.dld.2021.11.019] [Reference Citation Analysis]
117 Grgurevic I, Podrug K, Mikolasevic I, Kukla M, Madir A, Tsochatzis EA. Natural History of Nonalcoholic Fatty Liver Disease: Implications for Clinical Practice and an Individualized Approach. Can J Gastroenterol Hepatol 2020;2020:9181368. [PMID: 32051820 DOI: 10.1155/2020/9181368] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
118 Vipani A, Lindenmeyer CC, Sundaram V. Treatment of Severe Acute on Chronic Liver Failure: Management of Organ Failures, Investigational Therapeutics, and the Role of Liver Transplantation. J Clin Gastroenterol 2021;55:667-76. [PMID: 34028394 DOI: 10.1097/MCG.0000000000001568] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
119 Protopapas AA, Mylopoulou T, Papadopoulos VP, Vogiatzi K, Goulis I, Mimidis K. Validating and expanding the Baveno VI criteria for esophageal varices in patients with advanced liver disease: a multicenter study. Ann Gastroenterol. 2020;33:87-94. [PMID: 31892803 DOI: 10.20524/aog.2019.0429] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
120 Tseng Y, Ma L, Luo T, Zeng X, Li F, Li N, Wei Y, Chen S. Patient Response to Endoscopic Therapy for Gastroesophageal Varices Based on Endoscopic Ultrasound Findings. Gut Liver 2018;12:562-70. [PMID: 29699062 DOI: 10.5009/gnl17471] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
121 Korean Association for the Study of the Liver (KASL). KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy, and related complications. Clin Mol Hepatol 2020;26:83-127. [PMID: 31918536 DOI: 10.3350/cmh.2019.0010n] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
122 Cremonese C, Schierwagen R, Uschner FE, Torres S, Tyc O, Ortiz C, Schulz M, Queck A, Kristiansen G, Bader M, Sauerbruch T, Weiskirchen R, Walther T, Trebicka J, Klein S. Short-Term Western Diet Aggravates Non-Alcoholic Fatty Liver Disease (NAFLD) With Portal Hypertension in TGR(mREN2)27 Rats. Int J Mol Sci 2020;21:E3308. [PMID: 32392802 DOI: 10.3390/ijms21093308] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
123 Sun Y, Shen Z, Zhan Y, Wang Y, Ma S, Zhang S, Liu J, Wu S, Feng Y, Chen Y, Cai S, Shi Y, Ma L, Jiang Y. Investigation of optimal gestational weight gain based on the occurrence of adverse pregnancy outcomes for Chinese women: a prospective cohort study. Reprod Biol Endocrinol 2021;19:130. [PMID: 34461936 DOI: 10.1186/s12958-021-00797-y] [Reference Citation Analysis]
124 Merchante N, Saroli Palumbo C, Mazzola G, Pineda JA, Téllez F, Rivero-Juárez A, Ríos-Villegas MJ, Maurice JB, Westbrook RH, Judge R, Guaraldi G, Schepis F, Perazzo H, Rockstroh J, Boesecke C, Klein MB, Cervo A, Ghali P, Wong P, Petta S, De Ledinghen V, Macías J, Sebastiani G. Prediction of Esophageal Varices by Liver Stiffness and Platelets in Persons With Human Immunodeficiency Virus Infection and Compensated Advanced Chronic Liver Disease. Clin Infect Dis 2020;71:2810-7. [PMID: 31813962 DOI: 10.1093/cid/ciz1181] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
125 Zhao W, Xue N, Cui P, Liu L, Wang Y, Zhang X, Tang Y, Du H, Nan Y. Plasma YAP1 predicts esophageal varices and the risk of variceal bleeding in liver cirrhosis. Biomark Med 2021;15:1411-22. [PMID: 34533050 DOI: 10.2217/bmm-2020-0573] [Reference Citation Analysis]
126 Kong Y, Shi L. Comparison of the effectiveness of 11 mainstay treatments for secondary prophylaxis of variceal bleeding in patients with cirrhosis: A network meta-analysis. Exp Ther Med 2020;19:3479-96. [PMID: 32346409 DOI: 10.3892/etm.2020.8633] [Reference Citation Analysis]
127 Stine JG, Northup PG. Management of Non-tumoral Portal Vein Thrombosis in Patients with Cirrhosis. Dig Dis Sci 2019;64:619-26. [PMID: 30560339 DOI: 10.1007/s10620-018-5427-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
128 Ma L, Huang X, Lian J, Wang J, Chen S. Transparent cap-assisted endoscopic sclerotherapy in esophageal varices: a randomized-controlled trial. Eur J Gastroenterol Hepatol. 2018;30:626-630. [PMID: 29505477 DOI: 10.1097/meg.0000000000001107] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
129 Manrai M, Dawra S, Kapoor R, Srivastava S, Singh A. Anemia in cirrhosis: An underestimated entity. World J Clin Cases 2022; 10(3): 777-789 [DOI: 10.12998/wjcc.v10.i3.777] [Reference Citation Analysis]
130 Lamb C, Stanley AJ. Editorial: acute gastrointestinal bleeding – proposed new study outcomes. Aliment Pharmacol Ther 2021;54:715-6. [DOI: 10.1111/apt.16517] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
131 Kozek-langenecker SA, Ahmed AB, Afshari A, Albaladejo P, Aldecoa C, Barauskas G, De Robertis E, Faraoni D, Filipescu DC, Fries D, Haas T, Jacob M, Lancé MD, Pitarch JV, Mallett S, Meier J, Molnar ZL, Rahe-meyer N, Samama CM, Stensballe J, Van der Linden PJ, Wikkelsø AJ, Wouters P, Wyffels P, Zacharowski K. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology First update 2016. European Journal of Anaesthesiology 2017;34:332-95. [DOI: 10.1097/eja.0000000000000630] [Cited by in Crossref: 344] [Cited by in F6Publishing: 80] [Article Influence: 68.8] [Reference Citation Analysis]
132 Ueno M, Kayahara T, Sunami T, Takayama H, Takabatake H, Morimoto Y, Yamamoto H, Mizuno M. Universal antibiotic prophylaxis may no longer be necessary for patients with acute variceal bleeding: A retrospective observational study. Medicine (Baltimore) 2020;99:e19981. [PMID: 32443300 DOI: 10.1097/MD.0000000000019981] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
133 Schneider MD, Sarrazin C. Management of HCV-Associated Liver Cirrhosis. Visc Med 2016;32:96-104. [PMID: 27413726 DOI: 10.1159/000445330] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
134 Grimaudo S, Pipitone RM, Pennisi G, Celsa C, Cammà C, Di Marco V, Barcellona MR, Boemi R, Enea M, Giannetti A, Spatola F, Marchesini G, Craxì A, Petta S. Association Between PNPLA3 rs738409 C>G Variant and Liver-Related Outcomes in Patients With Nonalcoholic Fatty Liver Disease. Clin Gastroenterol Hepatol 2020;18:935-944.e3. [PMID: 31419571 DOI: 10.1016/j.cgh.2019.08.011] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 11.7] [Reference Citation Analysis]
135 Zhou J, Liu C, Ma L, Chen J, Luo T, Li F, Wang J, Zeng X, Chen S. Complications and management of elective endoscopic cyanoacrylate injection with lauromacrogol for gastric varices. Eur J Gastroenterol Hepatol 2021;33:680-5. [PMID: 33731585 DOI: 10.1097/MEG.0000000000002099] [Reference Citation Analysis]
136 Gómez-Centurión I, Bailén R, Oarbeascoa G, Muñoz C, Luque AÁ, Boyra ME, Calleja E, Rincón D, Dorado N, Barzallo P, Anguita J, Díez-Martín JL, Kwon M. Transjugular Intrahepatic Portosystemic Shunt for Very Severe Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) after Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation with Post-transplantation Cyclophosphamide. Biol Blood Marrow Transplant 2020;26:2089-97. [PMID: 32791193 DOI: 10.1016/j.bbmt.2020.08.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
137 Horvatits T, Drolz A, Roedl K, Rutter K, Ferlitsch A, Fauler G, Trauner M, Fuhrmann V. Serum bile acids as marker for acute decompensation and acute-on-chronic liver failure in patients with non-cholestatic cirrhosis. Liver Int 2017;37:224-31. [DOI: 10.1111/liv.13201] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
138 Ishida K, Namisaki T, Murata K, Fujimoto Y, Takeda S, Enomoto M, Ogawa H, Takagi H, Tsuji Y, Kaya D, Fujinaga Y, Furukawa M, Sawada Y, Kitagawa K, Sato S, Nishimura N, Takaya H, Kaji K, Shimozato N, Kawaratani H, Moriya K, Akahane T, Mitoro A, Yoshiji H. Accuracy of Fibrosis-4 Index in Identification of Patients with Cirrhosis Who Could Potentially Avoid Variceal Screening Endoscopy. J Clin Med 2020;9:E3510. [PMID: 33138335 DOI: 10.3390/jcm9113510] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
139 Chen WC, Hsin IF, Chen PH, Hsu PI, Wang YP, Cheng JS, Lin HS, Hou MC, Lee FY. Addition of Carvedilol to Gastric Variceal Obturation Does Not Decrease Recurrence of Gastric Variceal Bleeding in Patients With Cirrhosis.Clin Gastroenterol Hepatol. 2019;17:2356-2363. [PMID: 30772583 DOI: 10.1016/j.cgh.2019.02.021] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
140 Mandorfer M, Kozbial K, Peck-radosavljevic M, Ferenci P. Letter: can persisting liver stiffness indicate increased risk for HCC, after successful anti-HCV therapy? - authors’ reply. Aliment Pharmacol Ther 2016;43:544-5. [DOI: 10.1111/apt.13494] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
141 Ghazaleh S, Beran A, Aburayyan K, Nehme C, Patel D, Khader Y, Sharma S, Aziz M, Abdel-Aziz Y, Hammad T, Nawras A. Efficacy and safety of anticoagulation in non-malignant portal vein thrombosis in patients with liver cirrhosis: a systematic review and meta-analysis. Ann Gastroenterol 2021;34:104-10. [PMID: 33414629 DOI: 10.20524/aog.2020.0544] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
142 Lee HA, Kim SU, Seo YS, Lee Y, Kang SH, Jung YK, Kim MY, Kim JH, Kim SG, Suk KT, Jung SW, Jang JY, An H, Yim HJ, Um SH. Prediction of the varices needing treatment with non‐invasive tests in patients with compensated advanced chronic liver disease. Liver Int 2019;39:1071-9. [DOI: 10.1111/liv.14036] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
143 Kothari HG, Gupta SJ, Gaikwad NR, Sankalecha TH, Samarth AR. Role of non-invasive markers in prediction of esophageal varices and variceal bleeding in patients of alcoholic liver cirrhosis from central India. Turk J Gastroenterol 2019;30:1036-43. [PMID: 31854309 DOI: 10.5152/tjg.2019.18334] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
144 Riva N, Ageno W. Approach to thrombosis at unusual sites: Splanchnic and cerebral vein thrombosis. Vasc Med 2017;22:529-40. [PMID: 29202678 DOI: 10.1177/1358863X17734057] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 1.6] [Reference Citation Analysis]
145 Jansen C, Bogs C, Krag A, Francque S, Trebicka J. Sequential shear-wave elastography of liver and spleen rules out clinically significant portal hypertension in compensated advanced chronic liver disease. Gut 2017;66:558-9. [PMID: 27196577 DOI: 10.1136/gutjnl-2016-311955] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
146 Ferrarese A, Passigato N, Cusumano C, Gemini S, Tonon A, Dajti E, Marasco G, Ravaioli F, Colecchia A. Antibiotic prophylaxis in patients with cirrhosis: Current evidence for clinical practice. World J Hepatol 2021; 13(8): 840-852 [PMID: 34552691 DOI: 10.4254/wjh.v13.i8.840] [Reference Citation Analysis]
147 Wakabayashi SI, Joshita S, Kimura K, Motoki H, Kobayashi H, Yamashita Y, Sugiura A, Yamazaki T, Kuwahara K, Umemura T. Protocol: Prospective observational study investigating the prevalence and clinical outcome of portopulmonary hypertension in Japanese patients with chronic liver disease. PLoS One 2021;16:e0249435. [PMID: 33793649 DOI: 10.1371/journal.pone.0249435] [Reference Citation Analysis]
148 Kerbert AJ, Chiang FW, van der Werf M, Stijnen T, Slingerland H, Verspaget HW, van Hoek B, Coenraad MJ. Hemodynamic response to primary prophylactic therapy with nonselective β-blockers is related to a reduction of first variceal bleeding risk in liver cirrhosis: a meta-analysis. Eur J Gastroenterol Hepatol 2017;29:380-7. [PMID: 28002118 DOI: 10.1097/MEG.0000000000000812] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
149 Rasmussen DN, Thiele M, Johansen S, Kjærgaard M, Lindvig KP, Israelsen M, Antonsen S, Detlefsen S, Krag A; GALAXY., MicrobLiver consortia. Prognostic performance of 7 biomarkers compared to liver biopsy in early alcohol-related liver disease. J Hepatol 2021:S0168-8278(21)00411-6. [PMID: 34118335 DOI: 10.1016/j.jhep.2021.05.037] [Reference Citation Analysis]
150 Pfisterer N, Riedl F, Pachofszky T, Gschwantler M, König K, Schuster B, Mandorfer M, Gessl I, Illiasch C, Fuchs EM, Unger L, Dolak W, Maieron A, Kramer L, Madl C, Trauner M, Reiberger T. Outcomes after placement of a SX-ELLA oesophageal stent for refractory variceal bleeding-A national multicentre study. Liver Int 2019;39:290-8. [PMID: 30248224 DOI: 10.1111/liv.13971] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
151 Furuichi Y, Abe M, Kasai Y, Takeuchi H, Yoshimasu Y, Itoi T. Secure intravariceal sclerotherapy with red dichromatic imaging decreases the recurrence rate of esophageal varices: A propensity score matching analysis. J Hepatobiliary Pancreat Sci 2021;28:431-42. [PMID: 33453078 DOI: 10.1002/jhbp.894] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
152 Zaccherini G, Tufoni M, Iannone G, Caraceni P. Management of Ascites in Patients with Cirrhosis: An Update. J Clin Med 2021;10:5226. [PMID: 34830508 DOI: 10.3390/jcm10225226] [Reference Citation Analysis]
153 Reichert MC, Ripoll C, Casper M, Greinert R, Vandieken E, Grünhage F, Appenrodt B, Zipprich A, Lammert F. Common NOD2 Risk Variants as Major Susceptibility Factors for Bacterial Infections in Compensated Cirrhosis. Clin Transl Gastroenterol 2019;10:e00002. [PMID: 30702490 DOI: 10.14309/ctg.0000000000000002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
154 Subedi A, Suresh Kumar VC, Sharma Subedi A, Sapkota B. A Review of Hepatorenal Syndrome. Cureus 2021;13:e16084. [PMID: 34367745 DOI: 10.7759/cureus.16084] [Reference Citation Analysis]
155 Zanetto A, Shalaby S, Feltracco P, Gambato M, Germani G, Russo FP, Burra P, Senzolo M. Recent Advances in the Management of Acute Variceal Hemorrhage. J Clin Med 2021;10:3818. [PMID: 34501265 DOI: 10.3390/jcm10173818] [Reference Citation Analysis]
156 Turco L, Schepis F, Villa E. The Role of Anticoagulation in Treating Portal Hypertension. Curr Hepatol Rep 2018;17:200-8. [PMID: 30546994 DOI: 10.1007/s11901-018-0406-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
157 Attia D, Rodt T, Marquardt S, Hinrichs J, Meyer BC, Gebel M, Wacker F, Manns MP, Potthoff A. Shear wave elastography prior to transjugular intrahepatic portosystemic shunt may predict the decrease in hepatic vein pressure gradient. Abdom Radiol 2019;44:1127-34. [DOI: 10.1007/s00261-018-1795-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
158 Møller S, Kimer N, Barløse M, Bendtsen F. Pathophysiological-based treatments of complications of cirrhosis. Scand J Gastroenterol 2020;55:383-94. [PMID: 32233873 DOI: 10.1080/00365521.2020.1744709] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
159 Eriksen PL, Hartkopf-Mikkelsen AL, Ott P, Vilstrup H, Aagaard NK. Terlipressin for variceal bleeding induces large plasma sodium fluctuations in patients without cirrhosis. United European Gastroenterol J 2018;6:1199-205. [PMID: 30288282 DOI: 10.1177/2050640618781205] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
160 Lee PC, Chen YJ, Chou YC, Lee KC, Chen PH, Kao WY, Huang YH, Huo TI, Lin HC, Hou MC, Lee FY, Wu JC, Su CW. Low dose of propranolol treatment is associated with better survival in cirrhotic patients with hepatic encephalopathy. Eur J Gastroenterol Hepatol 2020;32:365-72. [PMID: 31688303 DOI: 10.1097/MEG.0000000000001511] [Reference Citation Analysis]
161 Piyachaturawat P, Siramolpiwat S, Sonsiri K, Tangkijvanich P, Treeprasertsuk S. Changes in transient elastography in early cirrhotic patients after receiving nonselective B-blocker for primary variceal bleeding prophylaxis: Three-month follow up. JGH Open 2018;2:172-7. [PMID: 30483585 DOI: 10.1002/jgh3.12063] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
162 Beer L, Bastati N, Ba-Ssalamah A, Pötter-Lang S, Lampichler K, Bican Y, Lauber D, Hodge J, Binter T, Pomej K, Simbrunner B, Semmler G, Trauner M, Mandorfer M, Reiberger T. MRI-defined sarcopenia predicts mortality in patients with chronic liver disease. Liver Int 2020;40:2797-807. [PMID: 32816394 DOI: 10.1111/liv.14648] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
163 Giudicelli H, Rautou PE, Paradis V, Bedossa P, Goria O, Lambert V, Hernandez-Gea V, Dutheil D, Plessier A, Bureau C, Valla D. Porto-sinusoidal vascular disease. Vascular liver diseases: Position papers from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and ERN-rare liver. Clin Res Hepatol Gastroenterol 2020;44:447-51. [PMID: 32335045 DOI: 10.1016/j.clinre.2020.03.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
164 Praktiknjo M, Abu-Omar J, Chang J, Thomas D, Jansen C, Kupczyk P, Schepis F, Garcia-Pagan JC, Merli M, Meyer C, Strassburg CP, Pieper CC, Trebicka J. Controlled underdilation using novel VIATORR® controlled expansion stents improves survival after transjugular intrahepatic portosystemic shunt implantation. JHEP Rep 2021;3:100264. [PMID: 34013182 DOI: 10.1016/j.jhepr.2021.100264] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
165 Kamal A, Abd Elmoety AA, Hamza Y, Zeid A. Endoscopic Variceal Ligation followed by Argon Plasma Coagulation Against Endoscopic Variceal Ligation Alone: A Randomized Controlled Trial. J Clin Gastroenterol. 2017;51:49-55. [PMID: 27136962 DOI: 10.1097/mcg.0000000000000535] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
166 Rodrigues SG, Maurer MH, Baumgartner I, De Gottardi A, Berzigotti A. Imaging and minimally invasive endovascular therapy in the management of portal vein thrombosis. Abdom Radiol (NY). 2018;43:1931-1946. [PMID: 28983654 DOI: 10.1007/s00261-017-1335-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
167 Aller R, Fernández-Rodríguez C, Lo Iacono O, Bañares R, Abad J, Carrión JA, García-Monzón C, Caballería J, Berenguer M, Rodríguez-Perálvarez M, Miranda JL, Vilar-Gómez E, Crespo J, García-Cortés M, Reig M, Navarro JM, Gallego R, Genescà J, Arias-Loste MT, Pareja MJ, Albillos A, Muntané J, Jorquera F, Solà E, Hernández-Guerra M, Rojo MÁ, Salmerón J, Caballería L, Diago M, Molina E, Bataller R, Romero-Gómez M. Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline. Gastroenterol Hepatol 2018;41:328-49. [PMID: 29631866 DOI: 10.1016/j.gastrohep.2017.12.003] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 5.8] [Reference Citation Analysis]
168 Njei B, McCarty TR, Laine L. Early transjugular intrahepatic portosystemic shunt in US patients hospitalized with acute esophageal variceal bleeding. J Gastroenterol Hepatol 2017;32:852-8. [PMID: 27624167 DOI: 10.1111/jgh.13593] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 5.6] [Reference Citation Analysis]
169 Shao R, Li Z, Wang J, Qi R, Liu Q, Zhang W, Mao X, Song X, Li L, Liu Y, Zhao X, Liu C, Li X, Zuo C, Wang W, Qi X. Hepatic venous pressure gradient-guided laparoscopic splenectomy and pericardial devascularisation versus endoscopic therapy for secondary prophylaxis for variceal rebleeding in portal hypertension (CHESS1803): study protocol of a multicenter randomised controlled trial in China. BMJ Open 2020;10:e030960. [PMID: 32580978 DOI: 10.1136/bmjopen-2019-030960] [Reference Citation Analysis]
170 Thiruvengadam SS, Sedarat A. The Role of Endoscopic Ultrasound (EUS) in the Management of Gastric Varices. Curr Gastroenterol Rep 2021;23:1. [PMID: 33389241 DOI: 10.1007/s11894-020-00801-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
171 Siddiqui MS, Harrison SA, Abdelmalek MF, Anstee QM, Bedossa P, Castera L, Dimick-Santos L, Friedman SL, Greene K, Kleiner DE, Megnien S, Neuschwander-Tetri BA, Ratziu V, Schabel E, Miller V, Sanyal AJ; Liver Forum Case Definitions Working Group. Case definitions for inclusion and analysis of endpoints in clinical trials for nonalcoholic steatohepatitis through the lens of regulatory science. Hepatology 2018;67:2001-12. [PMID: 29059456 DOI: 10.1002/hep.29607] [Cited by in Crossref: 63] [Cited by in F6Publishing: 64] [Article Influence: 15.8] [Reference Citation Analysis]
172 Tosetti G, Primignani M, La Mura V, D'Ambrosio R, Degasperi E, Mezzina N, Viganò M, Rumi M, Fracanzani AL, Lombardi R, Fargion S, Fraquelli M, Aghemo A, Lampertico P. Evaluation of three "beyond Baveno VI" criteria to safely spare endoscopies in compensated advanced chronic liver disease. Dig Liver Dis 2019;51:1135-40. [PMID: 30691777 DOI: 10.1016/j.dld.2018.12.025] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 4.7] [Reference Citation Analysis]
173 Loffroy R. Transjugular intrahepatic portosystemic shunt (TIPS): A major step forward for patients but a growing job for interventional radiologists! Diagnostic and Interventional Imaging 2016;97:1069-70. [DOI: 10.1016/j.diii.2016.10.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
174 Sartoris R, Calandra A, Lee KJ, Gauss T, Vilgrain V, Ronot M. Quantification of Pancreas Surface Lobularity on CT: A Feasibility Study in the Normal Pancreas. Korean J Radiol 2021;22:1300-9. [PMID: 33938646 DOI: 10.3348/kjr.2020.1049] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
175 Mallet M, Rudler M, Thabut D. Variceal bleeding in cirrhotic patients. Gastroenterol Rep (Oxf). 2017;5:185-192. [PMID: 28852523 DOI: 10.1093/gastro/gox024] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 3.6] [Reference Citation Analysis]
176 Laine L. Is there a role for combined sclerotherapy and ligation in the endoscopic treatment of gastroesophageal varices? Gastrointest Endosc 2017;86:316-8. [PMID: 28728669 DOI: 10.1016/j.gie.2017.02.005] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
177 Voiosu AM, Wiese S, Goetze JP, Hartmann O, Voiosu T, Santos K, Møller S. Dipeptidyl peptidase-3 is associated with severity of liver disease and circulatory complications in patients with cirrhosis. Biomarkers 2021;:1-12. [PMID: 34964404 DOI: 10.1080/1354750X.2021.2024599] [Reference Citation Analysis]
178 Kang SH, Lee M, Kim MY, Lee JH, Jun BG, Kim TS, Choi DH, Suk KT, Kim YD, Cheon GJ, Kim DJ, Baik SK. The longitudinal outcomes of applying non-selective beta-blockers in portal hypertension: real-world multicenter study. Hepatol Int 2021;15:424-36. [PMID: 33860898 DOI: 10.1007/s12072-021-10160-3] [Reference Citation Analysis]
179 Dunne PDJ, Sinha R, Stanley AJ, Lachlan N, Ireland H, Shams A, Kasthuri R, Forrest EH, Hayes PC. Randomised clinical trial: standard of care versus early-transjugular intrahepatic porto-systemic shunt (TIPSS) in patients with cirrhosis and oesophageal variceal bleeding. Aliment Pharmacol Ther. 2020;52:98-106. [PMID: 31153882 DOI: 10.1016/s2468-1253(19)30090-1] [Cited by in Crossref: 47] [Cited by in F6Publishing: 16] [Article Influence: 15.7] [Reference Citation Analysis]
180 Tejedor-Tejada J, Fuentes-Valenzuela E, García-Pajares F, Nájera-Muñoz R, Almohalla-Álvarez C, Sánchez-Martín F, Calero-Aguilar H, Villacastín-Ruiz E, Pintado-Garrido R, Sánchez-Antolín G. Long-term clinical outcome and survival predictors in patients with cirrhosis after 10-mm-covered transjugular intrahepatic portosystemic shunt. Gastroenterol Hepatol 2021;44:620-7. [PMID: 33249114 DOI: 10.1016/j.gastrohep.2020.10.018] [Reference Citation Analysis]
181 Mandorfer M, Schwabl P, Steiner S, Scheiner B, Chromy D, Bucsics T, Stättermayer AF, Aichelburg MC, Grabmeier-Pfistershammer K, Trauner M, Reiberger T, Peck-Radosavljevic M. Interferon-free treatment with sofosbuvir/daclatasvir achieves sustained virologic response in 100% of HIV/hepatitis C virus-coinfected patients with advanced liver disease. AIDS 2016;30:1039-47. [PMID: 26760453 DOI: 10.1097/QAD.0000000000001020] [Cited by in Crossref: 31] [Cited by in F6Publishing: 16] [Article Influence: 5.2] [Reference Citation Analysis]
182 Guillaume M, Bureau C. Should the Presence of Spontaneous Portosystemic Shunts Be Implemented to the Model for End-Stage Liver Disease Score for a Better Prediction of Outcome? Gastroenterology 2018;154:1569-71. [DOI: 10.1053/j.gastro.2018.03.035] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
183 Kapuria D, Bollipo S, Rabiee A, Ben-Yakov G, Kumar G, Siau K, Lee HW, Congly S, Turnes J, Dhanasekaran R, Lui RN; Global Online Alliance for Liver Studies (GOAL). Roadmap to resuming care for liver diseases after coronavirus disease-2019. J Gastroenterol Hepatol 2021;36:885-92. [PMID: 32656794 DOI: 10.1111/jgh.15178] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
184 An Y, Xu X, Ren T, Tong Z, Romeiro FG, Mancuso A, Guo X, Qi X. Adherence to Non-Selective Beta Blockers for Prevention of Variceal Bleeding in Cirrhotic Patients. Int J Gen Med 2021;14:6713-24. [PMID: 34675632 DOI: 10.2147/IJGM.S326192] [Reference Citation Analysis]
185 Wiest R, Albillos A, Trauner M, Bajaj JS, Jalan R. Targeting the gut-liver axis in liver disease. J Hepatol. 2017;67:1084-1103. [PMID: 28526488 DOI: 10.1016/j.jhep.2017.05.007] [Cited by in Crossref: 163] [Cited by in F6Publishing: 151] [Article Influence: 32.6] [Reference Citation Analysis]
186 Uojima H, Murakami S, Nakatani S, Hidaka H, Takeuchi A, Tanaka Y, Inoue T, Yamane K, Kubota K, Nakazawa T, Shibuya A, Tanaka Y, Koizumi W. Late Relapse after a Sustained Virologic Response at 24 Weeks after Treatment with Daclatasvir and Asunaprevir Combination Therapy for Chronic Hepatitis C Virus Genotype 1b Infection with Liver Cirrhosis. Intern Med 2018;57:951-6. [PMID: 29225269 DOI: 10.2169/internalmedicine.9671-17] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
187 Koc ÖM, Robaeys G, Topal H, Bielen R, Busschots D, Fevery J, Koek GH, Nevens F. Outcome in Caucasian patients with hepatitis B e antigen negative chronic infection: A long-term observational cohort study. J Med Virol 2020. [PMID: 32343427 DOI: 10.1002/jmv.25950] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
188 Rössle M, Bettinger D, Schultheiss M. The Transjugular Intrahepatic Portosystemic Shunt Improves Survival in Patients with Acute Variceal Bleeding: Evidence beyond Randomized Controlled Trials. J Vasc Interv Radiol 2020;31:1392-3. [PMID: 32868014 DOI: 10.1016/j.jvir.2020.07.001] [Reference Citation Analysis]
189 Ishikawa T, Hamamoto K, Sasaki R, Nishimura T, Matsuda T, Iwamoto T, Takami T, Sakaida I. Significant improvement in portal‐systemic liver failure symptoms and successful management of portal‐splenic venous hemodynamics by the combination of interventional radiology and pharmacotherapy. Hepatol Res 2020;50:1201-8. [DOI: 10.1111/hepr.13545] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
190 Karlas T, Blank V, Böhlig A. Diagnostic Value of Ultrasound in Fatty Liver Disease. Ultraschall Med 2021;42:128-53. [PMID: 33622003 DOI: 10.1055/a-1352-4313] [Reference Citation Analysis]
191 Balcar L, Semmler G, Pomej K, Simbrunner B, Bauer D, Hartl L, Jachs M, Paternostro R, Bucsics T, Pinter M, Trauner M, Mandorfer M, Reiberger T, Scheiner B. Patterns of acute decompensation in hospitalized patients with cirrhosis and course of acute-on-chronic liver failure. United European Gastroenterol J 2021;9:427-37. [PMID: 34050619 DOI: 10.1002/ueg2.12089] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
192 Martínez-Campreciós J, Pons M, Genescà J. Beyond Baveno VI: How far are we? Dig Liver Dis 2019;51:1141-3. [PMID: 31345765 DOI: 10.1016/j.dld.2019.06.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
193 Chang PE, Tan CK, Cheah CC, Li W, Chow WC, Wong YJ. Validation of the Expanded Baveno-VI Criteria for Screening Gastroscopy in Asian Patients with Compensated Advanced Chronic Liver Disease. Dig Dis Sci 2021;66:1343-8. [PMID: 32440746 DOI: 10.1007/s10620-020-06334-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
194 Henry ZH, Caldwell SH. Management of bleeding ectopic varices. Techniques in Gastrointestinal Endoscopy 2017;19:101-7. [DOI: 10.1016/j.tgie.2017.03.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.4] [Reference Citation Analysis]
195 Moctezuma-Velazquez C, Saffioti F, Tasayco-Huaman S, Casu S, Mason A, Roccarina D, Vargas V, Nilsson JE, Tsochatzis E, Augustin S, Montano-Loza AJ, Berzigotti A, Thorburn D, Genesca J, Abraldes JG. Non-Invasive Prediction of High-Risk Varices in Patients with Primary Biliary Cholangitis and Primary Sclerosing Cholangitis. Am J Gastroenterol. 2019;114:446-452. [PMID: 30315285 DOI: 10.1038/s41395-018-0265-7] [Cited by in Crossref: 32] [Cited by in F6Publishing: 22] [Article Influence: 10.7] [Reference Citation Analysis]
196 Garcia Garcia de Paredes A, Manicardi N, Tellez L, Ibañez L, Royo F, Bermejo J, Blanco C, Fondevila C, Fernandez Lanza V, Garcia-Bermejo L, Falcon-Perez JM, Bañares R, Gracia-Sancho J, Albillos A. Molecular Profiling of Decompensated Cirrhosis by a Novel MicroRNA Signature. Hepatol Commun 2021;5:309-22. [PMID: 33553977 DOI: 10.1002/hep4.1642] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
197 Oh JH, Goh MJ, Park Y, Kim J, Kang W, Sinn DH, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Paik YH. Different Performance of Liver Stiffness Measurement According to Etiology and Outcome for the Prediction of Liver-Related Events. Dig Dis Sci 2021;66:2816-25. [PMID: 32897445 DOI: 10.1007/s10620-020-06591-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
198 Mattos ÂZ, Schacher FC, John Neto G, Mattos AA. Screening for esophageal varices in cirrhotic patients - Non-invasive methods. Ann Hepatol 2019;18:673-8. [PMID: 31279653 DOI: 10.1016/j.aohep.2019.06.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
199 Pons M, Santos B, Simón-Talero M, Ventura-Cots M, Riveiro-Barciela M, Esteban R, Augustin S, Genescà J. Rapid liver and spleen stiffness improvement in compensated advanced chronic liver disease patients treated with oral antivirals. Therap Adv Gastroenterol 2017;10:619-29. [PMID: 28835776 DOI: 10.1177/1756283X17715198] [Cited by in Crossref: 31] [Cited by in F6Publishing: 8] [Article Influence: 6.2] [Reference Citation Analysis]
200 Fateen W, Ragunath K, White J, Khanna A, Coletta M, Samuel S, Ortiz J, James M, Wilkes E, Aithal GP, Guha IN, Sami SS. Validation of the AASLD recommendations for classification of oesophageal varices in clinical practice. Liver Int 2020;40:905-12. [PMID: 31762190 DOI: 10.1111/liv.14310] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
201 Sharma S, Agarwal S, Gunjan D, Kaushal K, Anand A, Gopi S, Mohta S, Saraya A. Outcomes of Portal Pressure-Guided Therapy in Decompensated Cirrhosis With Index Variceal Bleed in Asian Cohort. J Clin Exp Hepatol 2021;11:443-52. [PMID: 34276151 DOI: 10.1016/j.jceh.2020.11.001] [Reference Citation Analysis]
202 He L, Li P, Jiang Y, Hu J, Ma J, Ye X, Yang J, Zhou Y, Liang X, Ai Z, Lin Y, Wei H. A new algorithm for predicting long-term survival in chronic hepatitis B patients with variceal bleeding after endoscopic therapy. Dig Liver Dis 2019;51:1166-71. [PMID: 30723020 DOI: 10.1016/j.dld.2019.01.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
203 Fofiu R, Bende F, Popescu A, Şirli R, Lupușoru R, Ghiuchici AM, Sporea I. Spleen and Liver Stiffness for Predicting High-Risk Varices in Patients with Compensated Liver Cirrhosis. Ultrasound Med Biol 2021;47:76-83. [PMID: 33067019 DOI: 10.1016/j.ultrasmedbio.2020.09.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
204 Rajesh S, George T, Philips CA, Ahamed R, Kumbar S, Mohan N, Mohanan M, Augustine P. Transjugular intrahepatic portosystemic shunt in cirrhosis: An exhaustive critical update. World J Gastroenterol 2020; 26(37): 5561-5596 [PMID: 33088154 DOI: 10.3748/wjg.v26.i37.5561] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
205 Lagging M, Wejstål R, Norkrans G, Karlström O, Aleman S, Weiland O, Castedal M, Westin J; Swedish Consensus Group. Treatment of hepatitis C virus infection: updated Swedish Guidelines 2016. Infect Dis (Lond) 2017;49:561-75. [PMID: 28293974 DOI: 10.1080/23744235.2017.1300682] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
206 Henry Z. Treatment of Gastro-Fundal Varices (Including a Discussion of BRTO). Curr Hepatology Rep 2018;17:184-92. [DOI: 10.1007/s11901-018-0415-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
207 Vizzutti F, Schepis F, Arena U, Fanelli F, Gitto S, Aspite S, Turco L, Dragoni G, Laffi G, Marra F. Transjugular intrahepatic portosystemic shunt (TIPS): current indications and strategies to improve the outcomes. Intern Emerg Med 2020;15:37-48. [DOI: 10.1007/s11739-019-02252-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
208 Schaffner D, Lazaro A, Deibert P, Hasselblatt P, Stoll P, Fauth L, Baumstark MW, Merfort I, Schmitt-Graeff A, Kreisel W. Analysis of the nitric oxide-cyclic guanosine monophosphate pathway in experimental liver cirrhosis suggests phosphodiesterase-5 as potential target to treat portal hypertension. World J Gastroenterol 2018; 24(38): 4356-4368 [PMID: 30344420 DOI: 10.3748/wjg.v24.i38.4356] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
209 Ferreira CM, Rocha TR, Souza EO, Carrilho FJ, d’Amico EA, Farias AQ. Preservation of thrombin generation in cirrhosis despite abnormal results of international normalized ratio: implications for invasive procedures. Blood Coagulation & Fibrinolysis 2021;32:1-7. [DOI: 10.1097/mbc.0000000000000966] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
210 Valla DC. Recent developments in the field of vascular liver diseases. Liver Int 2020;40 Suppl 1:142-8. [PMID: 32077611 DOI: 10.1111/liv.14348] [Reference Citation Analysis]
211 Ferraioli G. Review of Liver Elastography Guidelines. J Ultrasound Med. 2019;38:9-14. [PMID: 30444274 DOI: 10.1002/jum.14856] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
212 Yokoyama S, Ishizu Y, Honda T, Imai N, Ito T, Yamamoto K, Tsuzuki T, Ishigami M. Absence of large portal collateral vessels is associated with spontaneous improvement of cirrhotic portal vein thrombosis. Hepatol Res 2021. [PMID: 34687492 DOI: 10.1111/hepr.13725] [Reference Citation Analysis]
213 Kola G, Sureshkumar S, Mohsina S, Sreenath GS, Kate V. Restrictive versus liberal transfusion strategy in upper gastrointestinal bleeding: A randomized controlled trial. Saudi J Gastroenterol 2021;27:13-9. [PMID: 32801255 DOI: 10.4103/sjg.SJG_152_20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
214 Barbier CE, Rorsman F, Eriksson LG, Sangfelt P, Sheikhi R, Vessby J, Nyman R. Placement of a transjugular intrahepatic portosystemic shunt in addition to recanalization of acute and chronic portomesenteric vein occlusions - a retrospective evaluation. Acta Radiol Open 2020;9:2058460120964074. [PMID: 33110628 DOI: 10.1177/2058460120964074] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
215 Piecha F, Paech D, Sollors J, Seitz HK, Rössle M, Rausch V, Mueller S. Rapid change of liver stiffness after variceal ligation and TIPS implantation. Am J Physiol Gastrointest Liver Physiol 2018;314:G179-87. [PMID: 29051188 DOI: 10.1152/ajpgi.00239.2017] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 4.4] [Reference Citation Analysis]
216 Oleas R, Robles-Medranda C. Endoscopic Treatment of Gastric and Ectopic Varices. Clin Liver Dis 2022;26:39-50. [PMID: 34802662 DOI: 10.1016/j.cld.2021.08.004] [Reference Citation Analysis]
217 Busk TM, Bendtsen F, Møller S. Hepatorenal syndrome in cirrhosis: diagnostic, pathophysiological, and therapeutic aspects.Expert Rev Gastroenterol Hepatol. 2016;10:1153-1161. [PMID: 27248461 DOI: 10.1080/17474124.2016.1196132] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
218 Kozieł S, Pawlak K, Błaszczyk Ł, Jagielski M, Wiechowska-Kozłowska A. Endoscopic Ultrasound-Guided Treatment of Gastric Varices Using Coils and Cyanoacrylate Glue Injections: Results after 1 Year of Experience. J Clin Med 2019;8:E1786. [PMID: 31731504 DOI: 10.3390/jcm8111786] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
219 Schwarzer R, Kivaranovic D, Paternostro R, Mandorfer M, Reiberger T, Trauner M, Peck-Radosavljevic M, Ferlitsch A. Carvedilol for reducing portal pressure in primary prophylaxis of variceal bleeding: a dose-response study. Aliment Pharmacol Ther. 2018;47:1162-1169. [PMID: 29492989 DOI: 10.1111/apt.14576] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 3.8] [Reference Citation Analysis]
220 Yen YH, Kuo FY, Chen CH, Hu TH, Lu SN, Wang JH, Hung CH. Ultrasound is highly specific in diagnosing compensated cirrhosis in chronic hepatitis C patients in real world clinical practice. Medicine (Baltimore) 2019;98:e16270. [PMID: 31277150 DOI: 10.1097/MD.0000000000016270] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
221 Isfordink CJ, Maan R, de Man RA, van Erpecum KJ, van der Meer AJ. Should we continue surveillance for hepatocellular carcinoma and gastroesophageal varices in patients with cirrhosis and cured HCV infection? Eur J Intern Med 2021:S0953-6205(21)00296-X. [PMID: 34563447 DOI: 10.1016/j.ejim.2021.08.023] [Reference Citation Analysis]
222 Kang SH, Baik SK, Kim MY. Application of Baveno Criteria and Modified Baveno Criteria with Shear-wave Elastography in Compensated Advanced Chronic Liver Disease. J Korean Med Sci 2020;35:e249. [PMID: 32743990 DOI: 10.3346/jkms.2020.35.e249] [Reference Citation Analysis]
223 Chalasani S, Mathur K, Shammas N, Orman E, Vuppalanchi R, Lammert C. Hepatic steatosis is highly prevalent but is not correlated with stiffness in autoimmune hepatitis. Medicine (Baltimore) 2020;99:e22805. [PMID: 33080756 DOI: 10.1097/MD.0000000000022805] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
224 Lv Y, Qi X, He C, Wang Z, Yin Z, Niu J, Guo W, Bai W, Zhang H, Xie H, Yao L, Wang J, Li T, Wang Q, Chen H, Liu H, Wang E, Xia D, Luo B, Li X, Yuan J, Han N, Zhu Y, Xia J, Cai H, Yang Z, Wu K, Fan D, Han G;  PVT-TIPS Study Group. Covered TIPS vs endoscopic band ligation plus propranolol for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: a randomised controlled trial. Gut. 2018;67:2156-2168. [PMID: 28970291 DOI: 10.1136/gutjnl-2017-314634] [Cited by in Crossref: 61] [Cited by in F6Publishing: 48] [Article Influence: 12.2] [Reference Citation Analysis]
225 Huang X, Li F, Wang L, Xiao M, Ni L, Jiang S, Ji Y, Zhang C, Zhang W, Wang J, Chen S. Endoscopic treatment of gastroesophageal variceal bleeding after oxaliplatin-based chemotherapy in patients with colorectal cancer. Endoscopy 2020;52:727-35. [PMID: 32380558 DOI: 10.1055/a-1157-8611] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
226 Kanwal F, Shubrook JH, Adams LA, Pfotenhauer K, Wai-Sun Wong V, Wright E, Abdelmalek MF, Harrison SA, Loomba R, Mantzoros CS, Bugianesi E, Eckel RH, Kaplan LM, El-Serag HB, Cusi K. Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease. Gastroenterology 2021;161:1657-69. [PMID: 34602251 DOI: 10.1053/j.gastro.2021.07.049] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
227 Lv Y, Zuo L, Zhu X, Zhao J, Xue H, Jiang Z, Zhuge Y, Zhang C, Sun J, Ding P, Ren W, Li Y, Zhang K, Zhang W, He C, Zhong J, Peng Q, Ma F, Luo J, Zhang M, Wang G, Sun M, Dong J, Bai W, Guo W, Wang Q, Yuan X, Wang Z, Yu T, Luo B, Li X, Yuan J, Han N, Zhu Y, Niu J, Li K, Yin Z, Nie Y, Fan D, Han G. Identifying optimal candidates for early TIPS among patients with cirrhosis and acute variceal bleeding: a multicentre observational study. Gut 2019;68:1297-310. [DOI: 10.1136/gutjnl-2018-317057] [Cited by in Crossref: 42] [Cited by in F6Publishing: 30] [Article Influence: 10.5] [Reference Citation Analysis]
228 Reig M, Forner A, Rimola J, Ferrer-Fábrega J, Burrel M, Garcia-Criado A, Kelley RK, Galle PR, Mazzaferro V, Salem R, Sangro B, Singal AG, Vogel A, Fuster J, Ayuso C, Bruix J. BCLC strategy for prognosis prediction and treatment recommendation Barcelona Clinic Liver Cancer (BCLC) staging system. The 2022 update. J Hepatol 2021:S0168-8278(21)02223-6. [PMID: 34801630 DOI: 10.1016/j.jhep.2021.11.018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
229 Thabut D, Weil D, Bouzbib C, Rudler M, Cassinotto C, Castéra L, Serste T, Oberti F, Ganne-Carrié N, de Lédinghen V, Bourlière M, Bureau C. NON-INVASIVE DIAGNOSIS AND FOLLOW-UP OF PORTAL HYPERTENSION. Clin Res Hepatol Gastroenterol 2021;:101767. [PMID: 34332128 DOI: 10.1016/j.clinre.2021.101767] [Reference Citation Analysis]
230 Ginès P, Krag A, Abraldes JG, Solà E, Fabrellas N, Kamath PS. Liver cirrhosis. Lancet 2021;398:1359-76. [PMID: 34543610 DOI: 10.1016/S0140-6736(21)01374-X] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
231 Liu J, Zhou C, Shi Q, Ma J, Ye T, Zheng C, Feng G, Xiong B. Exploration of interventional therapy strategy for portal vein occlusion: a case series study. Eur J Gastroenterol Hepatol 2020;32:507-16. [PMID: 31658174 DOI: 10.1097/MEG.0000000000001586] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
232 Harman DJ, Ryder SD, James MW, Wilkes EA, Card TR, Aithal GP, Guha IN. Obesity and type 2 diabetes are important risk factors underlying previously undiagnosed cirrhosis in general practice: a cross-sectional study using transient elastography. Aliment Pharmacol Ther 2018;47:504-15. [DOI: 10.1111/apt.14463] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
233 Voulgaris T, Karagiannakis D, Siakavellas S, Kalogera D, Angelopoulos T, Chloupi E, Karamanolis G, Papatheodoridis G, Vlachogiannakos J. High prevalence of asymptomatic peptic ulcers diagnosed during screening endoscopy in patients with cirrhosis. Ann Gastroenterol. 2019;32:451-456. [PMID: 31474790 DOI: 10.20524/aog.2019.0399] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
234 Sparchez Z, Craciun R, Caraiani C, Horhat A, Nenu I, Procopet B, Sparchez M, Stefanescu H, Mocan T. Ultrasound or Sectional Imaging Techniques as Screening Tools for Hepatocellular Carcinoma: Fall Forward or Move Forward? J Clin Med 2021;10:903. [PMID: 33668839 DOI: 10.3390/jcm10050903] [Reference Citation Analysis]
235 Kelly C, Nayagam JS, Vogli S, Samyn M, Joshi D. Paediatric cholestatic liver disorders for the adult gastroenterologist: a practical guide. Frontline Gastroenterol 2021;12:404-13. [DOI: 10.1136/flgastro-2020-101554] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
236 Marquez V, Abraldes JG. Editorial: is there a causal link between non-selective beta blockers and portal vein thrombosis in cirrhosis? Aliment Pharmacol Ther 2019;49:819-20. [DOI: 10.1111/apt.15182] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
237 Paternostro R, Pfeiffenberger J, Ferenci P, Stättermayer AF, Stauber RE, Wrba F, Longerich T, Lackner K, Trauner M, Ferlitsch A, Reiberger T, Weiss KH. Non-invasive diagnosis of cirrhosis and long-term disease monitoring by transient elastography in patients with Wilson disease. Liver Int 2020;40:894-904. [PMID: 31898387 DOI: 10.1111/liv.14368] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
238 Frankova S, Lunova M, Gottfriedova H, Senkerikova R, Neroldova M, Kovac J, Kieslichova E, Lanska V, Urbanek P, Spicak J, Jirsa M, Sperl J. Liver stiffness measured by two-dimensional shear-wave elastography predicts hepatic vein pressure gradient at high values in liver transplant candidates with advanced liver cirrhosis. PLoS One 2021;16:e0244934. [PMID: 33411729 DOI: 10.1371/journal.pone.0244934] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
239 Guo H, Xiao J, Wang Y, Zhang M, Zhuge Y, Zhang F. Increase in Free Hepatic Venous Pressure Response to Beta-Blockers Predicts Variceal Bleeding in Cirrhotic Patients. Biomed Res Int 2021;2021:5587566. [PMID: 33997022 DOI: 10.1155/2021/5587566] [Reference Citation Analysis]
240 Yokoyama S, Ishizu Y, Ishigami M, Honda T, Kuzuya T, Ito T, Hinoki A, Sumida W, Shirota C, Tainaka T, Makita S, Yokota K, Uchida H, Fujishiro M. Factors associated with bleeding after endoscopic variceal ligation in children. Pediatr Int 2021. [PMID: 33464654 DOI: 10.1111/ped.14614] [Reference Citation Analysis]
241 Khanna R, Sarin SK. Idiopathic portal hypertension and extrahepatic portal venous obstruction. Hepatol Int. 2018;12:148-167. [PMID: 29464506 DOI: 10.1007/s12072-018-9844-3] [Cited by in Crossref: 26] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
242 Aggeletopoulou I, Konstantakis C, Manolakopoulos S, Triantos C. Role of band ligation for secondary prophylaxis of variceal bleeding. World J Gastroenterol 2018; 24(26): 2902-2914 [PMID: 30018485 DOI: 10.3748/wjg.v24.i26.2902] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
243 Xiao N, Li XL, Zhu XD, Huang C, Shen YH, Zhou J, Fan J, Sun HC. Increase of Portal Vein Pressure Gradient After Hepatectomy Predicts Post-operative Liver Dysfunction. Surg Innov 2021;:15533506211018620. [PMID: 33993786 DOI: 10.1177/15533506211018620] [Reference Citation Analysis]
244 Henkel S, Vetterly C, Squires R, McKiernan P, Squires J. Pharmacological management of portal hypertension and its complications in children: lessons from adults and opportunities for the future. Expert Opin Pharmacother 2021;22:291-304. [PMID: 33074032 DOI: 10.1080/14656566.2020.1825685] [Reference Citation Analysis]
245 Mandorfer M, Kozbial K, Schwabl P, Freissmuth C, Schwarzer R, Stern R, Chromy D, Stättermayer AF, Reiberger T, Beinhardt S, Sieghart W, Trauner M, Hofer H, Ferlitsch A, Ferenci P, Peck-Radosavljevic M. Sustained virologic response to interferon-free therapies ameliorates HCV-induced portal hypertension. J Hepatol 2016;65:692-9. [PMID: 27242316 DOI: 10.1016/j.jhep.2016.05.027] [Cited by in Crossref: 165] [Cited by in F6Publishing: 151] [Article Influence: 27.5] [Reference Citation Analysis]
246 Shukla A, Jain A, Kahalekar V, Bendkhale S, Gogtay N, Thatte U, Bhatia S. Mutations in CYP2C9 and/or VKORC1 haplotype are associated with higher bleeding complications in patients with Budd-Chiari syndrome on warfarin. Hepatol Int 2019;13:214-21. [PMID: 30617764 DOI: 10.1007/s12072-018-9922-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
247 Mechelinck M, Hartmann B, Hamada S, Becker M, Andert A, Ulmer TF, Neumann UP, Wirtz TH, Koch A, Trautwein C, Roehl AB, Rossaint R, Hein M. Global Longitudinal Strain at Rest as an Independent Predictor of Mortality in Liver Transplant Candidates: A Retrospective Clinical Study. J Clin Med 2020;9:E2616. [PMID: 32806645 DOI: 10.3390/jcm9082616] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
248 Wang L, Feng Y, Ma X, Wang G, Wu H, Xie X, Zhang C, Zhu Q. Diagnostic efficacy of noninvasive liver fibrosis indexes in predicting portal hypertension in patients with cirrhosis. PLoS One 2017;12:e0182969. [PMID: 28820885 DOI: 10.1371/journal.pone.0182969] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
249 Deng H, Qi X, Guo X. Computed tomography for the diagnosis of varices in liver cirrhosis: a systematic review and meta-analysis of observational studies. Postgrad Med 2017;129:318-28. [PMID: 27677436 DOI: 10.1080/00325481.2017.1241664] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
250 Noronha Ferreira C, Reis D, Cortez-Pinto H, Tato Marinho R, Gonçalves A, Palma S, Leite I, Rodrigues T, Pedro AJ, Alexandrino P, Serejo F, Sobral Dias M, Ferreira P, Vasconcelos M, Damião F, Xavier Brito L, Baldaia C, Fatela N, Ramalho F, Velosa J. Anticoagulation in Cirrhosis and Portal Vein Thrombosis Is Safe and Improves Prognosis in Advanced Cirrhosis. Dig Dis Sci 2019;64:2671-83. [PMID: 30852769 DOI: 10.1007/s10620-019-05572-z] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 5.7] [Reference Citation Analysis]
251 Rodrigues SG, Sixt S, Abraldes JG, De Gottardi A, Klinger C, Bosch J, Baumgartner I, Berzigotti A. Systematic review with meta-analysis: portal vein recanalisation and transjugular intrahepatic portosystemic shunt for portal vein thrombosis. Aliment Pharmacol Ther. 2019;49:20-30. [PMID: 30450634 DOI: 10.1111/apt.15044] [Cited by in Crossref: 30] [Cited by in F6Publishing: 18] [Article Influence: 7.5] [Reference Citation Analysis]
252 Dajti E, Marasco G, Ravaioli F, Alemanni LV, Rossini B, Colecchia L, Vestito A, Festi D, Colecchia A. The role of liver and spleen elastography in advanced chronic liver disease. Minerva Gastroenterol (Torino) 2021;67:151-63. [PMID: 34027932 DOI: 10.23736/S2724-5985.20.02793-2] [Reference Citation Analysis]
253 Fofiu R, Bende F, Lupuşoru R, Roxana Şirli, Popescu A, Sporea I. Spleen Stiffness for Predicting Varices Needing Treatment: Comparison between Two Different Elastography Techniques (Point vs. 2D-SWE). Can J Gastroenterol Hepatol 2021;2021:6622726. [PMID: 34055675 DOI: 10.1155/2021/6622726] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
254 Wang X, Luo J, Liu C, Liu Y, Wu X, Zheng F, Wen Z, Tian H, Wei X, Guo Y, Li J, Chen X, Tao J, Qi X, Wu B. Impact of variceal eradication on rebleeding and prognosis in cirrhotic patients undergoing secondary prophylaxis. Ann Transl Med 2021;9:540. [PMID: 33987238 DOI: 10.21037/atm-20-3401] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
255 Webster CRL, Center SA, Cullen JM, Penninck DG, Richter KP, Twedt DC, Watson PJ. ACVIM consensus statement on the diagnosis and treatment of chronic hepatitis in dogs. J Vet Intern Med 2019;33:1173-200. [PMID: 30844094 DOI: 10.1111/jvim.15467] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 9.0] [Reference Citation Analysis]
256 Pfisterer N, Unger LW, Reiberger T. Clinical algorithms for the prevention of variceal bleeding and rebleeding in patients with liver cirrhosis. World J Hepatol 2021; 13(7): 731-746 [PMID: 34367495 DOI: 10.4254/wjh.v13.i7.731] [Reference Citation Analysis]
257 Tandon P, Ripoll C, Assis D, Wongcharatrawee S, Groszmann RJ, Garcia-Tsao G. The interpretation of hepatic venous pressure gradient tracings - excellent interobserver agreement unrelated to experience. Liver Int 2016;36:1160-6. [PMID: 26763558 DOI: 10.1111/liv.13065] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
258 Ahmad AK, Atzori S, Maurice J, Taylor-Robinson SD, Lim AKP. Non-invasive splenic parameters of portal hypertension: Assessment and utility. World J Hepatol 2020; 12(11): 1055-1066 [PMID: 33312429 DOI: 10.4254/wjh.v12.i11.1055] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
259 Imajo K, Honda Y, Yoneda M, Saito S, Nakajima A. Magnetic resonance imaging for the assessment of pathological hepatic findings in nonalcoholic fatty liver disease. J Med Ultrason (2001) 2020;47:535-48. [PMID: 33108553 DOI: 10.1007/s10396-020-01059-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
260 Garcia-Tsao G, Abraldes JG, Berzigotti A, Bosch J. Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatology. 2017;65:310-335. [PMID: 27786365 DOI: 10.1002/hep.28906] [Cited by in Crossref: 713] [Cited by in F6Publishing: 537] [Article Influence: 118.8] [Reference Citation Analysis]
261 Yang YT, Wang LL, Yan LT, Zhang LT, Zhou W, Chen QF, Chen Y, Zheng SJ, Duan ZP, Li JF. Platelet count is closely associated with the severity of liver injury in patients with chronic hepatitis B virus infection: A cross-sectional study. Exp Ther Med 2020;20:243-50. [PMID: 32550883 DOI: 10.3892/etm.2020.8703] [Reference Citation Analysis]
262 Gu W, Hortlik H, Erasmus HP, Schaaf L, Zeleke Y, Uschner FE, Ferstl P, Schulz M, Peiffer KH, Queck A, Sauerbruch T, Brol MJ, Rohde G, Sanchez C, Moreau R, Arroyo V, Zeuzem S, Welsch C, Trebicka J. Trends and the course of liver cirrhosis and its complications in Germany: Nationwide population-based study (2005 to 2018). Lancet Reg Health Eur 2022;12:100240. [PMID: 34901909 DOI: 10.1016/j.lanepe.2021.100240] [Reference Citation Analysis]
263 Jindal A, Sharma S, Agarwal S, Kumar M, Saraya A, Sarin SK. Liver stiffness can predict decompensation and need for beta-blockers in compensated cirrhosis: a step beyond Baveno-VI criteria. Hepatol Int. [DOI: 10.1007/s12072-021-10280-w] [Reference Citation Analysis]
264 von Köckritz L, De Gottardi A, Trebicka J, Praktiknjo M. Portal vein thrombosis in patients with cirrhosis. Gastroenterol Rep (Oxf) 2017;5:148-56. [PMID: 28533912 DOI: 10.1093/gastro/gox014] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
265 Pereira Guedes T, Fragoso P, Lemos C, Garrido M, Silva J, Falcão D, Maia L, Moreira T, Manuel Ferreira J, Pedroto I. Long-Term Follow-Up of Advanced Liver Disease after Sustained Virological Response to Treatment of Hepatitis C with Direct-Acting Antivirals: Outcomes from a Real-World Portuguese Cohort. GE Port J Gastroenterol 2020;27:149-59. [PMID: 32509920 DOI: 10.1159/000503074] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
266 Stotts MJ, Davis JPE, Shah NL. Coagulation testing and management in liver disease patients. Curr Opin Gastroenterol 2020;36:169-76. [PMID: 32141899 DOI: 10.1097/MOG.0000000000000635] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
267 Li Y, Guo X, Bai Z, Shao X, Wang R, Li H, Qi X. Banana may be forbidden after endoscopic variceal ligation: a case report. Transl Gastroenterol Hepatol 2019;4:13. [PMID: 30976716 DOI: 10.21037/tgh.2019.01.11] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
268 Sturm L, Bettinger D, Giesler M, Boettler T, Schmidt A, Buettner N, Thimme R, Schultheiss M. Treatment with proton pump inhibitors increases the risk for development of hepatic encephalopathy after implantation of transjugular intrahepatic portosystemic shunt (TIPS). United European Gastroenterol J 2018;6:1380-90. [PMID: 30386611 DOI: 10.1177/2050640618795928] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
269 Fernández-Iglesias A, Gracia-Sancho J. How to Face Chronic Liver Disease: The Sinusoidal Perspective. Front Med (Lausanne) 2017;4:7. [PMID: 28239607 DOI: 10.3389/fmed.2017.00007] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 4.2] [Reference Citation Analysis]
270 Pateu E, Oberti F, Calès P. The noninvasive diagnosis of esophageal varices and its application in clinical practice. Clinics and Research in Hepatology and Gastroenterology 2018;42:6-16. [DOI: 10.1016/j.clinre.2017.07.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
271 Romano C, Oliva S, Martellossi S, Miele E, Arrigo S, Graziani MG, Cardile S, Gaiani F, de’Angelis GL, Torroni F. Pediatric gastrointestinal bleeding: Perspectives from the Italian Society of Pediatric Gastroenterology. World J Gastroenterol 2017; 23(8): 1328-1337 [PMID: 28293079 DOI: 10.3748/wjg.v23.i8.1328] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 8] [Article Influence: 3.8] [Reference Citation Analysis]
272 Shiha G, Soliman R, Mikhail NNH, Alswat K, Abdo A, Sanai F, Derbala MF, Örmeci N, Dalekos GN, Al-Busafi S, Hamoudi W, Sharara AI, Zaky S, El-Raey F, Mabrouk M, Marzouk S, Toyoda H. Development and multicenter validation of FIB-6: A novel, machine learning, simple bedside score to rule out liver cirrhosis and compensated advanced chronic liver disease in patients with chronic hepatitis C. Hepatol Res 2021. [PMID: 34767312 DOI: 10.1111/hepr.13729] [Reference Citation Analysis]
273 Jangouk P, Turco L, De Oliveira A, Schepis F, Villa E, Garcia-Tsao G. Validating, deconstructing and refining Baveno criteria for ruling out high-risk varices in patients with compensated cirrhosis. Liver Int 2017;37:1177-83. [PMID: 28160373 DOI: 10.1111/liv.13379] [Cited by in Crossref: 58] [Cited by in F6Publishing: 46] [Article Influence: 11.6] [Reference Citation Analysis]
274 Li YH, Wu JF, Wu HM, Wu XN, Xu Y, Wan YM. The Effect of Transjugular Intrahepatic Portosystemic Shunt Plus Partial Splenic Embolization for the Treatment of Patients with Recurrent Variceal Bleeding. Acad Radiol 2020;27:323-31. [PMID: 31147236 DOI: 10.1016/j.acra.2019.04.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
275 Mandorfer M, Simbrunner B. Prevention of First Decompensation in Advanced Chronic Liver Disease. Clin Liver Dis 2021;25:291-310. [PMID: 33838851 DOI: 10.1016/j.cld.2021.01.003] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
276 Ferraioli G, Maiocchi L, Dellafiore C, Tinelli C, Above E, Filice C. Performance and cutoffs for liver fibrosis staging of a two-dimensional shear wave elastography technique. Eur J Gastroenterol Hepatol 2021;33:89-95. [PMID: 32118850 DOI: 10.1097/MEG.0000000000001702] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
277 Nair H, Berzigotti A, Bosch J. Emerging therapies for portal hypertension in cirrhosis. Expert Opin Emerg Drugs 2016;21:167-81. [PMID: 27148904 DOI: 10.1080/14728214.2016.1184647] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
278 Schiavon LL, Ejima FH, Menezes MR, Bittencourt PL, Moreira AM, Farias AQ, Chagas AL, Assis AM, Mattos ÂZ, Salomão BC, Terra C, Martins FPB, Carnevale FC, Rezende GFDM, Paulo GA, Pereira GHS, Leal Filho JMDM, Meneses J, Costa LSND, Carneiro MV, Álvares-DA-Silva MR, Soares MVA, Pereira OI, Ximenes RO, Durante RFS, Ferreira VA, Lima VM; Members of the Pannel of the 1st Joint Meeting of the SBH, SOBED and SOBRICE. RECOMMENDATIONS FOR INVASIVE PROCEDURES IN PATIENTS WITH DISEASES OF THE LIVER AND BILIARY TRACT: REPORT OF A JOINT MEETING OF THE BRAZILIAN SOCIETY OF HEPATOLOGY (SBH), BRAZILIAN SOCIETY OF DIGESTIVE ENDOSCOPY (SOBED) AND BRAZILIAN SOCIETY OF INTERVENTIONAL RADIOLOGY AND ENDOVASCULAR SURGERY (SOBRICE). Arq Gastroenterol 2019;56:213-31. [PMID: 31460590 DOI: 10.1590/S0004-2803.201900000-42] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
279 Shah ND, Ventura-Cots M, Abraldes JG, Alboraie M, Alfadhli A, Argemi J, Badia-Aranda E, Arús-Soler E, Barritt AS 4th, Bessone F, Biryukova M, Carrilho FJ, Fernández MC, Dorta Guiridi Z, El Kassas M, Eng-Kiong T, Queiroz Farias A, George J, Gui W, Thurairajah PH, Hsiang JC, Husić-Selimovic A, Isakov V, Karoney M, Kim W, Kluwe J, Kochhar R, Dhaka N, Costa PM, Nabeshima Pharm MA, Ono SK, Reis D, Rodil A, Domech CR, Sáez-Royuela F, Scheurich C, Siow W, Sivac-Burina N, Dos Santos Traquino ES, Some F, Spreckic S, Tan S, Vorobioff J, Wandera A, Wu P, Yacoub M, Yang L, Yu Y, Zahiragic N, Zhang C, Cortez-Pinto H, Bataller R. Alcohol-Related Liver Disease Is Rarely Detected at Early Stages Compared With Liver Diseases of Other Etiologies Worldwide. Clin Gastroenterol Hepatol 2019;17:2320-2329.e12. [PMID: 30708110 DOI: 10.1016/j.cgh.2019.01.026] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
280 Marot A, Trépo E, Doerig C, Schoepfer A, Moreno C, Deltenre P. Liver stiffness and platelet count for identifying patients with compensated liver disease at low risk of variceal bleeding. Liver Int 2017;37:707-16. [PMID: 27862856 DOI: 10.1111/liv.13318] [Cited by in Crossref: 48] [Cited by in F6Publishing: 41] [Article Influence: 8.0] [Reference Citation Analysis]
281 Tapper EB, Ezaz G, Patwardhan V, Mellinger J, Bonder A, Curry M, Saini SD. Hospital-level balloon tamponade use is associated with increased mortality for all patients presenting with acute variceal haemorrhage. Liver Int 2018;38:477-83. [DOI: 10.1111/liv.13559] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
282 Bouzbib C, Sultanik P, Thabut D, Rudler M. Unsolved Questions in Salvage TIPSS: Practical Modalities for Placement, Alternative Therapeutics, and Long-Term Outcomes. Can J Gastroenterol Hepatol 2019;2019:7956717. [PMID: 31058111 DOI: 10.1155/2019/7956717] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
283 Augustin S, Pons M, Maurice JB, Bureau C, Stefanescu H, Ney M, Blasco H, Procopet B, Tsochatzis E, Westbrook RH, Bosch J, Berzigotti A, Abraldes JG, Genescà J. Expanding the Baveno VI criteria for the screening of varices in patients with compensated advanced chronic liver disease: Augustin, Pons, et al. Hepatology 2017;66:1980-8. [DOI: 10.1002/hep.29363] [Cited by in Crossref: 129] [Cited by in F6Publishing: 100] [Article Influence: 25.8] [Reference Citation Analysis]
284 Sun G, Liu X, Liu Z, Tan J, Hao Y, Shan G, Luo Q, Wang D, Xing Y, Zhang X, Gong J, Kuang L, Stanworth SJ, Wen A. A multicenter study of blood component transfusion in patients with liver cirrhosis in China: Patient characteristics, transfusion practice, and outcomes. Digestive and Liver Disease 2016;48:1478-84. [DOI: 10.1016/j.dld.2016.08.119] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
285 Jansen C, Bogs C, Verlinden W, Thiele M, Möller P, Görtzen J, Lehmann J, Vanwolleghem T, Vonghia L, Praktiknjo M, Chang J, Krag A, Strassburg CP, Francque S, Trebicka J. Shear-wave elastography of the liver and spleen identifies clinically significant portal hypertension: A prospective multicentre study. Liver Int 2017;37:396-405. [DOI: 10.1111/liv.13243] [Cited by in Crossref: 74] [Cited by in F6Publishing: 67] [Article Influence: 12.3] [Reference Citation Analysis]
286 Mandorfer M, Reiberger T, Peck-Radosavljevic M. Monitoring the Evolution of Portal Hypertension After Sustained Virologic Response. Gastroenterology. 2018;154:1550-1551. [PMID: 29526728 DOI: 10.1053/j.gastro.2017.08.078] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
287 McDonald SA, Barclay ST, Hutchinson SJ, Stanley AJ, Fraser A, Dillon JF, Innes HA, Peters E, Kennedy N, Bathgate A, Bramley P, Morris J, Goldberg DJ, Hayes PC. Uptake of endoscopic screening for gastroesophageal varices and factors associated with variceal bleeding in patients with chronic hepatitis C infection and compensated cirrhosis, 2005-2016: a national database linkage study. Aliment Pharmacol Ther 2019;50:425-34. [PMID: 31157411 DOI: 10.1111/apt.15320] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
288 Giunta M, Conte D, Fraquelli M. Role of spleen elastography in patients with chronic liver diseases. World J Gastroenterol 2016; 22(35): 7857-7867 [PMID: 27672283 DOI: 10.3748/wjg.v22.i35.7857] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
289 Gioia S, Nardelli S, Pasquale C, Pentassuglio I, Nicoletti V, Aprile F, Merli M, Riggio O. Natural history of patients with non cirrhotic portal hypertension: Comparison with patients with compensated cirrhosis. Dig Liver Dis. 2018;50:839-844. [PMID: 29429910 DOI: 10.1016/j.dld.2018.01.132] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
290 Jachs M, Reiberger T. Prevention of Variceal Bleeding and Rebleeding by Nonselective Beta-Blockers: A Tailored Approach. Clin Liver Dis 2021;25:311-26. [PMID: 33838852 DOI: 10.1016/j.cld.2021.01.004] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
291 Vilarinho S, Sari S, Yilmaz G, Stiegler AL, Boggon TJ, Jain D, Akyol G, Dalgic B, Günel M, Lifton RP. Recurrent recessive mutation in deoxyguanosine kinase causes idiopathic noncirrhotic portal hypertension. Hepatology 2016;63:1977-86. [PMID: 26874653 DOI: 10.1002/hep.28499] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
292 Yoon KT, Liu H, Lee SS. β-blockers in advanced cirrhosis: More friend than enemy. Clin Mol Hepatol 2021;27:425-36. [PMID: 33317244 DOI: 10.3350/cmh.2020.0234] [Reference Citation Analysis]
293 Wu M, Wu L, Jin J, Wang J, Li S, Zeng J, Guo H, Zheng J, Chen S, Zheng R. Liver Stiffness Measured with Two-dimensional Shear-Wave Elastography Is Predictive of Liver-related Events in Patients with Chronic Liver Disease Due to Hepatis B Viral Infection. Radiology 2020;295:353-60. [PMID: 32125254 DOI: 10.1148/radiol.2020191481] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
294 Lim JK, Flamm SL, Singh S, Falck-Ytter YT; Clinical Guidelines Committee of the American Gastroenterological Association. American Gastroenterological Association Institute Guideline on the Role of Elastography in the Evaluation of Liver Fibrosis. Gastroenterology. 2017;152:1536-1543. [PMID: 28442119 DOI: 10.1053/j.gastro.2017.03.017] [Cited by in Crossref: 60] [Cited by in F6Publishing: 52] [Article Influence: 15.0] [Reference Citation Analysis]
295 Elkrief L, Houssel-Debry P, Ackermann O, Franchi-Abella S, Branchereau S, Valla D, Hillaire S, Dutheil D, Plessier A, Hernandez-Gea V, Bureau C. Portal cavernoma or chronic non cirrhotic extrahepatic portal vein obstruction. Clin Res Hepatol Gastroenterol 2020;44:491-6. [PMID: 32819872 DOI: 10.1016/j.clinre.2020.03.016] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
296 European Association for the Study of the Liver. EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. J Hepatol. 2017;67:145-172. [PMID: 28427765 DOI: 10.1016/j.jhep.2017.03.022] [Cited by in Crossref: 409] [Cited by in F6Publishing: 326] [Article Influence: 81.8] [Reference Citation Analysis]
297 Qi X, Guo X, Yoshida EM, Méndez-Sánchez N, De Stefano V, Tacke F, Mancuso A, Sugawara Y, Yang SS, Teschke R, Arora A, Valla DC. Transient portal vein thrombosis in liver cirrhosis. BMC Med 2018;16:83. [PMID: 29871683 DOI: 10.1186/s12916-018-1069-8] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 7.0] [Reference Citation Analysis]
298 Riva N, Ageno W. Timing of Anticoagulation for Portal Vein Thrombosis in Liver Cirrhosis: An Italian Internist's Perspective. J Transl Int Med 2018;6:6-10. [PMID: 29607297 DOI: 10.2478/jtim-2018-0002] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
299 Turco L, Garcia-Tsao G. Portal Hypertension: Pathogenesis and Diagnosis. Clin Liver Dis. 2019;23:573-587. [PMID: 31563212 DOI: 10.1016/j.cld.2019.07.007] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 8.5] [Reference Citation Analysis]
300 Pol S, Parlati L, Jadoul M. Hepatitis C virus and the kidney. Nat Rev Nephrol 2019;15:73-86. [DOI: 10.1038/s41581-018-0081-8] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 6.8] [Reference Citation Analysis]
301 Dietrich CF, Shi L, Wei Q, Dong Y, Cui XW, Löwe A, Worni M, Ferraioli G. What does liver elastography measure? Technical aspects and methodology. Minerva Gastroenterol (Torino) 2021;67:129-40. [PMID: 33267564 DOI: 10.23736/S2724-5985.20.02787-7] [Reference Citation Analysis]
302 Samuel D. Systemic inflammation and liver cirrhosis complications: Driving or secondary event? How to square the circle? J Hepatol 2021;74:508-10. [PMID: 33478857 DOI: 10.1016/j.jhep.2021.01.001] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
303 Piecha F, Gänßler JM, Ozga AK, Wehmeyer MH, Kluwe J, Lampalzer S, Creutzfeldt AM, Buescher G, Horvatits T, Sterneck M, Pischke S, Lohse AW, Schulze Zur Wiesch J. Evolution of liver stiffness and post-treatment surveillance by liver elastography for HCV patients in the DAA era. Scand J Gastroenterol 2021;56:840-8. [PMID: 34010581 DOI: 10.1080/00365521.2021.1915374] [Reference Citation Analysis]
304 Kockerling D, Nathwani R, Forlano R, Manousou P, Mullish BH, Dhar A. Current and future pharmacological therapies for managing cirrhosis and its complications. World J Gastroenterol 2019; 25(8): 888-908 [PMID: 30833797 DOI: 10.3748/wjg.v25.i8.888] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
305 Wang L, Guo X, Xu X, Philips CA, Primignani M, Mendez-Sanchez N, Li Q, Zheng K, Qi X. Association of portal venous system thrombosis with endoscopic variceal treatment: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol 2021;32:125-31. [PMID: 32501878 DOI: 10.1097/MEG.0000000000001774] [Reference Citation Analysis]
306 Best LM, Freeman S, Sutton AJ, Hawkins N, Tsochatzis E, Gurusamy KS; Cochrane Hepato-Biliary Group. Treatment for hepatorenal syndrome in people with decompensated liver cirrhosis: a network meta-analysis. Cochrane Database of Systematic Reviews. [DOI: 10.1002/14651858.cd013103] [Cited by in Crossref: 19] [Cited by in F6Publishing: 1] [Article Influence: 4.8] [Reference Citation Analysis]
307 Tsauo J, Noh SY, Shin JH, Gwon DI, Han K, Lee JM, Jeon UB, Kim YH. Retrograde transvenous obliteration for the prevention of variceal rebleeding in patients with portal vein thrombosis: a multicenter study. Eur Radiol 2021;31:559-66. [PMID: 32749587 DOI: 10.1007/s00330-020-07109-9] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
308 Mandorfer M, Hernández-gea V, Reiberger T, García-pagán JC. Hepatic Venous Pressure Gradient Response in Non-Selective Beta-Blocker Treatment—Is It Worth Measuring? Curr Hepatology Rep 2019;18:174-86. [DOI: 10.1007/s11901-019-00469-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
309 Mayer P, Felli E, Enescu I, Habersetzer F, Tripon S. Upper gastrointestinal bleeding due to left side portal hypertension after pancreatic surgery. Hepatobiliary Pancreat Dis Int 2021:S1499-3872(21)00235-6. [PMID: 35000846 DOI: 10.1016/j.hbpd.2021.12.010] [Reference Citation Analysis]
310 Rajakannu M, Coilly A, Adam R, Samuel D, Vibert E. Prospective validation of transient elastography for staging liver fibrosis in patients undergoing hepatectomy and liver transplantation. J Hepatol 2017:S0168-8278(17)32214-6. [PMID: 28837835 DOI: 10.1016/j.jhep.2017.07.032] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
311 Lee S, Saxinger L, Ma M, Prado V, Fernández J, Kumar D, Gonzalez-Abraldes J, Keough A, Bastiampillai R, Carbonneau M, Fernandez J, Tandon P. Bacterial infections in acute variceal hemorrhage despite antibiotics-a multicenter study of predictors and clinical impact. United European Gastroenterol J 2017;5:1090-9. [PMID: 29238587 DOI: 10.1177/2050640617704564] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
312 Luque S, Muñoz-Bermudez R, Echeverría-Esnal D, Sorli L, Campillo N, Martínez-Casanova J, González-Colominas E, Álvarez-Lerma F, Horcajada JP, Grau S, Roberts JA. Linezolid Dosing in Patients With Liver Cirrhosis: Standard Dosing Risk Toxicity. Ther Drug Monit 2019;41:732-9. [PMID: 31259884 DOI: 10.1097/FTD.0000000000000665] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
313 Liu J, Ma J, Yang C, Ye T, Meng J, Shi Q, Xiong B. Impact of TIPS on Splenic Volume and Thrombocytopenia. AJR Am J Roentgenol 2021;216:698-703. [PMID: 33439047 DOI: 10.2214/AJR.20.22958] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
314 D'Ambrosio R, Degasperi E, Anolli MP, Fanetti I, Borghi M, Soffredini R, Iavarone M, Tosetti G, Perbellini R, Sangiovanni A, Sypsa V, Lampertico P. Incidence of liver and non-liver-related outcomes in patients with HCV-cirrhosis after SVR. J Hepatol 2021:S0168-8278(21)02043-2. [PMID: 34592366 DOI: 10.1016/j.jhep.2021.09.013] [Reference Citation Analysis]
315 Zou Z, Yan X, Lu H, Qi X, Gu Y, Li X, Wu B, Qi X. Comparison of drugs facilitating endoscopy for patients with acute variceal bleeding: a systematic review and network meta-analysis. Ann Transl Med 2019;7:717. [PMID: 32042733 DOI: 10.21037/atm.2019.12.26] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
316 Huang X, Thansamay S, Yang K, Luo T, Chen S. Measurement of Exhaled Nitric Oxide in Cirrhotic Patients with Esophageal and Gastric Varices. Biomed Res Int 2019;2019:9673162. [PMID: 31781658 DOI: 10.1155/2019/9673162] [Reference Citation Analysis]
317 Njei B, McCarty TR, Luk J, Ewelukwa O, Ditah I, Lim JK. Use of transient elastography in patients with HIV-HCV coinfection: A systematic review and meta-analysis. J Gastroenterol Hepatol 2016;31:1684-93. [PMID: 26952020 DOI: 10.1111/jgh.13337] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
318 Moini M, Onofrio F, Hansen BE, Adeyi O, Khalili K, Patel K. Combination of FIB-4 with ultrasound surface nodularity or elastography as predictors of histologic advanced liver fibrosis in chronic liver disease. Sci Rep 2021;11:19275. [PMID: 34588540 DOI: 10.1038/s41598-021-98776-1] [Reference Citation Analysis]
319 Kalambokis GN, Baltayiannis G, Christou L, Christodoulou D. Red signs and not severity of cirrhosis should determine non-selective β-blocker treatment in Child-Pugh C cirrhosis with small varices: increased risk of hepatorenal syndrome and death beyond 6 months of propranolol use. Gut 2016;65:1228-30. [PMID: 26935875 DOI: 10.1136/gutjnl-2016-311527] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
320 Trebicka J, Sundaram V, Moreau R, Jalan R, Arroyo V. Liver Transplantation for Acute-on-Chronic Liver Failure: Science or Fiction? Liver Transpl. 2020;26:906-915. [PMID: 32365422 DOI: 10.1002/lt.25788] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 11.0] [Reference Citation Analysis]
321 Samanta T, Biswas K, Ghosh S, Gupta MK, Basu R, Purkait R, Naskar A, Butta S, Das D, Ganguly S. Validation of Revised Baveno VI Criteria for Screening of Varices Needing Treatment in Children with Cirrhosis. Clin Exp Gastroenterol 2020;13:503-9. [PMID: 33177858 DOI: 10.2147/CEG.S276182] [Reference Citation Analysis]
322 Fofiu R, Bende F, Popescu A, Șirli R, Miuţescu B, Sporea I. Assessing Baveno VI Criteria Using Liver Stiffness Measured with a 2D-Shear Wave Elastography Technique. Diagnostics (Basel) 2021;11:737. [PMID: 33919033 DOI: 10.3390/diagnostics11050737] [Reference Citation Analysis]
323 Nardelli S, Riggio O, Turco L, Gioia S, Puzzono M, Bianchini M, Ridola L, Aprile F, Gitto S, Pelle G, Di Martino M, Marzocchi G, Caporali C, Spagnoli A, Di Rocco A, Schepis F. Relevance of Spontaneous Portosystemic Shunts Detected with CT in Patients with Cirrhosis. Radiology 2021;299:133-40. [PMID: 33529134 DOI: 10.1148/radiol.2021203051] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
324 Yoo HW, Kim YS, Kim SG, Yoo J, Jeong SW, Jang JY, Lee SH, Kim HS, Kim YD, Cheon GJ, Jun B, Kim BS. Usefulness of noninvasive methods including assessment of liver stiffness by 2-dimensional shear wave elastography for predicting esophageal varices. Digestive and Liver Disease 2019;51:1706-12. [DOI: 10.1016/j.dld.2019.06.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
325 Qi X, Han G, Ye C, Zhang Y, Dai J, Peng Y, Deng H, Li J, Hou F, Ning Z, Zhao J, Zhang X, Wang R, Guo X. Splenectomy Causes 10-Fold Increased Risk of Portal Venous System Thrombosis in Liver Cirrhosis Patients. Med Sci Monit. 2016;22:2528-2550. [PMID: 27432511 DOI: 10.12659/msm.898866] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
326 Ertel AE, Chang AL, Kim Y, Shah SA. Management of gastrointestinal bleeding in patients with cirrhosis. Curr Probl Surg 2016;53:366-95. [PMID: 27585818 DOI: 10.1067/j.cpsurg.2016.06.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
327 Bruix J, Chan SL, Galle PR, Rimassa L, Sangro B. Systemic treatment of hepatocellular carcinoma: An EASL position paper. J Hepatol 2021:S0168-8278(21)01903-6. [PMID: 34256065 DOI: 10.1016/j.jhep.2021.07.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
328 European Association for the Study of the Liver. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Management of alcohol-related liver disease. J Hepatol. 2018;69:154-181. [PMID: 29628280 DOI: 10.1016/j.jhep.2018.03.018] [Cited by in Crossref: 210] [Cited by in F6Publishing: 169] [Article Influence: 52.5] [Reference Citation Analysis]
329 Nagai K, Ogawa Y, Kobayashi T, Iwaki M, Nogami A, Honda Y, Kessoku T, Saigusa Y, Imajo K, Yoneda M, Kirikoshi H, Komatsu T, Saito S, Nakajima A. Gastroesophageal varices evaluation using spleen‐dedicated stiffness measurement by vibration‐controlled transient elastography. JGH Open 2022;6:11-9. [DOI: 10.1002/jgh3.12689] [Reference Citation Analysis]
330 Degasperi E, Spinetti A, Lombardi A, Landonio S, Rossi MC, Pasulo L, Pozzoni P, Giorgini A, Fabris P, Romano A, Lomonaco L, Puoti M, Vinci M, Gatti F, Carolo G, Zoncada A, Bonfanti P, Russo FP, Aghemo A, Soria A, Centenaro R, Maggiolo F, Rovere P, Pasin F, Paon V, Faggiano G, Vario A, Grossi G, Soffredini R, Carriero C, Paolucci S, Noventa F, Alberti A, Lampertico P, Fagiuoli S. Real-life effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients with previous DAA failure. Journal of Hepatology 2019;71:1106-15. [DOI: 10.1016/j.jhep.2019.07.020] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 11.3] [Reference Citation Analysis]
331 Kulkarni AV, Arab JP, Premkumar M, Benítez C, Tirumalige Ravikumar S, Kumar P, Sharma M, Reddy DN, Simonetto DA, Rao PN. Terlipressin has stood the test of time: Clinical overview in 2020 and future perspectives. Liver Int 2020;40:2888-905. [DOI: 10.1111/liv.14703] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
332 Marmo R, Soncini M, Marmo C, Borbjerg Laursen S, Gralnek IM, Stanley AJ. Medical care setting is associated with survival in acute upper gastro-intestinal bleeding: A cohort study. Digestive and Liver Disease 2020;52:561-5. [DOI: 10.1016/j.dld.2020.01.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
333 Alvarado-Tapias E, Ardevol A, Garcia-Guix M, Montañés R, Pavel O, Cuyas B, Graupera I, Brujats A, Vilades D, Colomo A, Poca M, Torras X, Guarner C, Concepción M, Aracil C, Torres F, Villanueva C. Short-term hemodynamic effects of β-blockers influence survival of patients with decompensated cirrhosis. J Hepatol 2020;73:829-41. [PMID: 32298768 DOI: 10.1016/j.jhep.2020.03.048] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
334 Perera K, Kodisinghe SK, Ediriweera DS, Moratuwagama D, Williams S, Pathmeswaran A, Niriella MA, de Silva HJ. Percentage of small platelets on peripheral blood smear and Child-Turcott-Pugh class can predict the presence of oesophageal varices in newly diagnosed patients with cirrhosis: development of a prediction model for resource limited settings. BMC Gastroenterol 2019;19:134. [PMID: 31349807 DOI: 10.1186/s12876-019-1054-5] [Reference Citation Analysis]
335 Wu CK, Yang SC, Liang CM, Li YC, Yeh WS, Tai WC, Lee CH, Yang YH, Hsu CN, Tsai TH, Chuah SK. The role of antibiotics in upper gastrointestinal bleeding among cirrhotic patients without major complications after endoscopic hemostasis. J Gastroenterol Hepatol 2020;35:777-87. [PMID: 31674688 DOI: 10.1111/jgh.14873] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
336 Brusilovskaya K, Königshofer P, Lampach D, Szodl A, Supper P, Bauer D, Beer A, Stift J, Timelthaler G, Oberhuber G, Podesser BK, Seif M, Zinober K, Rohr-Udilova N, Trauner M, Reiberger T, Schwabl P. Soluble guanylyl cyclase stimulation and phosphodiesterase-5 inhibition improve portal hypertension and reduce liver fibrosis in bile duct-ligated rats. United European Gastroenterol J 2020;8:1174-85. [PMID: 32878579 DOI: 10.1177/2050640620944140] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
337 Wan S, Wei Y, Zhang X, Yang C, Song B. CT-derived quantitative liver volumetric parameters for prediction of severe esophageal varices and the risk of first variceal hemorrhage. Eur J Radiol 2021;144:109984. [PMID: 34638080 DOI: 10.1016/j.ejrad.2021.109984] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
338 Zheng J, Zhang Y, Li P, Zhang S, Li Y, Li L, Ding H. The endoscopic ultrasound probe findings in prediction of esophageal variceal recurrence after endoscopic variceal eradication therapies in cirrhotic patients: a cohort prospective study. BMC Gastroenterol. 2019;19:32. [PMID: 30782139 DOI: 10.1186/s12876-019-0943-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
339 Scheiner B, Kirstein M, Popp S, Hucke F, Bota S, Rohr-Udilova N, Reiberger T, Müller C, Trauner M, Peck-Radosavljevic M, Vogel A, Sieghart W, Pinter M. Association of Platelet Count and Mean Platelet Volume with Overall Survival in Patients with Cirrhosis and Unresectable Hepatocellular Carcinoma. Liver Cancer 2019;8:203-17. [PMID: 31192156 DOI: 10.1159/000489833] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
340 Huang Z, Yao Q, Zhu J, He Y, Chen Y, Wu F, Hua T. Efficacy and safety of transjugular intrahepatic portosystemic shunt (TIPS) created using covered stents of different diameters: A systematic review and meta-analysis. Diagn Interv Imaging 2021;102:279-85. [PMID: 33303394 DOI: 10.1016/j.diii.2020.11.004] [Reference Citation Analysis]
341 Ronca V, Podda GM, Cattaneo M. An "unmodifiable" risk factor that has been modified. Intern Emerg Med 2021;16:157-9. [PMID: 31396923 DOI: 10.1007/s11739-019-02170-9] [Reference Citation Analysis]
342 Ozturk A, Olson MC, Samir AE, Venkatesh SK. Liver fibrosis assessment: MR and US elastography. Abdom Radiol (NY) 2021. [PMID: 34687329 DOI: 10.1007/s00261-021-03269-4] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
343 Burza MA, Marschall HU, Napoleone L, Molinaro A. The 35-year odyssey of beta blockers in cirrhosis: any gender difference in sight? Pharmacol Res 2017;119:20-6. [PMID: 28099882 DOI: 10.1016/j.phrs.2017.01.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
344 Firat BT, Gulen M, Satar S, Firat A, Acehan S, Isikber C, Kaya A, Sahin GK, Akoglu H. Perfusion index: Could this be a new triage tool for upper gastrointestinal system bleeding in the emergency department? A prospective cohort study. Sao Paulo Med J 2021;139:583-90. [PMID: 34644767 DOI: 10.1590/1516-3180.2021.0106.R1.0904221] [Reference Citation Analysis]
345 Zia HA, Aby ES, Rabiee A. An Update on the Management of Esophageal Variceal Hemorrhage. Clin Liver Dis (Hoboken) 2021;18:179-83. [PMID: 34745574 DOI: 10.1002/cld.1108] [Reference Citation Analysis]
346 Wong VW, Irles M, Wong GL, Shili S, Chan AW, Merrouche W, Shu SS, Foucher J, Le Bail B, Chan WK, Chan HL, de Ledinghen V. Unified interpretation of liver stiffness measurement by M and XL probes in non-alcoholic fatty liver disease. Gut 2019;68:2057-64. [PMID: 30658997 DOI: 10.1136/gutjnl-2018-317334] [Cited by in Crossref: 48] [Cited by in F6Publishing: 44] [Article Influence: 16.0] [Reference Citation Analysis]
347 Chevallier O, Guillen K, Comby PO, Mouillot T, Falvo N, Bardou M, Midulla M, Aho-Glélé LS, Loffroy R. Safety, Efficacy, and Outcomes of N-Butyl Cyanoacrylate Glue Injection through the Endoscopic or Radiologic Route for Variceal Gastrointestinal Bleeding: A Systematic Review and Meta-Analysis. J Clin Med 2021;10:2298. [PMID: 34070534 DOI: 10.3390/jcm10112298] [Reference Citation Analysis]
348 Solà E, Solé C, Simón-talero M, Martín-llahí M, Castellote J, Garcia-martínez R, Moreira R, Torrens M, Márquez F, Fabrellas N, de Prada G, Huelin P, Lopez Benaiges E, Ventura M, Manríquez M, Nazar A, Ariza X, Suñé P, Graupera I, Pose E, Colmenero J, Pavesi M, Guevara M, Navasa M, Xiol X, Córdoba J, Vargas V, Ginès P. Midodrine and albumin for prevention of complications in patients with cirrhosis awaiting liver transplantation. A randomized placebo-controlled trial. Journal of Hepatology 2018;69:1250-9. [DOI: 10.1016/j.jhep.2018.08.006] [Cited by in Crossref: 52] [Cited by in F6Publishing: 39] [Article Influence: 13.0] [Reference Citation Analysis]
349 Baffy G. Potential mechanisms linking gut microbiota and portal hypertension. Liver Int. 2019;39:598-609. [PMID: 30312513 DOI: 10.1111/liv.13986] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
350 Thomas C, Glinskii V, de Jesus Perez V, Sahay S. Portopulmonary Hypertension: From Bench to Bedside. Front Med (Lausanne) 2020;7:569413. [PMID: 33224960 DOI: 10.3389/fmed.2020.569413] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
351 Williams MJ, Hayes P. Improving the management of gastrointestinal bleeding in patients with cirrhosis. Expert Rev Gastroenterol Hepatol 2016;10:505-15. [PMID: 26581713 DOI: 10.1586/17474124.2016.1122523] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
352 Chuah KH, Lai LL, Vethakkan SR, Nik Mustapha NR, Mahadeva S, Chan WK. Liver stiffness measurement in non-alcoholic fatty liver disease: Two is better than one. J Gastroenterol Hepatol 2020;35:1404-11. [PMID: 31907981 DOI: 10.1111/jgh.14978] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
353 Park MK, Lee YB. [Diagnosis and Management of Esophageal and Gastric Variceal Bleeding: Focused on 2019 KASL Clinical Practice Guidelines for Liver Cirrhosis]. Korean J Gastroenterol 2021;78:152-60. [PMID: 34565784 DOI: 10.4166/kjg.2021.113] [Reference Citation Analysis]
354 Ma JL, He LL, Jiang Y, Yang JR, Li P, Zang Y, Wei HS. New model predicting gastroesophageal varices and variceal hemorrhage in patients with chronic liver disease. Ann Hepatol 2020;19:287-94. [PMID: 32197976 DOI: 10.1016/j.aohep.2019.12.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
355 Zhou H, Hu H, Tian M, Chu J, Tian C, Yang Y, Lin S. Validation and Refinement of the Baveno VI Criteria for Ruling Out High-Risk Varices. Gastroenterol Res Pract 2020;2020:4217512. [PMID: 33376483 DOI: 10.1155/2020/4217512] [Reference Citation Analysis]
356 Cifci S, Ekmen N. Evaluation of Non-invasive Fibrosis Markers in Predicting Esophageal Variceal Bleeding. Clin Endosc 2021;54:857-63. [PMID: 34034454 DOI: 10.5946/ce.2021.028] [Reference Citation Analysis]
357 Wan S, Liu X, Jiang H, Teng Z, Song B. Noninvasive imaging assessment of portal hypertension: where are we now and where does the future lie? Expert Rev Mol Diagn 2021;21:343-5. [PMID: 33749473 DOI: 10.1080/14737159.2021.1904897] [Reference Citation Analysis]
358 Senzolo M, Piano S, Shalaby S, Tonon M, Tonello S, Zanetto A, Sacerdoti D, Simioni P, Bombonato G, Burra P, Angeli P. Comparison of Fondaparinux and Low-Molecular-Weight Heparin in the Treatment of Portal Vein Thrombosis in Cirrhosis. Am J Med 2021:S0002-9343(21)00389-2. [PMID: 34197784 DOI: 10.1016/j.amjmed.2021.05.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
359 Wang F, Cui S, Wang F, Li F, Tang F, Zhang X, Gao Y, Lv H. Different scoring systems to predict 6-week mortality in cirrhosis patients with acute variceal bleeding: a retrospective analysis of 202 patients. Scandinavian Journal of Gastroenterology 2018;53:885-90. [DOI: 10.1080/00365521.2018.1481518] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
360 Sigon G, D'Ambrosio R, Clerici M, Pisano G, Chantarangkul V, Sollazzi R, Lombardi R, Peyvandi F, Lampertico P, Fargion S, Tripodi A, Fracanzani AL. Procoagulant imbalance influences cardiovascular and liver damage in chronic hepatitis C independently of steatosis. Liver Int 2019;39:2309-16. [PMID: 31419372 DOI: 10.1111/liv.14213] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
361 Magaz M, Baiges A, Hernández-Gea V. Precision medicine in variceal bleeding: Are we there yet? J Hepatol. 2020;72:774-784. [PMID: 31981725 DOI: 10.1016/j.jhep.2020.01.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
362 Kojima S, Watanabe N, Koizumi J, Kokubu S, Murashima N, Matsutani S, Obara K. Current status of portal vein thrombosis in Japan: Results of a questionnaire survey by the Japan Society for Portal Hypertension: Current status of portal vein thrombosis in Japan. Hepatol Res 2018;48:244-54. [DOI: 10.1111/hepr.12983] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
363 Olson JC, Saeian K. Gastrointestinal Issues in Liver Disease. Crit Care Clin 2016;32:371-84. [PMID: 27339677 DOI: 10.1016/j.ccc.2016.03.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
364 Chen Y, Wang Y, Chen Y, Yu Z, Chi X, Hu KQ, Li Q, Tan L, Xiang D, Shang Q, Lei C, Chen L, Hu X, Wang J, Liu H, Lu W, Chi W, Dong Z, Wang X, Li Z, Xiao H, Chen D, Bai W, Zhang C, Xiao G, Qi X, Chen J, Zhou L, Sun H, Deng M, Qi X, Zhang Z, Qi X, Yang Y. A Novel Noninvasive Program for Staging Liver Fibrosis in Untreated Patients With Chronic Hepatitis B. Clin Transl Gastroenterol 2019;10:1-12. [PMID: 31033506 DOI: 10.14309/ctg.0000000000000033] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
365 Andrade F, Shukla A, Bureau C, Senzolo M, D'alteroche L, Heurgué A, Garcia-pagan J, Turon F, Oberti F, Tripathi D, Roux O, Ceccaldi P, de Raucourt E, Payancé A, Valla D, Plessier A, Rautou P. Pregnancy in idiopathic non-cirrhotic portal hypertension: A multicentric study on maternal and fetal management and outcome. Journal of Hepatology 2018;69:1242-9. [DOI: 10.1016/j.jhep.2018.08.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
366 Santos Lucio A, Rodríguez Tirado I, Aparicio Serrano A, Jurado García J, Barrera Baena P, González Galilea Á, Poyato González A, Pleguezuelo Navarro M, Costán Rodero G, Casáis Juanena L, Montero Álvarez JL, de la Mata M, Hervás Molina AJ, Rodríguez-Perálvarez ML. Endoscopic findings unrelated to portal hypertension in patients with liver cirrhosis undergoing a varicose vein screening programme. Gastroenterol Hepatol 2021:S0210-5705(21)00228-4. [PMID: 34400186 DOI: 10.1016/j.gastrohep.2021.07.010] [Reference Citation Analysis]
367 Schwabl P, Hambruch E, Budas GR, Supper P, Burnet M, Liles JT, Birkel M, Brusilovskaya K, Königshofer P, Peck-Radosavljevic M, Watkins WJ, Trauner M, Breckenridge DG, Kremoser C, Reiberger T. The Non-Steroidal FXR Agonist Cilofexor Improves Portal Hypertension and Reduces Hepatic Fibrosis in a Rat NASH Model. Biomedicines 2021;9:60. [PMID: 33435509 DOI: 10.3390/biomedicines9010060] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
368 Olveira A, Domínguez L, Troya J, Arias A, Pulido F, Ryan P, Benítez LM, González-García J, Montes ML; PALT-M-Study Group Investigators. Persistently altered liver test results in hepatitis C patients after sustained virological response with direct-acting antivirals. J Viral Hepat 2018;25:818-24. [PMID: 29476581 DOI: 10.1111/jvh.12883] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
369 Siramolpiwat S, Kiattikunrat K, Soontararatpong R, Pornthisarn B, Vilaichone RK, Chonprasertsuk S, Bhanthumkomol P, Nunanun P, Issariyakulkarn N. Frailty as tested by the Liver Frailty Index is associated with decompensation and unplanned hospitalization in patients with compensated cirrhosis. Scand J Gastroenterol 2021;:1-10. [PMID: 34338110 DOI: 10.1080/00365521.2021.1957497] [Reference Citation Analysis]
370 Saluja SS, Kumar A, Govind H, Varshney VK, Khullar R, Mishra PK. Splenectomy with endotherapy in non-cirrhotic portal fibrosis related portal hypertension: Can it be an alternative to proximal spleno-renal shunt? Ann Hepatobiliary Pancreat Surg 2020;24:168-73. [PMID: 32457262 DOI: 10.14701/ahbps.2020.24.2.168] [Reference Citation Analysis]
371 Wang H, Chen J. Reply to: "Prospective validation of Baveno VI criteria in virally supressed HBV cirrhosis - more evidence is needed". J Hepatol 2021;74:759-60. [PMID: 33353742 DOI: 10.1016/j.jhep.2020.12.002] [Reference Citation Analysis]
372 Hosokawa I, Adam R, Allard M, Pittau G, Vibert E, Cherqui D, Sa Cunha A, Bismuth H, Miyazaki M, Castaing D. Outcomes of surgical shunts and transjugular intrahepatic portasystemic stent shunts for complicated portal hypertension. British Journal of Surgery 2017;104:443-51. [DOI: 10.1002/bjs.10431] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
373 Liu K, Wong VW, Lau K, Liu SD, Tse Y, Yip TC, Kwok R, Chan AY, Chan HL, Wong GL. Prognostic Value of Controlled Attenuation Parameter by Transient Elastography. American Journal of Gastroenterology 2017;112:1812-23. [DOI: 10.1038/ajg.2017.389] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 8.8] [Reference Citation Analysis]
374 Ratti F, Cipriani F, Fiorentini G, Catena M, Paganelli M, Aldrighetti L. Reappraisal of the advantages of laparoscopic liver resection for intermediate hepatocellular carcinoma within a stage migration perspective: Propensity score analysis of the differential benefit. J Hepatobiliary Pancreat Sci 2020;27:510-21. [PMID: 32189450 DOI: 10.1002/jhbp.736] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
375 Qi X, Zhang X, Li Z, Hui J, Xiang Y, Chen J, Zhao J, Li J, Qi FZ, Xu Y. HVPG signature: A prognostic and predictive tool in hepatocellular carcinoma. Oncotarget 2016;7:62789-96. [PMID: 27566593 DOI: 10.18632/oncotarget.11558] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
376 Jeanniard-malet O, Duché M, Fabre A. Survey on Clinical Practice of Primary Prophylaxis in Portal Hypertension in Children. Journal of Pediatric Gastroenterology & Nutrition 2017;64:524-7. [DOI: 10.1097/mpg.0000000000001453] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 3.4] [Reference Citation Analysis]
377 Pavlides M, Mózes FE, Harrison SA. Reply to: Non-invasive tests and advanced chronic liver disease in NAFLD: two steps forward and one step back? Gut 2021:gutjnl-2021-326313. [PMID: 34706868 DOI: 10.1136/gutjnl-2021-326313] [Reference Citation Analysis]
378 Snowdon VK, Fallowfield JA. Editorial: measuring inflammatory and fibrotic components of portal hypertension - a noninvasive hepatic venous pressure gradient? Aliment Pharmacol Ther 2016;44:204-5. [PMID: 27296685 DOI: 10.1111/apt.13667] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
379 Simon K, Orłowska I, Pazgan-Simon M. The risk of complications of endoscopic procedures in patients with liver cirrhosis. Clin Exp Hepatol 2017;3:135-40. [PMID: 29062903 DOI: 10.5114/ceh.2017.70284] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
380 Baiges A, Magaz M, Turon F, Hernández-Gea V, García-Pagán JC. Treatment of Acute Variceal Bleeding in 2021-When to Use Transjugular Intrahepatic Portosystemic Shunts? Clin Liver Dis 2021;25:345-56. [PMID: 33838854 DOI: 10.1016/j.cld.2021.01.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
381 Görtzen J, Hunka LM, Vonnahme M, Praktiknjo M, Kaifie A, Fimmers R, Jansen C, Heine A, Lehmann J, Goethert JR, Gattermann N, Goekkurt E, Platzbecker U, Brossart P, Strassburg CP, Brummendorf TH, Koschmieder S, Wolf D, Trebicka J. γ-Glutamyl Transferase Is an Independent Biomarker of Splanchnic Thrombosis in Patients With Myeloproliferative Neoplasm. Medicine (Baltimore) 2016;95:e3355. [PMID: 27196445 DOI: 10.1097/MD.0000000000003355] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
382 Xu X, Liu B, Lin S, Li B, Wu Y, Li Y, Zhu Q, Yang Y, Tang S, Meng F, Chen Y, Yuan S, Shao L, Bernardi M, Yoshida EM, Qi X. Terlipressin May Decrease In-Hospital Mortality of Cirrhotic Patients with Acute Gastrointestinal Bleeding and Renal Dysfunction: A Retrospective Multicenter Observational Study. Adv Ther 2020;37:4396-413. [PMID: 32860184 DOI: 10.1007/s12325-020-01466-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
383 Galizzi HO, Couto CA, Taranto DOL, Araújo SIO, Vilela EG. Accuracy of non-invasive methods/models for predicting esophageal varices in patients with compensated advanced chronic liver disease secondary to nonalcoholic fatty liver disease. Ann Hepatol 2021;20:100229. [PMID: 32745630 DOI: 10.1016/j.aohep.2020.07.003] [Reference Citation Analysis]
384 Sanchez LO, Francoz C. Global strategy for the diagnosis and management of acute kidney injury in patients with liver cirrhosis. United European Gastroenterol J 2021;9:220-8. [PMID: 33337286 DOI: 10.1177/2050640620980713] [Reference Citation Analysis]
385 Procopet B, Berzigotti A. Diagnosis of cirrhosis and portal hypertension: imaging, non-invasive markers of fibrosis and liver biopsy. Gastroenterol Rep (Oxf). 2017;5:79-89. [PMID: 28533906 DOI: 10.1093/gastro/gox012] [Cited by in Crossref: 62] [Cited by in F6Publishing: 46] [Article Influence: 12.4] [Reference Citation Analysis]
386 Poddar U, Borkar V, Yachha SK, Srivastava A. Endoscopic management of bleeding gastric varices with N-butyl, 2-cyanoacrylate glue injection in children with non-cirrhotic portal hypertension. Endosc Int Open 2016;4:E1063-7. [PMID: 27757413 DOI: 10.1055/s-0042-114981] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
387 Lin TC, Chang WL. Multifocal gastrointestinal varices: a rare manifestation of immunoglobulin G4-related disease. Postgrad Med 2019;131:176-81. [PMID: 30632442 DOI: 10.1080/00325481.2019.1568018] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
388 Rajoriya N, Tripathi D. Non-selective beta-blockers in cirrhosis: Current concepts and controversies. World J Pharmacol 2016; 5(1): 15-31 [DOI: 10.5497/wjp.v5.i1.15] [Reference Citation Analysis]
389 Mendoza YP, Shengir M, Bosch J, Sebastiani G, Berzigotti A. FIB-4 Improves LSM-Based Prediction of Complications in Overweight or Obese Patients With Compensated Advanced Chronic Liver Disease. Clin Gastroenterol Hepatol 2021:S1542-3565(21)00271-8. [PMID: 33716139 DOI: 10.1016/j.cgh.2021.03.007] [Reference Citation Analysis]
390 Duan Z, Li L, Li J, Zhou S. Validation of the Combined Model Based on Platelet Count and Albumin to Rule out High-Risk Varices in Liver Cirrhosis. Biomed Res Int 2020;2020:5783748. [PMID: 32766309 DOI: 10.1155/2020/5783748] [Reference Citation Analysis]
391 Cho E, Jun CH, Cho SB, Park CH, Kim HS, Choi SK, Rew JS. Endoscopic variceal ligation-induced ulcer bleeding: What are the risk factors and treatment strategies? Medicine (Baltimore) 2017;96:e7157. [PMID: 28614248 DOI: 10.1097/MD.0000000000007157] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 1.8] [Reference Citation Analysis]
392 Cassinotto C, Lapuyade B, Guiu B, Marraud des Grottes H, Piron L, Merrouche W, Irles-depe M, Molinari N, De Ledinghen V. Agreement Between 2-Dimensional Shear Wave and Transient Elastography Values for Diagnosis of Advanced Chronic Liver Disease. Clinical Gastroenterology and Hepatology 2020;18:2971-2979.e3. [DOI: 10.1016/j.cgh.2020.04.034] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
393 Trebicka J. Non-cirrhotic portal hypertension: A possibly benign but complicated disease. Digestive and Liver Disease 2018;50:845-6. [DOI: 10.1016/j.dld.2018.05.018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
394 Pinter M, Trauner M, Peck-Radosavljevic M, Sieghart W. Cancer and liver cirrhosis: implications on prognosis and management. ESMO Open. 2016;1:e000042. [PMID: 27843598 DOI: 10.1136/esmoopen-2016-000042] [Cited by in Crossref: 108] [Cited by in F6Publishing: 94] [Article Influence: 18.0] [Reference Citation Analysis]
395 Yokoyama S, Ishigami M, Honda T, Kuzuya T, Ishizu Y, Ito T, Hirooka Y, Tanaka Y, Tainaka T, Shirota C, Chiba K, Uchida H, Fujishiro M. Spleen stiffness by 2-D shear wave elastography is the most accurate predictor of high-risk esophagogastric varices in children with biliary atresia. Hepatol Res 2019;49:1162-8. [PMID: 31132304 DOI: 10.1111/hepr.13381] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
396 Zhang ZL, Peng MS, Chen ZM, Long T, Wang LS, Xu ZL. Effect of aluminum phosphate gel on prevention of early rebleeding after ligation of esophageal variceal hemorrhage. World J Gastrointest Surg 2021; 13(12): 1651-1659 [DOI: 10.4240/wjgs.v13.i12.1651] [Reference Citation Analysis]
397 Zullo A, Soncini M, Bucci C, Marmo R; Gruppo Italiano per lo Studio dell'Emorragia Digestiva (GISED) (Appendix). Clinical outcomes in cirrhotics with variceal or nonvariceal gastrointestinal bleeding: A prospective, multicenter cohort study. J Gastroenterol Hepatol 2021. [PMID: 34189770 DOI: 10.1111/jgh.15601] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
398 Long B, Koyfman A, Gottlieb M. What is the Efficacy of Initial Therapies for Bleeding from Esophageal Varices in Adult Patients With Cirrhosis? Ann Emerg Med 2021:S0196-0644(21)00423-6. [PMID: 34353644 DOI: 10.1016/j.annemergmed.2021.05.014] [Reference Citation Analysis]
399 Toshikuni N, Takuma Y, Tsutsumi M. Management of gastroesophageal varices in cirrhotic patients: current status and future directions. Ann Hepatol 2016;15:314-25. [PMID: 27049485 DOI: 10.5604/16652681.1198800] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
400 Liu L, Nie Y, Zhang Y, Liu Q, Zhu X. Liver Stiffness Is a Predictor of Rebleeding in Patients With Hepatitis B-Related Cirrhosis: A Real-World Cohort Study. Front Med (Lausanne) 2021;8:690825. [PMID: 34395474 DOI: 10.3389/fmed.2021.690825] [Reference Citation Analysis]
401 Ravaioli F, Colecchia A, Alemanni LV, Vestito A, Dajti E, Marasco G, Sessa M, Pession A, Bonifazi F, Festi D. Role of imaging techniques in liver veno-occlusive disease diagnosis: recent advances and literature review. Expert Rev Gastroenterol Hepatol. 2019;13:463-484. [PMID: 30895833 DOI: 10.1080/17474124.2019.1588111] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
402 Globig AM, Heeg M, Larsen CS, Ferreira RD, Kindle G, Goldacker S, Strohmeier V, Silva SL, Cunningham-Rundles C, Quinti I, Thimme R, Bettinger D, Schultheiß M, Warnatz K. International multicenter experience of transjugular intrahepatic portosystemic shunt implantation in patients with common variable immunodeficiency. J Allergy Clin Immunol Pract 2021;9:2931-2935.e1. [PMID: 33722695 DOI: 10.1016/j.jaip.2021.02.056] [Reference Citation Analysis]
403 Plaz Torres MC, Best LM, Freeman SC, Roberts D, Cooper NJ, Sutton AJ, Roccarina D, Benmassaoud A, Iogna Prat L, Williams NR, Csenar M, Fritche D, Begum T, Arunan S, Tapp M, Milne EJ, Pavlov CS, Davidson BR, Tsochatzis E, Gurusamy KS. Secondary prevention of variceal bleeding in adults with previous oesophageal variceal bleeding due to decompensated liver cirrhosis: a network meta-analysis. Cochrane Database Syst Rev 2021;3:CD013122. [PMID: 33784794 DOI: 10.1002/14651858.CD013122.pub2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
404 Stefanescu H, Marasco G, Calès P, Fraquelli M, Rosselli M, Ganne‐carriè N, Ledinghen V, Ravaioli F, Colecchia A, Rusu C, Andreone P, Mazzella G, Festi D. A novel spleen‐dedicated stiffness measurement by FibroScan® improves the screening of high‐risk oesophageal varices. Liver Int 2019;40:175-85. [DOI: 10.1111/liv.14228] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
405 Abou-Ismail MY, Prchal JT, Deininger MW, Parker CJ, Lim MY. Anticoagulation management post-transjugular intrahepatic portosystemic shunt in portal hypertension associated with myeloproliferative neoplasms. Blood Coagul Fibrinolysis 2021;32:578-83. [PMID: 34608880 DOI: 10.1097/MBC.0000000000001087] [Reference Citation Analysis]
406 Tseng Y, Ma L, Luo T, Zeng X, Wei Y, Li L, Xu P, Chen S. Thromboembolic Events Secondary to Endoscopic Cyanoacrylate Injection: Can We Foresee Any Red Flags? Can J Gastroenterol Hepatol 2018;2018:1940592. [PMID: 29850452 DOI: 10.1155/2018/1940592] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
407 Tong H, Gan C, Wei B, Wang ZD, Li XD, Qian SJ, Huan H, Zhang LH, Yang Z, Chen YL, Gu YH, Chen LX, Yang YH, Wu H, Tang CW. Risk factors for overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt creation in patients with liver cirrhosis. J Dig Dis 2021;22:31-40. [PMID: 33128287 DOI: 10.1111/1751-2980.12957] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
408 You MW, Kim KW, Pyo J, Huh J, Kim HJ, Lee SJ, Park SH. A Meta-analysis for the Diagnostic Performance of Transient Elastography for Clinically Significant Portal Hypertension. Ultrasound Med Biol. 2017;43:59-68. [PMID: 27751595 DOI: 10.1016/j.ultrasmedbio.2016.07.025] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 7.0] [Reference Citation Analysis]
409 Sutton H, Dhawan A, Grammatikopoulos T. Non-invasive Markers of Portal Hypertension: Appraisal of Adult Experience and Potential Utilisation in Children. J Pediatr Gastroenterol Nutr 2018;66:559-69. [PMID: 29287004 DOI: 10.1097/MPG.0000000000001882] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
410 Hu T, Stock S, Hong W, Chen Y. Modified 'sandwich' injection with or without ligation for variceal bleeding in patients with both esophageal and gastric varices: a retrospective cohort study. Scand J Gastroenterol 2020;55:1219-24. [PMID: 32780613 DOI: 10.1080/00365521.2020.1803959] [Reference Citation Analysis]
411 Di Pasqua LG, Berardo C, Cagna M, Mannucci B, Milanesi G, Croce AC, Ferrigno A, Vairetti M. Long-term cold storage preservation does not affect fatty livers from rats fed with a methionine and choline deficient diet. Lipids Health Dis 2021;20:78. [PMID: 34320998 DOI: 10.1186/s12944-021-01503-y] [Reference Citation Analysis]
412 Tandon P, Bishay K, Fisher S, Yelle D, Carrigan I, Wooller K, Kelly E. Comparison of clinical outcomes between variceal and non-variceal gastrointestinal bleeding in patients with cirrhosis: Outcomes of UGIB in cirrhosis. Journal of Gastroenterology and Hepatology 2018;33:1773-9. [DOI: 10.1111/jgh.14147] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
413 Han H, Yang J, Zhuge Y, Zhang M, Wu M. Point Shear Wave Elastography to Evaluate and Monitor Changing Portal Venous Pressure in Patients with Decompensated Cirrhosis. Ultrasound in Medicine & Biology 2017;43:1134-40. [DOI: 10.1016/j.ultrasmedbio.2017.01.019] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
414 Strnad P, Tacke F, Koch A, Trautwein C. Liver - guardian, modifier and target of sepsis. Nat Rev Gastroenterol Hepatol. 2017;14:55-66. [PMID: 27924081 DOI: 10.1038/nrgastro.2016.168] [Cited by in Crossref: 168] [Cited by in F6Publishing: 155] [Article Influence: 28.0] [Reference Citation Analysis]
415 Rêgo HMC, Medronha EF, Junior EZ, Tovo CV, de Mattos AA. Transjugular intrahepatic portosystemic shunt with transhepatic portal vein puncture guided by ultrasound: a technical alternative. Eur J Gastroenterol Hepatol 2022;34:112-6. [PMID: 34748302 DOI: 10.1097/MEG.0000000000002174] [Reference Citation Analysis]
416 Ishizu Y, Ishigami M, Kuzuya T, Honda T, Hayashi K, Ishikawa T, Hirooka Y, Goto H. Low skeletal muscle mass predicts early mortality in cirrhotic patients with acute variceal bleeding. Nutrition 2017;42:87-91. [DOI: 10.1016/j.nut.2017.06.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
417 Dillon A, Egan K, Kevane B, Galvin Z, Maguire P, Ní Áinle F, Stewart S. Liver stiffness and thrombin generation in compensated cirrhosis. Res Pract Thromb Haemost 2019;3:291-7. [PMID: 31011714 DOI: 10.1002/rth2.12173] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
418 Ishida J, Konishi M, Ebner N, Springer J. Repurposing of approved cardiovascular drugs. J Transl Med 2016;14:269. [PMID: 27646033 DOI: 10.1186/s12967-016-1031-5] [Cited by in Crossref: 38] [Cited by in F6Publishing: 28] [Article Influence: 6.3] [Reference Citation Analysis]
419 Mangas-Sanjuan C, Martínez-Moreno B, Bozhychko M, Compañy L, Martinez J, Ruiz F, Casellas JA, Aparicio JR. Over-the-scope clip for acute esophageal variceal bleeding. Dig Endosc 2019;31:712-6. [PMID: 31330068 DOI: 10.1111/den.13493] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
420 Lin JY, Zhang CH, Zheng L, Song CL, Deng WS, Zhu YM, Zheng L, Wu LZ, Sun LC, Luo M. Assessment of a biofluid mechanics-based model for calculating portal pressure in canines. BMC Vet Res 2020;16:308. [PMID: 32843036 DOI: 10.1186/s12917-020-02478-1] [Reference Citation Analysis]
421 Gotlieb N, Schwartz N, Zelber-Sagi S, Chodick G, Shalev V, Shibolet O. Longitudinal decrease in platelet counts as a surrogate marker of liver fibrosis. World J Gastroenterol 2020; 26(38): 5849-5862 [PMID: 33132639 DOI: 10.3748/wjg.v26.i38.5849] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
422 Yoo JJ, Kim SG, Kim YS. The Diagnostic Accuracy of LOGIQ S8 and E9 Shear Wave Elastography for Staging Hepatic Fibrosis, in Comparison with Transient Elastography. Diagnostics (Basel) 2021;11:1817. [PMID: 34679515 DOI: 10.3390/diagnostics11101817] [Reference Citation Analysis]
423 Faillaci F, Marzi L, Critelli R, Milosa F, Schepis F, Turola E, Andreani S, Vandelli G, Bernabucci V, Lei B, D'Ambrosio F, Bristot L, Cavalletto L, Chemello L, Sighinolfi P, Manni P, Maiorana A, Caporali C, Bianchini M, Marsico M, Turco L, de Maria N, Del Buono M, Todesca P, di Lena L, Romagnoli D, Magistri P, di Benedetto F, Bruno S, Taliani G, Giannelli G, Martinez-Chantar ML, Villa E. Liver Angiopoietin-2 Is a Key Predictor of De Novo or Recurrent Hepatocellular Cancer After Hepatitis C Virus Direct-Acting Antivirals. Hepatology. 2018;68:1010-1024. [PMID: 29604220 DOI: 10.1002/hep.29911] [Cited by in Crossref: 63] [Cited by in F6Publishing: 54] [Article Influence: 21.0] [Reference Citation Analysis]
424 Lu HS, Hsin IF, Chen PH, Yang TC, Chang CY, Huang YH, Hou MC. The indocyanine green retention test as a noninvasive marker for esophageal varices in patients with hepatocellular carcinoma. J Chin Med Assoc 2020;83:737-42. [PMID: 32649412 DOI: 10.1097/JCMA.0000000000000378] [Reference Citation Analysis]
425 Karagiannakis DS, Voulgaris T, Siakavellas SI, Papatheodoridis GV, Vlachogiannakos J. Evaluation of portal hypertension in the cirrhotic patient: hepatic vein pressure gradient and beyond. Scand J Gastroenterol 2018;53:1153-64. [PMID: 30345856 DOI: 10.1080/00365521.2018.1506046] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
426 Alonso López S, Manzano ML, Gea F, Gutiérrez ML, Ahumada AM, Devesa MJ, Olveira A, Polo BA, Márquez L, Fernández I, Cobo JCR, Rayón L, Riado D, Izquierdo S, Usón C, Real Y, Rincón D, Fernández-Rodríguez CM, Bañares R. A Model Based on Noninvasive Markers Predicts Very Low Hepatocellular Carcinoma Risk After Viral Response in Hepatitis C Virus-Advanced Fibrosis. Hepatology 2020;72:1924-34. [PMID: 33022803 DOI: 10.1002/hep.31588] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
427 Kim JH, Sinn DH, Kim K, Kang W, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW. Primary Prophylaxis for Variceal Bleeding and the Improved Survival of Patients with Newly Diagnosed Hepatocellular Carcinoma. Dig Dis Sci 2016;61:3354-62. [PMID: 27435325 DOI: 10.1007/s10620-016-4255-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
428 Robles-Medranda C, Nebel JA, Puga-Tejada M, Oleas R, Baquerizo-Burgos J, Ospina-Arboleda J, Valero M, Pitanga-Lukashok H. Cost-effectiveness of endoscopic ultrasound-guided coils plus cyanoacrylate injection compared to endoscopic cyanoacrylate injection in the management of gastric varices. World J Gastrointest Endosc 2021; 13(1): 13-23 [PMID: 33520103 DOI: 10.4253/wjge.v13.i1.13] [Cited by in CrossRef: 2] [Article Influence: 2.0] [Reference Citation Analysis]
429 Moulin B, Chevallier O, Abdulmalak G, Luu M, Latournerie M, Minello A, Gehin S, Cercueil JP, Midulla M, Loffroy R. Persistence of gastric or esophageal varices on final angiography increases transjugular intrahepatic portosystemic shunt revision rate after polytetrafluoroethylene-covered stent shunt creation. Quant Imaging Med Surg 2018;8:174-81. [PMID: 29675358 DOI: 10.21037/qims.2018.03.05] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
430 Unger LW, Forstner B, Schneglberger S, Muckenhuber M, Eigenbauer E, Bauer D, Scheiner B, Mandorfer M, Trauner M, Reiberger T. Guideline-conform statin use reduces overall mortality in patients with compensated liver disease. Sci Rep. 2019;9:11674. [PMID: 31406146 DOI: 10.1038/s41598-019-47943-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
431 Wong GL, Espinosa WZ, Wong VW. Personalized management of cirrhosis by non-invasive tests of liver fibrosis. Clin Mol Hepatol 2015;21:200-11. [PMID: 26523265 DOI: 10.3350/cmh.2015.21.3.200] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 3.4] [Reference Citation Analysis]
432 Liu F, Ning Z, Liu Y, Liu D, Tian J, Luo H, An W, Huang Y, Zou J, Liu C, Liu C, Wang L, Liu Z, Qi R, Zuo C, Zhang Q, Wang J, Zhao D, Duan Y, Peng B, Qi X, Zhang Y, Yang Y, Hou J, Dong J, Li Z, Ding H, Zhang Y, Qi X. Development and validation of a radiomics signature for clinically significant portal hypertension in cirrhosis (CHESS1701): a prospective multicenter study. EBioMedicine 2018;36:151-8. [PMID: 30268833 DOI: 10.1016/j.ebiom.2018.09.023] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 7.0] [Reference Citation Analysis]
433 Shalimar, Vaishnav M, Elhence A, Kumar R, Mohta S, Palle C, Kumar P, Ranjan M, Vajpai T, Prasad S, Yegurla J, Dhooria A, Banyal V, Agarwal S, Bansal R, Bhattacharjee S, Aggarwal R, Soni KD, Rudravaram S, Singh AK, Altaf I, Choudekar A, Mahapatra SJ, Gunjan D, Kedia S, Makharia G, Trikha A, Garg P, Saraya A. Outcome of Conservative Therapy in Coronavirus disease-2019 Patients Presenting With Gastrointestinal Bleeding. J Clin Exp Hepatol 2021;11:327-33. [PMID: 33519132 DOI: 10.1016/j.jceh.2020.09.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
434 Kim NJ, Su F, Biggins SW. CON: Noninvasive Modalities Are Preferred to Screen for the Diagnosis of Esophageal and Gastric Varices When the Diagnosis of Cirrhosis Is Made. Clin Liver Dis (Hoboken) 2020;16:48-52. [PMID: 32922749 DOI: 10.1002/cld.952] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
435 Téllez L, Ibáñez-Samaniego L, Pérez Del Villar C, Yotti R, Martínez J, Carrión L, Rodríguez de Santiago E, Rivera M, González-Mansilla A, Pastor Ó, Bermejo J, Bañares R, Albillos A. Non-selective beta-blockers impair global circulatory homeostasis and renal function in cirrhotic patients with refractory ascites. J Hepatol 2020;73:1404-14. [PMID: 32446716 DOI: 10.1016/j.jhep.2020.05.011] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
436 Yan X, Shao R, Wang Y, Mao X, Lei J, Zhang L, Zheng J, Liu A, Zhao H, Gao F, Wang J, Li P, Yao S, Xu M, Xu J, Liu D, Mi Y, Gong X, Ye J, Deng M, Dang T, Ji J, Shao C, Liu C, Gu Y, Wu Y, Wang F, Teng G, Li X, Qi X, Ju S, Qi X. Functional magnetic resonance imaging-based assessment of terlipressin vs. octreotide on renal function in cirrhotic patients with acute variceal bleeding (CHESS1903): study protocol of a multicenter randomized controlled trial. Ann Transl Med 2019;7:586. [PMID: 31807567 DOI: 10.21037/atm.2019.09.141] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
437 Intagliata NM, Maitland H, Pellitier S, Caldwell SH. Reversal of direct oral anticoagulants for liver transplantation in cirrhosis: A step forward. Liver Transpl 2017;23:396-7. [DOI: 10.1002/lt.24708] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 4.2] [Reference Citation Analysis]
438 Xiaoqing Z, Na L, Lili M, Jie C, Tiancheng L, Jian W, Shiyao C. Endoscopic Cyanoacrylate Injection with Lauromacrogol for Gastric Varices: Long-Term Outcomes and Predictors in a Retrospective Cohort Study. J Laparoendosc Adv Surg Tech A 2019;29:1135-43. [PMID: 31313965 DOI: 10.1089/lap.2019.0360] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
439 Genescà J, Abraldes JG, Bosch J. Do we need to re-define the Baveno VI elastography criteria for compensated advanced chronic liver disease (cACLD)? Journal of Hepatology 2021;75:750-2. [DOI: 10.1016/j.jhep.2021.04.019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
440 Mantaka A, Augoustaki A, Kouroumalis EA, Samonakis DN. Portal vein thrombosis in cirrhosis: diagnosis, natural history, and therapeutic challenges. Ann Gastroenterol 2018;31:315-29. [PMID: 29720857 DOI: 10.20524/aog.2018.0245] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
441 Loomba R, Adams LA. Advances in non-invasive assessment of hepatic fibrosis. Gut 2020;69:1343-52. [PMID: 32066623 DOI: 10.1136/gutjnl-2018-317593] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 19.5] [Reference Citation Analysis]
442 杨黎, 华建荣, 王定良. 肝硬化消化道出血并急性肠系膜静脉血栓形成的影响因素. 世界华人消化杂志 2017; 25(15): 1396-1399 [DOI: 10.11569/wcjd.v25.i15.1396] [Reference Citation Analysis]
443 Karstensen JG, Ebigbo A, Bhat P, Dinis-Ribeiro M, Gralnek I, Guy C, Le Moine O, Vilmann P, Antonelli G, Ijoma U, Anigbo G, Afiheni M, Duduyemi B, Desalegn H, De Franchis R, Ponchon T, Hassan C, Aabakken L. Endoscopic treatment of variceal upper gastrointestinal bleeding: European Society of Gastrointestinal Endoscopy (ESGE) Cascade Guideline. Endosc Int Open 2020;8:E990-7. [PMID: 32626821 DOI: 10.1055/a-1187-1154] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
444 Li JL, Cheng P, Sheng WY, Zhang JX. Progress in new hemostasis techniques for acute upper gastrointestinal bleeding. Shijie Huaren Xiaohua Zazhi 2021; 29(18): 1035-1042 [DOI: 10.11569/wcjd.v29.i18.1035] [Reference Citation Analysis]
445 Maimone S, Saffioti F, Filomia R, Caccamo G, Saitta C, Pallio S, Consolo P, Sabatini S, Sitajolo K, Franzè MS, Cacciola I, Raimondo G, Squadrito G. Elective endoscopic variceal ligation is not a risk factor for bacterial infection in patients with liver cirrhosis. Dig Liver Dis 2018;50:366-9. [PMID: 29317174 DOI: 10.1016/j.dld.2017.12.012] [Cited by in Crossref: 5] [Article Influence: 1.3] [Reference Citation Analysis]
446 Giuffrè M, Macor D, Masutti F, Abazia C, Tinè F, Patti R, Buonocore MR, Colombo A, Visintin A, Campigotto M, Crocè LS. Evaluation of spleen stiffness in healthy volunteers using point shear wave elastography. Ann Hepatol 2019;18:736-41. [PMID: 31054978 DOI: 10.1016/j.aohep.2019.03.004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 6.7] [Reference Citation Analysis]
447 Kumar A, Lal SB, Bhatia A, Das A. Role of noninvasive tools for prediction of clinically evident portal hypertension in children. Eur J Gastroenterol Hepatol 2020;32:931-7. [PMID: 32243346 DOI: 10.1097/MEG.0000000000001716] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
448 Patel K, Sebastiani G. Limitations of non-invasive tests for assessment of liver fibrosis. JHEP Rep. 2020;2:100067. [PMID: 32118201 DOI: 10.1016/j.jhepr.2020.100067] [Cited by in Crossref: 47] [Cited by in F6Publishing: 36] [Article Influence: 23.5] [Reference Citation Analysis]
449 Abe H, Midorikawa Y, Okada M, Takayama T. Clinical application of magnetic resonance elastography in chronic liver disease: Performance of MRE in CLD. Hepatol Res 2018;48:780-7. [DOI: 10.1111/hepr.13231] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
450 Paternostro R, Becker J, Hofer BS, Panagl V, Schiffke H, Simbrunner B, Semmler G, Schwabl P, Scheiner B, Bucsics T, Bauer D, Binter T, Trauner M, Mandorfer M, Reiberger T. The prognostic value of HVPG-response to non-selective beta-blockers in patients with NASH cirrhosis and varices. Dig Liver Dis 2021:S1590-8658(21)00778-7. [PMID: 34799282 DOI: 10.1016/j.dld.2021.09.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
451 Kim BH, Chung JW, Lee CS, Jang ES, Jeong SH, Kim N, Kim JW. Liver volume index predicts the risk of esophageal variceal hemorrhage in cirrhotic patients on propranolol prophylaxis. Korean J Intern Med 2019;34:1233-43. [PMID: 30759966 DOI: 10.3904/kjim.2018.120] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
452 Piano S, Tonon M, Vettore E, Stanco M, Pilutti C, Romano A, Mareso S, Gambino C, Brocca A, Sticca A, Fasolato S, Angeli P. Incidence, predictors and outcomes of acute-on-chronic liver failure in outpatients with cirrhosis. J Hepatol 2017;67:1177-84. [PMID: 28733221 DOI: 10.1016/j.jhep.2017.07.008] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 8.2] [Reference Citation Analysis]
453 Bultas AC, Teshome B, Richter SK, Schafers S, Cooke E, Call WB. Use of Nonselective β-Blockers in Patients With End-Stage Liver Disease and Select Complications. Ann Pharmacother 2020;54:583-93. [DOI: 10.1177/1060028019893092] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
454 Sarma MS, Seetharaman J. Pediatric non-cirrhotic portal hypertension: Endoscopic outcome and perspectives from developing nations. World J Hepatol 2021; 13(10): 1269-1288 [PMID: 34786165 DOI: 10.4254/wjh.v13.i10.1269] [Reference Citation Analysis]
455 Gunarathne LS, Rajapaksha H, Shackel N, Angus PW, Herath CB. Cirrhotic portal hypertension: From pathophysiology to novel therapeutics. World J Gastroenterol 2020; 26(40): 6111-6140 [PMID: 33177789 DOI: 10.3748/wjg.v26.i40.6111] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
456 Shearer J, Chizhande D, Jones R, Rowe IA. Non-invasive prediction of oesophageal varices in patients with cirrhosis secondary to non-alcoholic fatty liver disease. Journal of Hepatology 2018;69:1202-3. [DOI: 10.1016/j.jhep.2018.08.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
457 Carrier P, Girard M, Debette-gratien M, Ouedraogo N, Loustaud-ratti V, Nubukpo P. Liver elastometry and alcohol withdrawal: Median-term follow-up in a psychiatric unit. Alcohol 2020;89:49-56. [DOI: 10.1016/j.alcohol.2020.07.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
458 Simbrunner B, Röthenbacher A, Haslacher H, Bauer D, Chromy D, Bucsics T, Schwabl P, Paternostro R, Scheiner B, Trauner M, Mandorfer M, Schwarzinger I, Reiberger T. Ascitic fluid polymorphic nuclear cell count impacts on outcome of cirrhotic patients with ascites. United European Gastroenterol J 2019;7:651-61. [PMID: 31210943 DOI: 10.1177/2050640619843000] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
459 Peng Z, Liu L, Han B, Zhou X, Guo X, Qi X. Pharmacological therapy alone or in combination with endoscopic therapy for acute variceal bleeding in hepatocellular carcinoma. Eur J Gastroenterol Hepatol 2018;30:1530-1. [PMID: 30395016 DOI: 10.1097/MEG.0000000000001268] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
460 Ding Q, Li Z, Liu B, Ling L, Tian X, Zhang C. Propranolol prevents liver cirrhosis by inhibiting hepatic stellate cell activation mediated by the PDGFR/Akt pathway. Hum Pathol 2018;76:37-46. [PMID: 29514109 DOI: 10.1016/j.humpath.2018.02.018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
461 Albillos A, Martínez J, Téllez L. Continued controversy over the safety of beta-blockers in decompensated cirrhosis. Hepatology 2016;63:1726-9. [PMID: 26474289 DOI: 10.1002/hep.28293] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
462 Hsieh WY, Chen PH, Lin IY, Su CW, Chao Y, Huo TI, Huang YH, Hou MC, Lin HC, Wu JC. The impact of esophagogastric varices on the prognosis of patients with hepatocellular carcinoma. Sci Rep 2017;7:42577. [PMID: 28209963 DOI: 10.1038/srep42577] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
463 Florea M, Serban T, Tirpe GR, Tirpe A, Lupsor-Platon M. Noninvasive Assessment of Hepatitis C Virus Infected Patients Using Vibration-Controlled Transient Elastography. J Clin Med 2021;10:2575. [PMID: 34200885 DOI: 10.3390/jcm10122575] [Reference Citation Analysis]
464 Unger LW, Forstner B, Muckenhuber M, Scheuba K, Eigenbauer E, Scheiner B, Pfisterer N, Paternostro R, Trauner M, Mandorfer M, Reiberger T. Hepatic Steatosis in Lean Patients: Risk Factors and Impact on Mortality. Dig Dis Sci. 2020;65:2712-2718. [PMID: 31875288 DOI: 10.1007/s10620-019-06000-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
465 Paugam-burtz C, Levesque E, Louvet A, Thabut D, Amathieu R, Bureau C, Camus C, Chanques G, Faure S, Ferrandière M, Francoz C, Galbois A, Gustot T, Ichai C, Ichai P, Jaber S, Lescot T, Moreau R, Roullet S, Saliba F, Thévenot T, Velly L, Weiss E. Management of liver failure in general intensive care unit. Anaesthesia Critical Care & Pain Medicine 2020;39:143-61. [DOI: 10.1016/j.accpm.2019.06.014] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
466 Reiberger T. The Value of Liver and Spleen Stiffness for Evaluation of Portal Hypertension in Compensated Cirrhosis. Hepatol Commun 2021. [PMID: 34904404 DOI: 10.1002/hep4.1855] [Reference Citation Analysis]
467 Kew GS, Chen ZJ, Yip AW, Huang YWC, Tan LY, Dan YY, Gowans M, Huang DQ, Lee GH, Lee YM, Lim SG, Low HC, Muthiah MD, Tai BC, Tan PS. Identifying Patients With Cirrhosis Who Might Avoid Screening Endoscopy Based on Serum Albumin and Bilirubin and Platelet Counts. Clin Gastroenterol Hepatol. 2021;19:199-201.e2. [PMID: 31712081 DOI: 10.1016/j.cgh.2019.11.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
468 Zhang H, Xiao J, Tu J, Zhang M, Zhang F, Yin Q, Zhuge Y. Prevention of variceal rebleeding in cirrhotic patients with spontaneous portosystemic shunts: transjugular intrahepatic portosystemic shunt versus endoscopic treatment. Eur J Gastroenterol Hepatol 2021;33:752-61. [PMID: 33731589 DOI: 10.1097/MEG.0000000000002079] [Reference Citation Analysis]
469 Roccarina D, Rosselli M, Genesca J, Tsochatzis EA. Elastography methods for the non-invasive assessment of portal hypertension. Expert Rev Gastroenterol Hepatol 2018;12:155-64. [PMID: 28856972 DOI: 10.1080/17474124.2017.1374852] [Cited by in Crossref: 31] [Cited by in F6Publishing: 21] [Article Influence: 6.2] [Reference Citation Analysis]
470 Maruyama H, Kobayashi K, Kiyono S, Ogasawara S, Ooka Y, Suzuki E, Chiba T, Kato N. Left gastric vein-based noninvasive test for esophageal varices: a same-day comparison of portal hemodynamic assessment with endoscopic appearance. Clin Transl Gastroenterol 2018;9:154. [PMID: 29795388 DOI: 10.1038/s41424-018-0021-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
471 Darweesh SK, Yosry A, Salah M, Zayed N, Khairy A, Awad A, Mabrouk M, Albuhairi A. Acoustic radiation forced impulse-based splenic prediction model using data mining for the noninvasive prediction of esophageal varices in hepatitis C virus advanced fibrosis. Eur J Gastroenterol Hepatol 2019;31:1533-9. [PMID: 31689264 DOI: 10.1097/MEG.0000000000001458] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
472 Liu J, Shi Q, Xiao S, Zhou C, Zhou B, Yuan F, Zheng C, Lin S, Qian K, Feng G, Xiong B. Using transjugular intrahepatic portosystemic shunt as the first-line therapy in secondary prophylaxis of variceal hemorrhage. J Gastroenterol Hepatol 2020;35:278-83. [PMID: 31222830 DOI: 10.1111/jgh.14761] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
473 Bosch J. EASL Recognition Award Recipient 2015: Prof. Roberto de Franchis. J Hepatol 2015;63:787-8. [PMID: 26272824 DOI: 10.1016/j.jhep.2015.07.019] [Reference Citation Analysis]
474 Nevens F, Bittencourt PL, Coenraad MJ, Ding H, Hou MC, Laterre PF, Mendizabal M, Ortiz-Olvera NX, Vorobioff JD, Zhang W, Angeli P. Recommendations on the Diagnosis and Initial Management of Acute Variceal Bleeding and Hepatorenal Syndrome in Patients with Cirrhosis. Dig Dis Sci 2019;64:1419-31. [PMID: 30684079 DOI: 10.1007/s10620-018-5448-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
475 Bianchini M, Cavani G, Bonaccorso A, Turco L, Vizzutti F, Sartini A, Gitto S, Merighi A, Banchelli F, Villa E, Schepis F. Low molecular weight heparin does not increase bleeding and mortality post-endoscopic variceal band ligation in cirrhotic patients. Liver Int 2018;38:1253-62. [DOI: 10.1111/liv.13728] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
476 Qi X, Méndez-Sánchez N, Mancuso A, Romeiro FG, Guo X. Who should receive endoscopic variceal ligation after recovering from acute variceal bleeding? Hepatology 2018;67:2057-8. [PMID: 29171864 DOI: 10.1002/hep.29684] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
477 Diehl F, Balderramo D. 1-week versus 2-week interval for endoscopic eradication of esophageal varices. Dig Liver Dis 2017;49:230-1. [PMID: 28065525 DOI: 10.1016/j.dld.2016.12.017] [Reference Citation Analysis]
478 Bazarbashi AN, Ryou M. Portal pressure measurement: Have we come full circle? Gastrointest Endosc 2021;93:573-6. [PMID: 33583516 DOI: 10.1016/j.gie.2020.08.007] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
479 Ardevol A, Ibañez-Sanz G, Profitos J, Aracil C, Castellvi JM, Alvarado E, Cachero A, Horta D, Miñana J, Gomez-Pastrana B, Pavel O, Dueñas E, Casas M, Planella M, Castellote J, Villanueva C. Survival of patients with cirrhosis and acute peptic ulcer bleeding compared with variceal bleeding using current first-line therapies. Hepatology 2018;67:1458-71. [PMID: 28714072 DOI: 10.1002/hep.29370] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 5.5] [Reference Citation Analysis]
480 Kimer N, Wiese S, Mo S, Møller S, Bendtsen F. Advances in the treatment of portal hypertension in cirrhosis. Expert Rev Gastroenterol Hepatol 2016;10:961-9. [PMID: 26982499 DOI: 10.1586/17474124.2016.1166952] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
481 Sidali S, Nault JC. Portal hypertension and hepatocellular carcinoma: Navigating uncharted waters. United European Gastroenterol J 2022. [PMID: 34997990 DOI: 10.1002/ueg2.12193] [Reference Citation Analysis]
482 Simón-talero M, Roccarina D, Martínez J, Lampichler K, Baiges A, Low G, Llop E, Praktiknjo M, Maurer MH, Zipprich A, Triolo M, Vangrinsven G, Garcia-martinez R, Dam A, Majumdar A, Picón C, Toth D, Darnell A, Abraldes JG, Lopez M, Kukuk G, Krag A, Bañares R, Laleman W, La Mura V, Ripoll C, Berzigotti A, Trebicka J, Calleja JL, Tandon P, Hernandez-gea V, Reiberger T, Albillos A, Tsochatzis EA, Augustin S, Genescà J, Quiroga S, Yu D, Téllez L, Mandorfer M, Garcia-pagan JC, Berbel C, Ferrusquia J, Ble M, Garcia-criado MA, Belmonte E, Ney M, Margini C, Casu S, Murgia G, Ludwig C, Rönsch M, Stoevesandt D, Carrion L, Botella ER. Association Between Portosystemic Shunts and Increased Complications and Mortality in Patients With Cirrhosis. Gastroenterology 2018;154:1694-1705.e4. [DOI: 10.1053/j.gastro.2018.01.028] [Cited by in Crossref: 66] [Cited by in F6Publishing: 52] [Article Influence: 16.5] [Reference Citation Analysis]
483 Zhang X, Goh GB, Chan W, Wong GL, Fan J, Seto W, Huang Y, Lin H, Lee I, Lee HW, Kim SU, Chow WC, Wong VW, Petta S. Unhealthy lifestyle habits and physical inactivity among Asian patients with non‐alcoholic fatty liver disease. Liver Int 2020;40:2719-31. [DOI: 10.1111/liv.14638] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
484 Schultheiß M, Giesler M, Maruschke L, Schmidt A, Sturm L, Thimme R, Rössle M, Bettinger D. Adjuvant Transjugular Variceal Occlusion at Creation of a Transjugular Intrahepatic Portosystemic Shunt (TIPS): Efficacy and Risks of Bucrylate Embolization. Cardiovasc Intervent Radiol 2019;42:729-36. [PMID: 30788517 DOI: 10.1007/s00270-019-02176-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
485 Chaney A. A Review for the Practicing Clinician: Hepatorenal Syndrome, a Form of Acute Kidney Injury, in Patients with Cirrhosis. Clin Exp Gastroenterol 2021;14:385-96. [PMID: 34675586 DOI: 10.2147/CEG.S323778] [Reference Citation Analysis]
486 El-Zimaity H, Riddell RH. Beyond Helicobacter: dealing with other variants of gastritis-an algorithmic approach. Histopathology 2021;78:48-69. [PMID: 33382486 DOI: 10.1111/his.14283] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
487 Königshofer P, Brusilovskaya K, Schwabl P, Podesser BK, Trauner M, Reiberger T. Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats. J Vis Exp 2018. [PMID: 30124644 DOI: 10.3791/57261] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
488 Ebel NH, Carlin K, Shaffer ML, Shivaram G, Hawkins M, Lane ER, Cooper K, Lindquester WS, Gadodia G, Murray KF. Hepatic Venous Pressure Gradient Measurements in Children: Correlation With Hepatic Histology and Clinical Indicators of Portal Hypertension. J Pediatr Gastroenterol Nutr 2019;68:788-92. [PMID: 30921261 DOI: 10.1097/MPG.0000000000002327] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
489 von Köckritz L, Dufour JF. Management of chronic hepatitis C in 2017. Hamostaseologie 2017;37:186-95. [PMID: 27896359 DOI: 10.5482/HAMO-16-07-0019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
490 Kidney Disease: Improving Global Outcomes (KDIGO) Hepatitis C Work Group. KDIGO 2018 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease. Kidney Int Suppl (2011) 2018;8:91-165. [PMID: 30675443 DOI: 10.1016/j.kisu.2018.06.001] [Cited by in Crossref: 61] [Cited by in F6Publishing: 55] [Article Influence: 15.3] [Reference Citation Analysis]
491 Dalekos GN, Gatselis NK. Variant and Specific Forms of Autoimmune Cholestatic Liver Diseases. Arch Immunol Ther Exp (Warsz) 2019;67:197-211. [PMID: 31165900 DOI: 10.1007/s00005-019-00550-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
492 Liu J, Meng J, Zhou C, Shi Q, Yang C, Ma J, Chen M, Xiong B. A new choice of stent for transjugular intrahepatic portosystemic shunt creation: Viabahn ePTFE covered stent/bare metal stent combination. J Interv Med 2021;4:32-8. [PMID: 34805945 DOI: 10.1016/j.jimed.2020.10.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
493 Zhou Y, Zhang W, Zhang Z, Luo J, Gu J, Liu Q, Ma J, Yan Z, Chen S, Wang J. PTFE-covered TIPS is an effective treatment for secondary preventing variceal rebleeding in cirrhotic patients with high risks. Eur J Gastroenterol Hepatol 2020;32:1235-43. [PMID: 32744824 DOI: 10.1097/MEG.0000000000001686] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
494 Wang J, Zhang X, Zhao S. Transparent cap-assisted endoscopic injection sclerotherapy for the treatment of patients with esophageal varices. Medicine (Baltimore) 2020;99:e20721. [PMID: 32541523 DOI: 10.1097/MD.0000000000020721] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
495 European Association for the Study of the Liver. European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69:406-460. [PMID: 29653741 DOI: 10.1016/j.jhep.2018.03.024] [Cited by in Crossref: 660] [Cited by in F6Publishing: 520] [Article Influence: 165.0] [Reference Citation Analysis]
496 Rashidi-Alavijeh J, Kahraman A, Gerken G, Theysohn JM, Willuweit K, Hoyer DP, Lange CM, Buechter M. Enzymatic liver function measured by LiMAx is superior to current standard methods in predicting transplant-free survival after TIPS implantation. Sci Rep 2021;11:13834. [PMID: 34226640 DOI: 10.1038/s41598-021-93392-5] [Reference Citation Analysis]
497 Libânio D, Marinho RT. Impact of hepatitis C oral therapy in portal hypertension. World J Gastroenterol 2017; 23(26): 4669-4674 [PMID: 28765688 DOI: 10.3748/wjg.v23.i26.4669] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
498 Northup P, Reutemann B. Management of Coagulation and Anticoagulation in Liver Transplantation Candidates. Liver Transpl 2018;24:1119-32. [DOI: 10.1002/lt.25198] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
499 Alves da Silva J, Falcão D, Maia L, Guedes TP, Garrido M, Novo MI, Rocha M, Pinto P, Moreira T, Ferreira JM, Pedroto I. Acute variceal bleeding and out-of-hours endoscopy: Evaluation of an emergency care setting according to Baveno VI guidelines adherence. Dig Liver Dis 2021;53:1320-6. [PMID: 34348881 DOI: 10.1016/j.dld.2021.07.004] [Reference Citation Analysis]
500 Semmler G, Pomej K, Bauer DJM, Balcar L, Simbrunner B, Binter T, Hartl L, Becker J, Pinter M, Quehenberger P, Trauner M, Mandorfer M, Lisman T, Reiberger T, Scheiner B. Safety of direct oral anticoagulants in patients with advanced liver disease. Liver Int 2021;41:2159-70. [PMID: 34152697 DOI: 10.1111/liv.14992] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
501 Marzano A, Tucci A, Chialà C, Saracco GM, Fadda M, Debernardi Venon W. Liver stiffness-based model for portal hypertension and hepatocellular cancer risk in HBV responsive to antivirals. Minerva Gastroenterol Dietol 2019;65. [DOI: 10.23736/s1121-421x.18.02534-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
502 Maurice JB, Brodkin E, Arnold F, Navaratnam A, Paine H, Khawar S, Dhar A, Patch D, O'Beirne J, Mookerjee R, Pinzani M, Tsochatzis E, Westbrook RH. Validation of the Baveno VI criteria to identify low risk cirrhotic patients not requiring endoscopic surveillance for varices. J Hepatol 2016;65:899-905. [PMID: 27388923 DOI: 10.1016/j.jhep.2016.06.021] [Cited by in Crossref: 116] [Cited by in F6Publishing: 90] [Article Influence: 19.3] [Reference Citation Analysis]
503 Hernández-Gea V, Baiges A, Turon F, Garcia-Pagán JC. Idiopathic Portal Hypertension. Hepatology 2018;68:2413-23. [PMID: 30066417 DOI: 10.1002/hep.30132] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
504 Faisal MS, Singh T, Esfeh JM. Performance of elevated PT/INR as a risk factor for re-bleeding after band ligation in patients with acute variceal hemorrhage. Dig Liver Dis 2020;52:1213-4. [PMID: 32778396 DOI: 10.1016/j.dld.2020.07.017] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
505 Chan SS, Colecchia A, Duarte RF, Bonifazi F, Ravaioli F, Bourhis JH. Imaging in Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome. Biol Blood Marrow Transplant 2020;26:1770-9. [PMID: 32593647 DOI: 10.1016/j.bbmt.2020.06.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
506 Hsieh YC, Lee KC, Chen PH, Su CW, Hou MC, Lin HC. Acute kidney injury predicts mortality in cirrhotic patients with gastric variceal bleeding. J Gastroenterol Hepatol 2017;32:1859-66. [PMID: 28271564 DOI: 10.1111/jgh.13777] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
507 Hoshino Y, Sugihara T, Ikeda S, Matsuki Y, Nagahara T, Okano JI, Isomoto H. A vein-viewing application enabled detecting abdominal wall varices related to the presence of non-treated gastroesophageal varices: a cross-sectional study. BMC Med Imaging 2021;21:120. [PMID: 34372801 DOI: 10.1186/s12880-021-00655-8] [Reference Citation Analysis]
508 Cheng S, Chen M, Cai J; National Research Cooperative Group for Diagnosis and Treatment of Hepatocellular Carcinoma with Tumor Thrombus. Chinese expert consensus on multidisciplinary diagnosis and treatment of hepatocellular carcinoma with portal vein tumor thrombus: 2016 edition. Oncotarget. 2017;8:8867-8876. [PMID: 27780939 DOI: 10.18632/oncotarget.12817] [Cited by in Crossref: 27] [Cited by in F6Publishing: 39] [Article Influence: 6.8] [Reference Citation Analysis]
509 Elalfy H, Elsherbiny W, Abdel Rahman A, Elhammady D, Shaltout SW, Elsamanoudy AZ, El Deek B. Diagnostic non-invasive model of large risky esophageal varices in cirrhotic hepatitis C virus patients. World J Hepatol 2016; 8(24): 1028-1037 [PMID: 27648155 DOI: 10.4254/wjh.v8.i24.1028] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
510 Kmeid M, Liu X, Ballentine S, Lee H. Idiopathic Non-Cirrhotic Portal Hypertension and Porto-Sinusoidal Vascular Disease: Review of Current Data. Gastroenterology Res 2021;14:49-65. [PMID: 34007347 DOI: 10.14740/gr1376] [Reference Citation Analysis]
511 Asphaug L, Thiele M, Krag A, Melberg HO. Cost-Effectiveness of Noninvasive Screening for Alcohol-Related Liver Fibrosis.Hepatology. 2020;71:2093-2104. [PMID: 31595545 DOI: 10.1002/hep.30979] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
512 Vine LJ, Subhani M, Acevedo JG. Update on management of gastric varices. World J Hepatol 2019; 11(3): 250-260 [PMID: 30967903 DOI: 10.4254/wjh.v11.i3.250] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
513 Zhou LL, Wang GC, Zhang MY, Huang GJ, Li W, Wang LY, Wang AH, Zhang CQ. Nomogram for hepatic venous pressure gradient in patients with cirrhosis. J Dig Dis 2021;22:488-95. [PMID: 34272920 DOI: 10.1111/1751-2980.13033] [Reference Citation Analysis]
514 Lagging M, Wejstål R, Duberg AS, Aleman S, Weiland O, Westin J; ; for the Swedish Consensus Group. Treatment of hepatitis C virus infection for adults and children: updated Swedish consensus guidelines 2017. Infect Dis (Lond) 2018;50:569-83. [PMID: 29495923 DOI: 10.1080/23744235.2018.1445281] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
515 Wang L, Guo X, Xu X, De Stefano V, Plessier A, Noronha Ferreira C, Qi X. Anticoagulation Favors Thrombus Recanalization and Survival in Patients With Liver Cirrhosis and Portal Vein Thrombosis: Results of a Meta-Analysis. Adv Ther 2021;38:495-520. [PMID: 33155180 DOI: 10.1007/s12325-020-01550-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
516 Zhu Y, Ding H, Fu T, Peng S, Chen S, Luo J, Wang W. Portal hypertension in hepatitis B‐related cirrhosis: Diagnostic accuracy of liver and spleen stiffness by 2‐D shear‐wave elastography. Hepatol Res 2019;49:540-9. [DOI: 10.1111/hepr.13306] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
517 Jung DH, Huh CW, Kim NJ, Kim BW. Optimal endoscopy timing in patients with acute variceal bleeding: A systematic review and meta-analysis. Sci Rep 2020;10:4046. [PMID: 32132589 DOI: 10.1038/s41598-020-60866-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
518 de Mattos ÂZ, Terra C, Farias AQ, Bittencourt PL, Alliance of Brazilian Centers for Cirrhosis Care–the ABC Group. Primary prophylaxis of variceal bleeding in patients with cirrhosis: A comparison of different strategies. World J Gastrointest Endosc 2021; 13(12): 628-637 [DOI: 10.4253/wjge.v13.i12.628] [Reference Citation Analysis]
519 Westbrook RH, Dusheiko G, Williamson C. Pregnancy and liver disease. J Hepatol. 2016;64:933-945. [PMID: 26658682 DOI: 10.1016/j.jhep.2015.11.030] [Cited by in Crossref: 92] [Cited by in F6Publishing: 54] [Article Influence: 13.1] [Reference Citation Analysis]
520 Abd El-salam SM, Ezz MM, Hashem S, Elakel W, Salama R, Elmakhzangy H, Elhefnawi M. Performance of machine learning approaches on prediction of esophageal varices for Egyptian chronic hepatitis C patients. Informatics in Medicine Unlocked 2019;17:100267. [DOI: 10.1016/j.imu.2019.100267] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
521 Trivedi PS, Jensen AM, Kriss MS, Brown MA, Morgan RL, Lindrooth RC, Ho PM, Ryu RK. Ethnoracial Disparity in Hospital Survival following Transjugular Intrahepatic Portosystemic Shunt Creation for Acute Variceal Bleeding in the United States. J Vasc Interv Radiol 2021;32:941-949.e3. [PMID: 33901695 DOI: 10.1016/j.jvir.2021.02.027] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
522 Kotwal V, Mbachi C, Wang Y, Attar B, Randhawa T, Flores E, Robles J, Rosenstengle C, Demetria M, Adeyemi O, Huhn G, Murali AR. A Novel Score to Predict Esophageal Varices in Patients with Compensated Advanced Chronic Liver Disease. Dig Dis Sci 2021;66:2084-91. [PMID: 32648078 DOI: 10.1007/s10620-020-06456-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
523 Blasco-Algora S, Masegosa-Ataz J, Alonso S, Gutiérrez ML, Fernández-Rodriguez C. Non-selective β-blockers in advanced cirrhosis: a critical review of the effects on overall survival and renal function. BMJ Open Gastroenterol 2016;3:e000104. [PMID: 28074149 DOI: 10.1136/bmjgast-2016-000104] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
524 Laschtowitz A, de Veer RC, Van der Meer AJ, Schramm C. Diagnosis and treatment of primary biliary cholangitis. United European Gastroenterol J 2020;8:667-74. [PMID: 32299307 DOI: 10.1177/2050640620919585] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
525 Abbar B, Vimpere D, Khater S, Cellier C, Diehl JL. Cerebral infarction following cyanoacrylate endoscopic therapy of duodenal varices in a patient with a patent foramen ovale. Intern Emerg Med. 2018;13:817-819. [PMID: 29948836 DOI: 10.1007/s11739-018-1892-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
526 Grammatikopoulos T, McKiernan PJ, Dhawan A. Portal hypertension and its management in children. Arch Dis Child 2018;103:186-91. [PMID: 28814423 DOI: 10.1136/archdischild-2015-310022] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
527 Bai Z, Primignani M, Guo X, Zheng K, Li H, Qi X. Incidence and mortality of renal dysfunction in cirrhotic patients with acute gastrointestinal bleeding: a systematic review and meta-analysis. Expert Rev Gastroenterol Hepatol 2019;13:1181-8. [PMID: 31736376 DOI: 10.1080/17474124.2019.1694904] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
528 Wang X, Luo X, Yang L. The use of transjugular intrahepatic portosystemic shunt should be cautious in patients without cirrhosis with obliterative portal vein thrombosis. Hepatology 2016;64:1374-5. [PMID: 27018638 DOI: 10.1002/hep.28583] [Reference Citation Analysis]
529 Sissingh NJ, Groen JV, Koole D, Klok FA, Boekestijn B, Bollen TL, van Santvoort HC, Verdonk RC, Bonsing BA, van Eijck CHJ, van Hooft JE, Mieog JSD; Dutch Pancreatitis Study Group. Therapeutic anticoagulation for splanchnic vein thrombosis in acute pancreatitis: A systematic review and meta-analysis. Pancreatology 2021:S1424-3903(21)00655-4. [PMID: 35012902 DOI: 10.1016/j.pan.2021.12.008] [Reference Citation Analysis]
530 Hamesch K, Guldiken N, Aly M, Hüser N, Hartmann D, Rufat P, Ziol M, Remih K, Lurje G, Scheiner B, Trautwein C, Mandorfer M, Reiberger T, Mueller S, Bruns T, Nahon P, Strnad P. Serum keratin 19 (CYFRA21-1) links ductular reaction with portal hypertension and outcome of various advanced liver diseases. BMC Med 2020;18:336. [PMID: 33176798 DOI: 10.1186/s12916-020-01784-7] [Reference Citation Analysis]
531 Hirschfield GM, Dyson JK, Alexander GJM, Chapman MH, Collier J, Hübscher S, Patanwala I, Pereira SP, Thain C, Thorburn D, Tiniakos D, Walmsley M, Webster G, Jones DEJ. The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines. Gut 2018;67:1568-94. [PMID: 29593060 DOI: 10.1136/gutjnl-2017-315259] [Cited by in Crossref: 93] [Cited by in F6Publishing: 69] [Article Influence: 23.3] [Reference Citation Analysis]
532 Cervo A, Shengir M, Patel K, Sebastiani G. NASH in HIV. Curr HIV/AIDS Rep 2020;17:601-14. [PMID: 32984925 DOI: 10.1007/s11904-020-00531-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
533 Eder SK, Feldman A, Strebinger G, Kemnitz J, Zandanell S, Niederseer D, Strasser M, Haufe H, Sotlar K, Stickel F, Paulweber B, Datz C, Aigner E. Mesenchymal iron deposition is associated with adverse long-term outcome in non-alcoholic fatty liver disease. Liver Int 2020;40:1872-82. [PMID: 32378295 DOI: 10.1111/liv.14503] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
534 Nicoară-farcău O, Han G, Rudler M, Angrisani D, Monescillo A, Torres F, Casanovas G, Bosch J, Lv Y, Thabut D, Fan D, Hernández-gea V, García-pagán JC, Bureau C, Abraldes JG, Nevens F, Caca K, Laleman W, Appenrodt B, Luca A, Vinel JP, Mössner J, Di Pascoli M, Zipprich A, Sauerbruch T, Martinez-lagares F, Ruiz-del-arbol L, Sierra A, Guevara C, Jimenez E, Marrero JM, Buceta E, Sanchez J, Castellot A, Penate M, Cruz A, Pena E, Procopeț B, Giráldez Á, Amitrano L, Villanueva C, Ibañez-samaniego L, Silva-junior G, Martinez J, Genescà J, Trebicka J, Llop E, Palazon JM, Castellote J, Rodrigues S, Gluud LL, Ferreira CN, Barcelo R, Cañete N, Rodríguez M, Ferlitsch A, Mundi JL, Gronbaek H, Hernández-guerra M, Sassatelli R, Dell’era A, Senzolo M, Romero-gómez M, Casas M, Masnou H, Primignani M, Krag A, Calleja JL, Jansen C, Robic MA, Conejo I, Catalina M, Albillos A, Alvarado E, Guardascione MA, Tanțău M, Zuo L, Zhu X, Zhao J, Xue H, Jiang Z, Zhuge Y, Zhang C, Sun J, Ding P, Ren W, Li Y, Zhang K, Zhang W, He C, Zhong J, Peng Q, Ma F, Luo J, Zhang M, Wang G, Sun M, Dong J, Bai W, Guo W, Wang Q, Yuan X, Wang Z, Yu T, Luo B, Li X, Yuan J, Han N, Zhu Y, Niu J, Li K, Yin Z, Nie Y, Fischer P, Horia Ștefănescu, Pop A, Laursen SB, Turon F, Baiges A, Ferrusquía-acosta J, Magaz M, Cerda E, Tellez L, Allegretti G, Macedo G, Haldrup D, Santos P, Moura M, Reis D, Meireles L, Sousa P, Alexandrino P, Navascues C, Augustin S, La Mura V, Bañares R, Diaz R, Gómez ML, Ripoll C. Effects of Early Placement of Transjugular Portosystemic Shunts in Patients With High-Risk Acute Variceal Bleeding: a Meta-analysis of Individual Patient Data. Gastroenterology 2021;160:193-205.e10. [DOI: 10.1053/j.gastro.2020.09.026] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
535 Ogasawara N, Saitoh S, Akuta N, Sezaki H, Suzuki F, Fujiyama S, Kawamura Y, Hosaka T, Kobayashi M, Suzuki Y, Arase Y, Ikeda K, Kumada H. Advantage of liver stiffness measurement before and after direct‐acting antiviral therapy to predict hepatocellular carcinoma and exacerbation of esophageal varices in chronic hepatitis C. Hepatol Res 2020;50:426-38. [DOI: 10.1111/hepr.13467] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
536 Kuetting D, Wolter K, Luetkens J, Trebicka J, Praktiknjo M, Thomas D, Meyer C. AngioJet-assisted transvenous-transhepatic mechanical thrombectomy in the portal vein. Pol J Radiol 2018;83:e536-44. [PMID: 30805065 DOI: 10.5114/pjr.2018.81380] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
537 Kirnake V, Arora A, Sharma P, Goyal M, Chawlani R, Toshniwal J, Kumar A. Non-invasive aspartate aminotransferase to platelet ratio index correlates well with invasive hepatic venous pressure gradient in cirrhosis. Indian J Gastroenterol 2018;37:335-41. [DOI: 10.1007/s12664-018-0879-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
538 Snoga JL, Lusk KA, Attridge RT, Attridge RL. Effect of Nonselective β-Blockers on Mortality in Patients With End-Stage Cirrhosis. Ann Pharmacother 2020;54:322-30. [PMID: 31701773 DOI: 10.1177/1060028019886529] [Reference Citation Analysis]
539 Giannelli V, Roux O, Laouénan C, Manchon P, Ausloos F, Bachelet D, Rautou PE, Weiss E, Moreau R, Mebazaa A, Cohen-Solal A, Durand F, Francoz C. Impact of cardiac function, refractory ascites and beta blockers on the outcome of patients with cirrhosis listed for liver transplantation. J Hepatol 2020;72:463-71. [PMID: 31622697 DOI: 10.1016/j.jhep.2019.10.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
540 Conde I, Vinaixa C, Berenguer M. Hepatitis C-related cirrhosis. Current status. Med Clin (Barc) 2017;148:78-85. [PMID: 27855947 DOI: 10.1016/j.medcli.2016.09.019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
541 Simbrunner B, Mandorfer M, Trauner M, Reiberger T. Gut-liver axis signaling in portal hypertension. World J Gastroenterol 2019; 25(39): 5897-5917 [PMID: 31660028 DOI: 10.3748/wjg.v25.i39.5897] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 19] [Article Influence: 8.7] [Reference Citation Analysis]
542 Díez C, Berenguer J, Ibañez-Samaniego L, Llop E, Pérez-Latorre L, Catalina MV, Hontañón V, Jiménez-Sousa MA, Aldámiz-Echevarría T, Martínez J, Calleja JL, Albillos A, Bellón JM, Resino S, González-García J, Bañares R. Persistence of Clinically Significant Portal Hypertension After Eradication of Hepatitis C Virus in Patients With Advanced Cirrhosis. Clin Infect Dis 2020;71:2726-9. [PMID: 32386053 DOI: 10.1093/cid/ciaa502] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
543 Stanley AJ, Laine L. Management of acute upper gastrointestinal bleeding. BMJ. [DOI: 10.1136/bmj.l536] [Cited by in Crossref: 40] [Cited by in F6Publishing: 25] [Article Influence: 13.3] [Reference Citation Analysis]
544 Ksheerasagar S, Monnappa G, Nagaraj V. Pregnancy in Budd Chiari Syndrome-A Case Report. J Obstet Gynaecol India 2019;69:17-9. [PMID: 30956484 DOI: 10.1007/s13224-018-1138-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
545 Hui RW, Leung CM. Incidence of Gastrointestinal Bleeding after Transesophageal Echocardiography in Patients with Gastroesophageal Varices: A Systematic Review and Meta-Analysis. J Am Soc Echocardiogr 2021:S0894-7317(21)00861-0. [PMID: 34875315 DOI: 10.1016/j.echo.2021.11.014] [Reference Citation Analysis]
546 Arroyo V, Moreau R, Kamath PS, Jalan R, Ginès P, Nevens F, Fernández J, To U, García-Tsao G, Schnabl B. Acute-on-chronic liver failure in cirrhosis. Nat Rev Dis Primers 2016;2:16041. [PMID: 27277335 DOI: 10.1038/nrdp.2016.41] [Cited by in Crossref: 159] [Cited by in F6Publishing: 144] [Article Influence: 26.5] [Reference Citation Analysis]
547 Gîrleanu I, Trifan A, Sfarti C. Splanchnic Vein Thrombosis in Cirrhosis - Areas Still in the Shadow. Clin Transl Gastroenterol 2018;9:211. [PMID: 30523247 DOI: 10.1038/s41424-018-0079-3] [Reference Citation Analysis]
548 Miao Z, Lu J, Yan J, Lu L, Ye B, Gu M. Comparison of Therapies for Secondary Prophylaxis of Esophageal Variceal Bleeding in Cirrhosis: A Network Meta-analysis of Randomized Controlled Trials. Clin Ther 2020;42:1246-1275.e3. [PMID: 32624321 DOI: 10.1016/j.clinthera.2020.04.014] [Reference Citation Analysis]
549 Tran A, Shili-Masmoudi S, Moga L, Chevaliez S, Luciani A, Ruiz I, Ganne-Carrié N, Bureau C, Bourlière M, de Lédinghen V. NON-INVASIVE DIAGNOSIS AND FOLLOW-UP OF CHRONIC INFECTION WITH HEPATITIS C VIRUS. Clin Res Hepatol Gastroenterol 2021;:101771. [PMID: 34332129 DOI: 10.1016/j.clinre.2021.101771] [Reference Citation Analysis]
550 Rout G, Sharma S, Gunjan D, Kedia S, Saraya A, Nayak B, Singh V, Kumar R, Shalimar. Development and Validation of a Novel Model for Outcomes in Patients with Cirrhosis and Acute Variceal Bleeding. Dig Dis Sci 2019;64:2327-37. [PMID: 30830520 DOI: 10.1007/s10620-019-05557-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.7] [Reference Citation Analysis]
551 Siddiqui MS, Vuppalanchi R, Van Natta ML, Hallinan E, Kowdley KV, Abdelmalek M, Neuschwander-Tetri BA, Loomba R, Dasarathy S, Brandman D, Doo E, Tonascia JA, Kleiner DE, Chalasani N, Sanyal AJ; NASH Clinical Research Network. Vibration-Controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease. Clin Gastroenterol Hepatol 2019;17:156-163.e2. [PMID: 29705261 DOI: 10.1016/j.cgh.2018.04.043] [Cited by in Crossref: 112] [Cited by in F6Publishing: 97] [Article Influence: 28.0] [Reference Citation Analysis]
552 Wu WY, Kong DR. Advances in diagnosis and treatment of portal venous thrombosis. Shijie Huaren Xiaohua Zazhi 2021; 29(4): 165-173 [DOI: 10.11569/wcjd.v29.i4.165] [Reference Citation Analysis]
553 Liu X, Wang AJ, Li BM. Progress in endoscopic treatment of gastric varices in patients with liver cirrhosis. Shijie Huaren Xiaohua Zazhi 2018; 26(22): 1355-1359 [DOI: 10.11569/wcjd.v26.i22.1355] [Reference Citation Analysis]
554 Wu CK, Liang CM, Hsu CN, Hung TH, Yuan LT, Nguang SH, Wang JW, Tseng KL, Ku MK, Yang SC, Tai WC, Shih CW, Hsu PI, Wu DC, Chuah SK. The Role of Adjuvant Acid Suppression on the Outcomes of Bleeding Esophageal Varices after Endoscopic Variceal Ligation. PLoS One 2017;12:e0169884. [PMID: 28118373 DOI: 10.1371/journal.pone.0169884] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
555 Schwarzer R, Reiberger T, Mandorfer M, Kivaranovic D, Hametner S, Hametner S, Paternostro R, Scheiner B, Schneeweiss-Friedl J, Trauner M, Schoefl R, Maieron A. The von Willebrand Factor antigen to platelet ratio (VITRO) score predicts hepatic decompensation and mortality in cirrhosis. J Gastroenterol 2020;55:533-42. [PMID: 31832759 DOI: 10.1007/s00535-019-01656-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
556 Gentile I, Scotto R, Coppola C, Staiano L, Amoruso DC, De Simone T, Portunato F, De Pascalis S, Martini S, Macera M, Viceconte G, Tosone G, Buonomo AR, Borgia G, Coppola N. Treatment with direct-acting antivirals improves the clinical outcome in patients with HCV-related decompensated cirrhosis: results from an Italian real-life cohort (Liver Network Activity—LINA cohort). Hepatol Int 2019;13:66-74. [DOI: 10.1007/s12072-018-9914-6] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 5.5] [Reference Citation Analysis]
557 Takehara T, Sakamori R. Remaining challenges for the noninvasive diagnosis of esophageal varices in liver cirrhosis. Esophagus 2020;17:19-24. [PMID: 31620917 DOI: 10.1007/s10388-019-00699-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
558 Marot A, Barbosa J, Duran R, Deltenre P, Denys A. Percutaneous portal vein recanalization using self-expandable nitinol stents in patients with non-cirrhotic non-tumoral portal vein occlusion. Diagnostic and Interventional Imaging 2019;100:147-56. [DOI: 10.1016/j.diii.2018.07.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 3.3] [Reference Citation Analysis]
559 Téllez L, Rodríguez de Santiago E, Albillos A. Enfermedad hepática crónica asociada con cirugía de Fontan. Revista Española de Cardiología 2018;71:192-202. [DOI: 10.1016/j.recesp.2017.10.014] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
560 Noronha Ferreira C, Marinho RT, Cortez-Pinto H, Ferreira P, Dias MS, Vasconcelos M, Alexandrino P, Serejo F, Pedro AJ, Gonçalves A, Palma S, Leite I, Reis D, Damião F, Valente A, Xavier Brito L, Baldaia C, Fatela N, Ramalho F, Velosa J. Incidence, predictive factors and clinical significance of development of portal vein thrombosis in cirrhosis: A prospective study. Liver Int 2019;39:1459-67. [PMID: 31021512 DOI: 10.1111/liv.14121] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 6.3] [Reference Citation Analysis]
561 Garbuzenko DV, Arefyev NO, Kazachkov EL. Antiangiogenic therapy for portal hypertension in liver cirrhosis: Current progress and perspectives. World J Gastroenterol 2018; 24(33): 3738-3748 [PMID: 30197479 DOI: 10.3748/wjg.v24.i33.3738] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
562 Pitton MB, Weinmann A, Kloeckner R, Mittler J, Ruckes C, Düber C, Otto G. Transjugular Portosystemic Stent Shunt: Impact of Right Atrial Pressure on Portal Venous Hemodynamics Within the First Week. Cardiovasc Intervent Radiol 2022;45:102-11. [PMID: 34853873 DOI: 10.1007/s00270-021-03003-z] [Reference Citation Analysis]
563 Boregowda U, Umapathy C, Halim N, Desai M, Nanjappa A, Arekapudi S, Theethira T, Wong H, Roytman M, Saligram S. Update on the management of gastrointestinal varices. World J Gastrointest Pharmacol Ther 2019; 10(1): 1-21 [PMID: 30697445 DOI: 10.4292/wjgpt.v10.i1.1] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 10] [Article Influence: 7.3] [Reference Citation Analysis]
564 Simbrunner B, Beer A, Wöran K, Schmitz F, Primas C, Wewalka M, Pinter M, Dolak W, Scheiner B, Puespoek A, Trauner M, Oberhuber G, Mandorfer M, Reiberger T. Portal hypertensive gastropathy is associated with iron deficiency anemia. Wien Klin Wochenschr 2020;132:1-11. [PMID: 31912289 DOI: 10.1007/s00508-019-01593-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
565 Quentin V, Remy AJ, Macaigne G, Leblanc-Boubchir R, Arpurt JP, Prieto M, Koudougou C, Tsakiris L, Grasset D, Vitte RL, Cuen D, Verlynde J, Elriz K, Ripault MP, Ehrhard F, Baconnier M, Herrmann S, Talbodec N, Lam YH, Bideau K, Costes L, Skinazi F, Touze I, Heresbach D, Lahmek P, Nahon S; Members of the Association Nationale des Hépato-gastroentérologues des Hôpitaux Généraux (ANGH) SANGHRIA Study Group . Prognostic factors associated with upper gastrointestinal bleeding based on the French multicenter SANGHRIA trial. Endosc Int Open 2021;9:E1504-11. [PMID: 34540542 DOI: 10.1055/a-1508-5871] [Reference Citation Analysis]
566 García-Pagán JC, Saffo S, Mandorfer M, Garcia-Tsao G. Where does TIPS fit in the management of patients with cirrhosis? JHEP Rep 2020;2:100122. [PMID: 32671331 DOI: 10.1016/j.jhepr.2020.100122] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
567 Krige J, Spence RT, Jonas E, Hoogerboord M, Ellsmere J. A New Recalibrated Four-Category Child-Pugh Score Performs Better than the Original Child-Pugh and MELD Scores in Predicting In-Hospital Mortality in Decompensated Alcoholic Cirrhotic Patients with Acute Variceal Bleeding: a Real-World Cohort Analysis. World J Surg. 2020;44:241-246. [PMID: 31583458 DOI: 10.1007/s00268-019-05211-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
568 Invernizzi P, Floreani A, Carbone M, Marzioni M, Craxi A, Muratori L, Vespasiani Gentilucci U, Gardini I, Gasbarrini A, Kruger P, Mennini FS, Ronco V, Lanati E, Canonico PL, Alvaro D. Primary Biliary Cholangitis: advances in management and treatment of the disease. Digestive and Liver Disease 2017;49:841-6. [DOI: 10.1016/j.dld.2017.05.001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
569 Nagaoki Y, Imamura M, Teraoka Y, Morio K, Fujino H, Ono A, Nakahara T, Murakami E, Yamauchi M, Kawaoka T, Miki D, Tsuge M, Hiramatsu A, Hayes CN, Chayama K, Aikata H. Impact of viral eradication by direct-acting antivirals on the risk of hepatocellular carcinoma development, prognosis, and portal hypertension in hepatitis C virus-related compensated cirrhosis patients. Hepatol Res 2020;50:1222-33. [PMID: 32767446 DOI: 10.1111/hepr.13554] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
570 Wang S, Huang Y, Hu W, Mao H, McAlindon ME, Liu Y, Yang L, Zhang C, Xu M, He C, Dang T, Wu B, Ji D, Zhang L, Mao X, Zhang L, Liu C, Xu D, Li Y, Li G, Han J, Lv F, Liang X, Jin S, Zhang S, Tai FWD, Xu Q, Yang C, Wang G, Wang L, Li B, Yang H, Xie P, Deng L, Ren L, Chang Z, Wang X, Wang S, Gao X, Li J, Zhu L, Wang F, Zhang L, Zhang G, Jiang X, Pan J, Meng W, Li X, Hou J, Dray X, Liao Z, Qi X. Detachable string magnetically controlled capsule endoscopy for detecting high-risk varices in compensated advanced chronic liver disease (CHESS1801): A prospective multicenter study. Lancet Reg Health West Pac 2021;6:100072. [PMID: 34327406 DOI: 10.1016/j.lanwpc.2020.100072] [Reference Citation Analysis]
571 Bastard C, Miette V, Calès P, Stefanescu H, Festi D, Sandrin L. A Novel FibroScan Examination Dedicated to Spleen Stiffness Measurement. Ultrasound Med Biol 2018;44:1616-26. [PMID: 29731186 DOI: 10.1016/j.ultrasmedbio.2018.03.028] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
572 Tosetti G, Degasperi E, Farina E, D'Ambrosio R, Soffredini R, Borghi M, La Mura V, Primignani M, Lampertico P. Decompensation in Direct-Acting Antiviral Cured Hepatitis C Virus Compensated Patients With Clinically Significant Portal Hypertension: Too Rare to Warrant Universal Β-Blocker Therapy. Am J Gastroenterol 2021;116:1342-4. [PMID: 33606382 DOI: 10.14309/ajg.0000000000001158] [Reference Citation Analysis]
573 Semmler G, Meyer EL, Kozbial K, Schwabl P, Hametner-Schreil S, Zanetto A, Bauer D, Chromy D, Simbrunner B, Scheiner B, Stättermayer AF, Pinter M, Schöfl R, Russo FP, Greenfield H, Schwarz M, Schwarz C, Gschwantler M, Alonso López S, Manzano ML, Ahumada A, Bañares R, Pons M, Rodriguez-Tajes S, Genesca J, Lens S, Trauner M, Ferenci P, Reiberger T, Mandorfer M. HCC risk stratification after cure of hepatitis C in patients with compensated advanced chronic liver disease. J Hepatol 2021:S0168-8278(21)02234-0. [PMID: 34871626 DOI: 10.1016/j.jhep.2021.11.025] [Reference Citation Analysis]
574 Berzigotti A, França M, Martí-aguado D, Martí-bonmatí L. Cuantificación de la fibrosis hepática mediante biomarcadores de imagen. Radiología 2018;60:74-84. [DOI: 10.1016/j.rx.2017.09.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
575 Wong YJ, Kew GS, Tan PS, Chen Z, Putera M, Yip WA, Ang TL, Fock KM, Lee GH, Hsiang J, Huang DQ, Kwek A, Muthiah MD, Kumar R, Tan M, Tan J, Thurairajah PH, Teo EK, Tai BC, Lim SG. Novel albumin, bilirubin and platelet criteria for the exclusion of high-risk varices in compensated advanced chronic liver disease: A validation study. Clin Res Hepatol Gastroenterol 2021;45:101598. [PMID: 33780835 DOI: 10.1016/j.clinre.2020.101598] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
576 Aluizio CLS, Montes CG, Reis GFSR, Nagasako CK. Risk stratification in acute variceal bleeding: Far from an ideal score. Clinics (Sao Paulo) 2021;76:e2921. [PMID: 34190855 DOI: 10.6061/clinics/2021/e2921] [Reference Citation Analysis]
577 Boursier J, Guillaume M, Bouzbib C, Lannes A, Pais R, Smatti S, Cariou B, Bureau C, Ganne-Carrié N, Bourlière M, de Lédinghen V. NON-INVASIVE DIAGNOSIS AND FOLLOW-UP OF NON-ALCOHOLIC FATTY LIVER DISEASE. Clin Res Hepatol Gastroenterol 2021;:101769. [PMID: 34332133 DOI: 10.1016/j.clinre.2021.101769] [Reference Citation Analysis]
578 Simonetto DA, Liu M, Kamath PS. Portal Hypertension and Related Complications: Diagnosis and Management. Mayo Clinic Proceedings 2019;94:714-26. [DOI: 10.1016/j.mayocp.2018.12.020] [Cited by in Crossref: 25] [Cited by in F6Publishing: 13] [Article Influence: 8.3] [Reference Citation Analysis]
579 Mousa N, Abdel-Razik A, Sheta T, G Deiab A, Habib A, Diasty M, Eldesoky A, Taha A, Mousa E, Yassen A, Fathy A, Elgamal A. Endoscopic management of acute oesophageal variceal bleeding within 12 hours of admission is superior to 12-24 hours. Br J Biomed Sci 2021;78:130-4. [PMID: 33305686 DOI: 10.1080/09674845.2020.1857049] [Reference Citation Analysis]
580 Chen M, Wang J, Xiao Y, Wu L, Hu S, Chen S, Yi G, Hu W, Xie X, Zhu Y, Chen Y, Yang Y, Yu H. Automated and real-time validation of gastroesophageal varices under esophagogastroduodenoscopy using a deep convolutional neural network: a multicenter retrospective study (with video). Gastrointestinal Endoscopy 2021;93:422-432.e3. [DOI: 10.1016/j.gie.2020.06.058] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
581 Tandon P, Ismond KP, Riess K, Duarte-rojo A, Al-judaibi B, Dunn MA, Holman J, Howes N, Haykowsky MJF, Josbeno DA, Mcneely M. Exercise in cirrhosis: Translating evidence and experience to practice. Journal of Hepatology 2018;69:1164-77. [DOI: 10.1016/j.jhep.2018.06.017] [Cited by in Crossref: 65] [Cited by in F6Publishing: 59] [Article Influence: 16.3] [Reference Citation Analysis]
582 Chen LT, Martinelli E, Cheng AL, Pentheroudakis G, Qin S, Bhattacharyya GS, Ikeda M, Lim HY, Ho GF, Choo SP, Ren Z, Malhotra H, Ueno M, Ryoo BY, Kiang TC, Tai D, Vogel A, Cervantes A, Lu SN, Yen CJ, Huang YH, Chen SC, Hsu C, Shen YC, Tabernero J, Yen Y, Hsu CH, Yoshino T, Douillard JY. Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: a TOS-ESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO. Ann Oncol. 2020;31:334-351. [PMID: 32067677 DOI: 10.1016/j.annonc.2019.12.001] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 8.3] [Reference Citation Analysis]
583 Karagiannakis DS, Voulgaris T, Koureta E, Chloupi E, Papatheodoridis GV, Vlachogiannakos J. Role of Spleen Stiffness Measurement by 2D-Shear Wave Elastography in Ruling Out the Presence of High-Risk Varices in Cirrhotic Patients. Dig Dis Sci 2019;64:2653-60. [PMID: 30989464 DOI: 10.1007/s10620-019-05616-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
584 Giri S, Sundaram S. Does timing of endoscopy matter for acute upper gastrointestinal bleeding in pediatric portal hypertension? Dig Liver Dis 2022;54:144-5. [PMID: 34782280 DOI: 10.1016/j.dld.2021.10.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
585 Qu JY, Li Z, Su JR, Ma MJ, Xu CQ, Zhang AJ, Liu CX, Yuan HP, Chu YL, Lang CC, Huang LY, Lu L, Li YQ, Zuo XL. Development and Validation of an Automatic Image-Recognition Endoscopic Report Generation System: A Multicenter Study. Clin Transl Gastroenterol. 2020;12:e00282. [PMID: 33395075 DOI: 10.14309/ctg.0000000000000282] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
586 Berenguer J, Gil-Martin Á, Jarrin I, Moreno A, Dominguez L, Montes M, Aldámiz-Echevarría T, Téllez MJ, Santos I, Benitez L, Sanz J, Ryan P, Gaspar G, Alvarez B, Losa JE, Torres-Perea R, Barros C, Martin JVS, Arponen S, de Guzmán MT, Monsalvo R, Vegas A, Garcia-Benayas MT, Serrano R, Gotuzzo L, Menendez MA, Belda LM, Malmierca E, Calvo MJ, Cruz-Martos E, González-García JJ. All-oral direct-acting antiviral therapy against hepatitis C virus (HCV) in human immunodeficiency virus/HCV-coinfected subjects in real-world practice: Madrid coinfection registry findings. Hepatology 2018;68:32-47. [PMID: 29377274 DOI: 10.1002/hep.29814] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 11.3] [Reference Citation Analysis]
587 Brichard M, Iesari S, Lerut J, Reding R, Goffette P, Coubeau L. Meso-Rex bypass for the management of extrahepatic portal vein obstruction in adults (with video). Hepatobiliary Pancreat Dis Int 2021:S1499-3872(21)00159-4. [PMID: 34426078 DOI: 10.1016/j.hbpd.2021.08.003] [Reference Citation Analysis]
588 Pinchot JW, Kalva SP, Majdalany BS, Kim CY, Ahmed O, Asrani SK, Cash BD, Eldrup-Jorgensen J, Kendi AT, Scheidt MJ, Sella DM, Dill KE, Hohenwalter EJ; Expert Panels on Interventional Radiology and Vascular Imaging. ACR Appropriateness Criteria® Radiologic Management of Portal Hypertension. J Am Coll Radiol 2021;18:S153-73. [PMID: 33958110 DOI: 10.1016/j.jacr.2021.02.013] [Reference Citation Analysis]
589 Zhong BY, Wang WS, Shen J, Du H, Zhang S, Li WC, Yin Y, Yang J, Ni CF, Zhu XL. Single-Centre Retrospective Training Cohort Using Artificial Intelligence for Prognostic Prediction of Encephalopathy, Mortality, and Liver Dysfunction after Early TIPS Creation. Cardiovasc Intervent Radiol 2021. [PMID: 34240232 DOI: 10.1007/s00270-021-02907-0] [Reference Citation Analysis]
590 Morrison JD, Mendoza-elias N, Lipnik AJ, Lokken RP, Bui JT, Ray CE, Gaba RC. Gastric Varices Bleed at Lower Portosystemic Pressure Gradients than Esophageal Varices. Journal of Vascular and Interventional Radiology 2018;29:636-41. [DOI: 10.1016/j.jvir.2017.10.014] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
591 Smirne C, Rigamonti C, De Benedittis C, Sainaghi PP, Bellan M, Burlone ME, Castello LM, Avanzi GC. Gas6/TAM Signaling Components as Novel Biomarkers of Liver Fibrosis. Dis Markers 2019;2019:2304931. [PMID: 31583026 DOI: 10.1155/2019/2304931] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
592 Moctezuma-Velazquez C, Kalainy S, Abraldes JG. Beta-blockers in patients with advanced liver disease: Has the dust settled? Liver Transpl. 2017;23:1058-1069. [PMID: 28590564 DOI: 10.1002/lt.24794] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
593 Qi X, Liu F, Li Z, Chen S, Liu Y, Yang Y, Hou J; Chinese Portal Hypertension Noninvasive Diagnosis Study (CHESS) Group. Insufficient accuracy of computed tomography-based portal pressure assessment in hepatitis B virus-related cirrhosis: An analysis of data from CHESS-1601 trial. J Hepatol 2017:S0168-8278(17)32277-8. [PMID: 28887165 DOI: 10.1016/j.jhep.2017.07.037] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
594 Crossan C, Majumdar A, Srivastava A, Thorburn D, Rosenberg W, Pinzani M, Longworth L, Tsochatzis EA. Referral pathways for patients with NAFLD based on non-invasive fibrosis tests: Diagnostic accuracy and cost analysis. Liver Int. 2019;39:2052-2060. [PMID: 31332938 DOI: 10.1111/liv.14198] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
595 Keepanasseril A, Gupta A, Ramesh D, Kothandaraman K, Jeganathan YS, Maurya DK. Maternal-fetal outcome in pregnancies complicated with non-cirrhotic portal hypertension: experience from a Tertiary Centre in South India. Hepatol Int 2020;14:842-9. [PMID: 32588317 DOI: 10.1007/s12072-020-10067-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
596 Pfisterer N, Dexheimer C, Fuchs EM, Bucsics T, Schwabl P, Mandorfer M, Gessl I, Sandrieser L, Baumann L, Riedl F, Scheiner B, Pachofszky T, Dolak W, Schrutka-Kölbl C, Ferlitsch A, Schöniger-Hekele M, Peck-Radosavljevic M, Trauner M, Madl C, Reiberger T. Betablockers do not increase efficacy of band ligation in primary prophylaxis but they improve survival in secondary prophylaxis of variceal bleeding. Aliment Pharmacol Ther 2018;47:966-79. [PMID: 29388229 DOI: 10.1111/apt.14485] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
597 Qi X, An W, Liu F, Qi R, Wang L, Liu Y, Liu C, Xiang Y, Hui J, Liu Z, Qi X, Liu C, Peng B, Ding H, Yang Y, He X, Hou J, Tian J, Li Z. Virtual Hepatic Venous Pressure Gradient with CT Angiography (CHESS 1601): A Prospective Multicenter Study for the Noninvasive Diagnosis of Portal Hypertension. Radiology. 2019;290:370-377. [PMID: 30457484 DOI: 10.1148/radiol.2018180425] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
598 Nawalerspanya S, Sripongpun P, Chamroonkul N, Kongkamol C, Piratvisuth T. Validation of original, expanded Baveno VI, and stepwise & platelet-MELD criteria to rule out varices needing treatment in compensated cirrhosis from various etiologies. Ann Hepatol 2020;19:209-13. [PMID: 31607647 DOI: 10.1016/j.aohep.2019.08.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
599 Haque LYK, Lim JK. Budd-Chiari Syndrome: An Uncommon Cause of Chronic Liver Disease that Cannot Be Missed. Clin Liver Dis 2020;24:453-81. [PMID: 32620283 DOI: 10.1016/j.cld.2020.04.012] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
600 Westin J, Aleman S, Castedal M, Duberg A, Eilard A, Fischler B, Kampmann C, Lindahl K, Lindh M, Norkrans G, Stenmark S, Weiland O, Wejstål R. Management of hepatitis B virus infection, updated Swedish guidelines. Infectious Diseases 2020;52:1-22. [DOI: 10.1080/23744235.2019.1675903] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 3.3] [Reference Citation Analysis]
601 Nakano C, Nishimura T, Tada T, Yoshida M, Takashima T, Aizawa N, Ikeda N, Nishikawa H, Enomoto H, Hatano E, Yano H, Hirota S, Hachiya H, Iijima H. Severity of liver fibrosis using shear wave elastography is influenced by hepatic necroinflammation in chronic hepatitis patients, but not in cirrhotic patients. Hepatol Res 2021;51:436-44. [PMID: 33462941 DOI: 10.1111/hepr.13617] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
602 Paternostro R, Bardach C, Hofer BS, Scheiner B, Schwabl P, Asenbaum U, Ba-Ssalamah A, Scharitzer M, Bucscis T, Simbrunner B, Bauer D, Trauner M, Mandorfer M, Reiberger T, Lampichler K. Prognostic impact of sarcopenia in cirrhotic patients stratified by different severity of portal hypertension. Liver Int. 2021;41:799-809. [PMID: 33290614 DOI: 10.1111/liv.14758] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
603 Barr RG. Ultrasound of Diffuse Liver Disease Including Elastography. Radiol Clin North Am 2019;57:549-62. [PMID: 30928077 DOI: 10.1016/j.rcl.2019.01.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
604 Piccinni R, Rodrigues SG, Montani M, Murgia G, Delgado MG, Casu S, Stirnimann G, Semmo N, De Gottardi A, Dufour JF, Berzigotti A. Controlled attenuation parameter reflects steatosis in compensated advanced chronic liver disease. Liver Int 2020;40:1151-8. [PMID: 31823449 DOI: 10.1111/liv.14325] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
605 Robles‐medranda C, Valero M, Nebel JA, Britto Junior SR, Puga‐tejada M, Ospina J, Muñoz‐jurado G, Pitanga‐lukashok H. Endoscopic‐ultrasound‐guided coil and cyanoacrylate embolization for gastric varices and the roles of endoscopic Doppler and endosonographic varicealography in vascular targeting. Digestive Endoscopy 2019;31:283-90. [DOI: 10.1111/den.13305] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
606 Hu X, Huang X, Hou J, Ding L, Su C, Meng F. Diagnostic accuracy of spleen stiffness to evaluate portal hypertension and esophageal varices in chronic liver disease: a systematic review and meta-analysis. Eur Radiol 2021;31:2392-404. [PMID: 32974686 DOI: 10.1007/s00330-020-07223-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
607 Wu K, Song Q, Gou Y, He S. Sandwich method with or without lauromacrogol in the treatment of gastric variceal bleeding with liver cirrhosis: A meta-analysis. Medicine (Baltimore). 2019;98:e16201. [PMID: 31261565 DOI: 10.1097/md.0000000000016201] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
608 Ibrahim M, Mostafa I, Devière J. New Developments in Managing Variceal Bleeding. Gastroenterology 2018;154:1964-9. [DOI: 10.1053/j.gastro.2018.02.023] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
609 Huh CW, Kim JS, Jung DH, Yang JD, Nam SW, Kwon JH, Kim B. Optimal endoscopy timing according to the severity of underlying liver disease in patients with acute variceal bleeding. Digestive and Liver Disease 2019;51:993-8. [DOI: 10.1016/j.dld.2019.01.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
610 Merchante N, Rivero-Juárez A, Téllez F, Merino D, Ríos-Villegas MJ, Ojeda-Burgos G, Omar M, Macías J, Rivero A, Pérez-Pérez M, Raffo M, López-Montesinos I, Márquez-Solero M, Gómez-Vidal MA, Pineda JA; Grupo Andaluz para el Estudio de las Hepatitis Víricas (HEPAVIR) de la Sociedad Andaluza de Enfermedades Infecciosas (SAEI). Liver stiffness predicts variceal bleeding in HIV/HCV-coinfected patients with compensated cirrhosis. AIDS 2017;31:493-500. [PMID: 27922855 DOI: 10.1097/QAD.0000000000001358] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 3.3] [Reference Citation Analysis]
611 Zhou X, Tripathi D, Song T, Shao L, Han B, Zhu J, Han D, Liu F, Qi X. Terlipressin for the treatment of acute variceal bleeding: A systematic review and meta-analysis of randomized controlled trials. Medicine (Baltimore). 2018;97:e13437. [PMID: 30508958 DOI: 10.1097/md.0000000000013437] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
612 de Wit K, Schaapman JJ, Nevens F, Verbeek J, Coenen S, Cuperus FJC, Kramer M, Tjwa ETTL, Mostafavi N, Dijkgraaf MGW, van Delden OM, Beuers UHW, Coenraad MJ, Takkenberg RB. Prevention of hepatic encephalopathy by administration of rifaximin and lactulose in patients with liver cirrhosis undergoing placement of a transjugular intrahepatic portosystemic shunt (TIPS): a multicentre randomised, double blind, placebo controlled trial (PEARL trial). BMJ Open Gastroenterol 2020;7:e000531. [PMID: 33372103 DOI: 10.1136/bmjgast-2020-000531] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
613 Trivedi HD, Patwardhan VR, Malik R. Chronic hepatitis C infection — Noninvasive assessment of liver fibrosis in the era of direct acting antivirals. Digestive and Liver Disease 2019;51:183-9. [DOI: 10.1016/j.dld.2018.11.016] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
614 Huang X, Zhang W, Chen S, Liu C, Sheng R, Li F, Wang J, Luo J, Xu P. Therapeutic evaluation of arterio-portal fistula-related gastroesophageal variceal bleeding. Oncotarget 2017;8:66584-92. [PMID: 29029539 DOI: 10.18632/oncotarget.16579] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
615 Fabrellas N, Carol M, Palacio E, Aban M, Lanzillotti T, Nicolao G, Chiappa MT, Esnault V, Graf-Dirmeier S, Helder J, Gossard A, Lopez M, Cervera M, Dols LL; LiverHope Consortium Investigators. Nursing Care of Patients With Cirrhosis: The LiverHope Nursing Project. Hepatology 2020;71:1106-16. [PMID: 31944340 DOI: 10.1002/hep.31117] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
616 Liu J, Yang C, Huang S, Zhou C, Shi Q, Qian K, Song S, Xiong B. The combination of balloon-assisted antegrade transvenous obliteration and transjugular intrahepatic portosystemic shunt for the management of cardiofundal varices hemorrhage. Eur J Gastroenterol Hepatol. 2020;32:656-662. [PMID: 32175982 DOI: 10.1097/meg.0000000000001705] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
617 Mitchell J, O'Beirne J. Benefit of haemostatic spray in variceal bleeding: early application of spray or early application of guidelines? Gut 2019;68:1134-5. [PMID: 29871971 DOI: 10.1136/gutjnl-2018-316820] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
618 Bucsics T, Schoder M, Diermayr M, Feldner-Busztin M, Goeschl N, Bauer D, Schwabl P, Mandorfer M, Angermayr B, Cejna M, Ferlitsch A, Sieghart W, Trauner M, Peck-Radosavljevic M, Karner J, Karnel F, Reiberger T. Transjugular intrahepatic portosystemic shunts (TIPS) for the prevention of variceal re-bleeding - A two decades experience. PLoS One 2018;13:e0189414. [PMID: 29315304 DOI: 10.1371/journal.pone.0189414] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
619 Chow JC, Wong GL, Chan AW, Shu SS, Chan CK, Leung JK, Choi PC, Chim AM, Chan HL, Wong VW. Repeating measurements by transient elastography in non-alcoholic fatty liver disease patients with high liver stiffness: Repeating liver stiffness measurements. Journal of Gastroenterology and Hepatology 2019;34:241-8. [DOI: 10.1111/jgh.14311] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 4.8] [Reference Citation Analysis]
620 Zuberbuhler F, Boursier J. Noninvasive diagnosis of liver fibrosis in NAFLD: Tips tricks. Clin Res Hepatol Gastroenterol 2019;43:658-62. [PMID: 31029645 DOI: 10.1016/j.clinre.2019.03.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
621 Fatourou EM, Tsochatzis EA. Transfusion strategies in patients with cirrhosis: less is more. Liver Int 2016;36:503-4. [PMID: 27005695 DOI: 10.1111/liv.13056] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
622 Sharma S, Agarwal S. Prospective validation of Baveno VI criteria in virally supressed HBV cirrhosis - more evidence is needed. J Hepatol 2021;74:758-9. [PMID: 33353741 DOI: 10.1016/j.jhep.2020.10.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
623 Sauerbruch T, Schierwagen R, Trebicka J. Managing portal hypertension in patients with liver cirrhosis. F1000Res 2018;7:F1000 Faculty Rev-533. [PMID: 29780579 DOI: 10.12688/f1000research.13943.1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 3.8] [Reference Citation Analysis]
624 De Stefano V, Qi X, Betti S, Rossi E. Splanchnic vein thrombosis and myeloproliferative neoplasms: molecular-driven diagnosis and long-term treatment. Thromb Haemost 2016;115:240-9. [PMID: 26333846 DOI: 10.1160/TH15-04-0326] [Cited by in Crossref: 37] [Cited by in F6Publishing: 27] [Article Influence: 5.3] [Reference Citation Analysis]
625 Cardoso AC, A Villela-Nogueira C, de Figueiredo-Mendes C, Leão Filho H, Pinto Silva RA, Valle Tovo C, Perazzo H, Matteoni AC, de Carvalho-Filho RJ, Lisboa Bittencourt P. Brazilian Society of Hepatology and Brazilian College of Radiology practice guidance for the use of elastography in liver diseases. Ann Hepatol 2021;22:100341. [PMID: 33737252 DOI: 10.1016/j.aohep.2021.100341] [Reference Citation Analysis]
626 Aghemo A, Piroth L, Bhagani S. What do clinicians need to watch for with direct-acting antiviral therapy? J Int AIDS Soc 2018;21 Suppl 2:e25076. [PMID: 29633552 DOI: 10.1002/jia2.25076] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
627 Labenz C, Beul L, Toenges G, Schattenberg JM, Nagel M, Sprinzl MF, Nguyen-Tat M, Zimmermann T, Huber Y, Marquardt JU, Galle PR, Wörns MA. Validation of the simplified Animal Naming Test as primary screening tool for the diagnosis of covert hepatic encephalopathy. Eur J Intern Med 2019;60:96-100. [PMID: 30131209 DOI: 10.1016/j.ejim.2018.08.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
628 Lampela H, Hukkinen M, Kosola S, Jahnukainen T, Pakarinen MP. Poor performance of noninvasive predictors of esophageal varices during primary prophylaxis surveillance in biliary atresia. J Pediatr Surg 2020;55:2662-7. [PMID: 32682540 DOI: 10.1016/j.jpedsurg.2020.06.017] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
629 Nordmann T, Schlabe S, Feldt T, Gobbi F, Krieg A, Bode JG, Fuchs A, Kraef C, Praktiknjo M, Trebicka J, Ramharter M, Addo MM, Strassburg C, Lohse AW, Luedde T, Schmiedel S, Orth HM. TIPS and splenorenal shunt for complications of portal hypertension in chronic hepatosplenic schistosomiasis-A case series and review of the literature. PLoS Negl Trop Dis 2021;15:e0010065. [PMID: 34932562 DOI: 10.1371/journal.pntd.0010065] [Reference Citation Analysis]
630 Ferraioli G, Barr RG, Dillman JR. Elastography for Pediatric Chronic Liver Disease: A Review and Expert Opinion. J Ultrasound Med 2021;40:909-28. [PMID: 32881048 DOI: 10.1002/jum.15482] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
631 Dunne PDJ, Sinha R, Stanley AJ, Lachlan N, Ireland H, Shams A, Kasthuri R, Forrest EH, Hayes PC. Randomised clinical trial: standard of care versus early-transjugular intrahepatic porto-systemic shunt (TIPSS) in patients with cirrhosis and oesophageal variceal bleeding. Aliment Pharmacol Ther 2020;52:98-106. [PMID: 32452561 DOI: 10.1111/apt.15797] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
632 Jothimani D, Danielraj S, Nallathambi B, Pandurangan B, Kalyanasundaram S, Subbiah K, Ramachandran H, Venugopal R, Dhas D, Rela M. Re: Optimal diagnostic tool for surveillance of oesophageal varices during COVID-19 pandemic. A reply. Clin Radiol 2021;76:782-3. [PMID: 34261596 DOI: 10.1016/j.crad.2021.06.010] [Reference Citation Analysis]
633 Giuffrè M, Macor D, Masutti F, Abazia C, Tinè F, Bedogni G, Tiribelli C, Crocè LS. Spleen Stiffness Probability Index (SSPI): A simple and accurate method to detect esophageal varices in patients with compensated liver cirrhosis. Ann Hepatol 2020;19:53-61. [PMID: 31740162 DOI: 10.1016/j.aohep.2019.09.004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 6.7] [Reference Citation Analysis]
634 Llop E, Lopez M, de la Revilla J, Fernandez N, Trapero M, Hernandez M, Fernández-Carrillo C, Pons F, Martinez JL, Calleja JL. Validation of noninvasive methods to predict the presence of gastroesophageal varices in a cohort of patients with compensated advanced chronic liver disease. J Gastroenterol Hepatol 2017;32:1867-72. [PMID: 28295587 DOI: 10.1111/jgh.13781] [Cited by in Crossref: 36] [Cited by in F6Publishing: 27] [Article Influence: 9.0] [Reference Citation Analysis]
635 Gîrleanu I, Trifan A, Stanciu C, Sfarti C. Portal vein thrombosis in cirrhotic patients - it is always the small pieces that make the big picture. World J Gastroenterol 2018; 24(39): 4419-4427 [PMID: 30356984 DOI: 10.3748/wjg.v24.i39.4419] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
636 Jachs M, Hartl L, Simbrunner B, Bauer D, Paternostro R, Scheiner B, Schwabl P, Stättermayer AF, Pinter M, Eigenbauer E, Quehenberger P, Trauner M, Reiberger T, Mandorfer M. Decreasing von Willebrand Factor Levels Upon Nonselective Beta Blocker Therapy Indicate a Decreased Risk of Further Decompensation, Acute-on-chronic Liver Failure, and Death. Clin Gastroenterol Hepatol 2021:S1542-3565(21)00726-6. [PMID: 34256145 DOI: 10.1016/j.cgh.2021.07.012] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
637 Yan Y, Xing X, Lu Q, Wang X, Men R, Luo X, Yang L. Two-dimensional shear wave elastography for screening varices in Asian patients with primary biliary cholangitis. Expert Rev Gastroenterol Hepatol 2021;15:965-73. [PMID: 33513034 DOI: 10.1080/17474124.2021.1884071] [Reference Citation Analysis]
638 Tseng Y, Ma L, Luo T, Zeng X, Li N, Wei Y, Zhou J, Li F, Chen S. Non-invasive predictive model for hepatic venous pressure gradient based on a 3-dimensional computed tomography volume rendering technology. Exp Ther Med 2018;15:3329-35. [PMID: 29545851 DOI: 10.3892/etm.2018.5816] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
639 Gao Z, Zhao J, Liu X, Li S, Wang M, Gao Y. Portal vein thrombosis associated with high 14-day and 6-week rebleeding in patients after oesophageal variceal band ligation: a retrospective, multicentre, nested case-control study. Hepatol Int 2021. [PMID: 34292507 DOI: 10.1007/s12072-021-10224-4] [Reference Citation Analysis]
640 Kumar A, Sharma P, Anikhindi SA, Prajapati R, Agarwal R, Sharma B, Bansal N, Singla V, Arora A. Can Non-Selective Beta-Blockers (NSBBs) Prevent Enlargement of Small Esophageal Varices in Patients with Cirrhosis? A Meta-analysis. J Clin Exp Hepatol. 2017;7:275-283. [PMID: 29234190 DOI: 10.1016/j.jceh.2017.09.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
641 Rodrigues SG, Montani M, Guixé-Muntet S, De Gottardi A, Berzigotti A, Bosch J. Patients With Signs of Advanced Liver Disease and Clinically Significant Portal Hypertension Do Not Necessarily Have Cirrhosis. Clin Gastroenterol Hepatol 2019;17:2101-2109.e1. [PMID: 30625404 DOI: 10.1016/j.cgh.2018.12.038] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
642 Berzigotti A, Albillos A, Villanueva C, Genescá J, Ardevol A, Augustín S, Calleja JL, Bañares R, García-Pagán JC, Mesonero F, Bosch J; Ciberehd SportDiet Collaborative Group. Effects of an intensive lifestyle intervention program on portal hypertension in patients with cirrhosis and obesity: The SportDiet study. Hepatology 2017;65:1293-305. [PMID: 27997989 DOI: 10.1002/hep.28992] [Cited by in Crossref: 120] [Cited by in F6Publishing: 110] [Article Influence: 24.0] [Reference Citation Analysis]
643 Lesmana CRA, Raharjo M, Gani RA. Managing liver cirrhotic complications: Overview of esophageal and gastric varices. Clin Mol Hepatol 2020;26:444-60. [PMID: 33053928 DOI: 10.3350/cmh.2020.0022] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
644 Rout G, Sharma S, Gunjan D, Kedia S, Nayak B, Shalimar. Comparison of various prognostic scores in variceal and non-variceal upper gastrointestinal bleeding: A prospective cohort study. Indian J Gastroenterol 2019;38:158-66. [PMID: 30830583 DOI: 10.1007/s12664-018-0928-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
645 Lee HA, Chang JM, Goh HG, Kim TH, Lee Y, Suh SJ, Jung YK, Choi HS, Kim ES, Kim JH, An H, Seo YS, Yim HJ, Jeen YT, Yeon JE, Chun HJ, Byun KS, Um SH, Kim CD. Prognosis of patients with gastric variceal bleeding after endoscopic variceal obturation according to the type of varices. European Journal of Gastroenterology & Hepatology 2019;31:211-7. [DOI: 10.1097/meg.0000000000001271] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
646 Li X, Kang N, Qi X, Huang Y. Artificial intelligence in the diagnosis of cirrhosis and portal hypertension. J Med Ultrason (2001) 2021. [PMID: 34787742 DOI: 10.1007/s10396-021-01153-8] [Reference Citation Analysis]
647 Manatsathit W, Samant H, Kapur S, Ingviya T, Esmadi M, Wijarnpreecha K, McCashland T. Accuracy of liver stiffness, spleen stiffness, and LS-spleen diameter to platelet ratio score in detection of esophageal varices: Systemic review and meta-analysis. J Gastroenterol Hepatol 2018;33:1696-706. [PMID: 29736946 DOI: 10.1111/jgh.14271] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 6.5] [Reference Citation Analysis]
648 Liang XE, Chen YP. Clinical Application of Vibration Controlled Transient Elastography in Patients with Chronic Hepatitis B. J Clin Transl Hepatol 2017;5:368-75. [PMID: 29226103 DOI: 10.14218/JCTH.2017.00006] [Reference Citation Analysis]
649 Manguso G, Vignone A, Merli M, Miotti C, Caputo A, Vizza CD, Badagliacca R. Hemodynamic Evaluation of the Right Heart-Pulmonary Circulation Unit in Patients Candidate to Transjugular Intrahepatic Portosystemic Shunt. JCM 2022;11:461. [DOI: 10.3390/jcm11020461] [Reference Citation Analysis]
650 Schwarzer R, Kivaranovic D, Mandorfer M, Paternostro R, Wolrab D, Heinisch B, Reiberger T, Ferlitsch M, Gerner C, Trauner M, Peck-radosavljevic M, Ferlitsch A. Randomised clinical study: the effects of oral taurine 6g/day vs placebo on portal hypertension. Aliment Pharmacol Ther 2018;47:86-94. [DOI: 10.1111/apt.14377] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
651 Nadarevic T, Giljaca V, Colli A, Fraquelli M, Casazza G, Miletic D, Štimac D. Computed tomography for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease. Cochrane Database Syst Rev 2021;10:CD013362. [PMID: 34611889 DOI: 10.1002/14651858.CD013362.pub2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
652 Baffy G. Origins of Portal Hypertension in Nonalcoholic Fatty Liver Disease. Dig Dis Sci 2018;63:563-76. [DOI: 10.1007/s10620-017-4903-5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
653 Parola M, Pinzani M. Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues. Mol Aspects Med. 2019;65:37-55. [PMID: 30213667 DOI: 10.1016/j.mam.2018.09.002] [Cited by in Crossref: 121] [Cited by in F6Publishing: 127] [Article Influence: 30.3] [Reference Citation Analysis]
654 Wei W, Pu YS, Wang XK, Jiang A, Zhou R, Li Y, Zhang QJ, Wei YJ, Chen B, Li ZF. Wall shear stress in portal vein of cirrhotic patients with portal hypertension. World J Gastroenterol 2017; 23(18): 3279-3286 [PMID: 28566887 DOI: 10.3748/wjg.v23.i18.3279] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
655 Liu J, Zhou B, Chen D, Zhou C, Shi Q, Zheng C, Feng G, Yuan F, Ge Y, Xiong B. Transjugular Intrahepatic Portosystemic Shunt Placement in Patients with Schistosomiasis-Induced Liver Fibrosis. Cardiovasc Intervent Radiol 2019;42:1760-70. [PMID: 31363898 DOI: 10.1007/s00270-019-02295-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
656 Bae J, Sinn DH, Kang W, Gwak GY, Choi MS, Paik YH, Lee JH, Koh KC, Paik SW. Validation of the Baveno VI and the expanded Baveno VI criteria to identify patients who could avoid screening endoscopy. Liver Int. 2018;38:1442-1448. [PMID: 29495113 DOI: 10.1111/liv.13732] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 9.8] [Reference Citation Analysis]
657 Surana P, Hercun J, Takyar V, Kleiner DE, Heller T, Koh C. Platelet count as a screening tool for compensated cirrhosis in chronic viral hepatitis. World J Gastrointest Pathophysiol 2021; 12(3): 40-50 [PMID: 34084591 DOI: 10.4291/wjgp.v12.i3.40] [Reference Citation Analysis]
658 Grassi G, Lenci I, Signorello A, Milana M, Baiocchi L. Gastrointestinal endoscopy in cirrhotic patient: Issues on the table. World J Gastrointest Endosc 2021; 13(7): 210-220 [PMID: 34326942 DOI: 10.4253/wjge.v13.i7.210] [Reference Citation Analysis]
659 Becq A, Houdeville C, Tran Minh ML, Steuer N, Danan D, Guillaumot MA, Abou Ali E, Barret M, Amiot A, Carbonell N, Marteau P, Chaput U, Dray X, Camus M; Parisian On-call Endoscopy Team (POET). Experience with the use of a hemostatic powder in 152 patients undergoing urgent endoscopy for gastrointestinal bleeding. Clin Res Hepatol Gastroenterol 2021;45:101558. [PMID: 33168481 DOI: 10.1016/j.clinre.2020.10.003] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
660 Nilles KM, Caldwell SH, Flamm SL. Thrombocytopenia and Procedural Prophylaxis in the Era of Thrombopoietin Receptor Agonists. Hepatol Commun 2019;3:1423-34. [PMID: 31701067 DOI: 10.1002/hep4.1423] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
661 Sun X, Song MQ. Endoscopic treatments for esophageal gastric varices bleeding. Shijie Huaren Xiaohua Zazhi 2018; 26(26): 1562-1566 [DOI: 10.11569/wcjd.v26.i26.1562] [Reference Citation Analysis]
662 Ling L, Li G, Wang G, Meng D, Li Z, Zhang C. Carvedilol improves liver cirrhosis in rats by inhibiting hepatic stellate cell activation, proliferation, invasion and collagen synthesis. Mol Med Rep 2019;20:1605-12. [PMID: 31257490 DOI: 10.3892/mmr.2019.10401] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
663 Ruiz-Blard E, Baiges A, Turon F, Hernández-Gea V, García-Pagán JC. [Early transjugular intrahepatic portosystemic shunt: When, how and in whom?]. Gastroenterol Hepatol 2016;39:472-6. [PMID: 26610770 DOI: 10.1016/j.gastrohep.2015.09.013] [Reference Citation Analysis]
664 Solà E, Pose E, Campion D, Piano S, Roux O, Simon-Talero M, Uschner F, de Wit K, Zaccherini G, Alessandria C, Beuers U, Caraceni P, Francoz C, Mookerjee RP, Trebicka J, Vargas V, Serra M, Torres F, Montagnese S, Krag A, Hernaez R, Korenjak M, Watson H, Abraldes JG, Kamath PS, Ginès P; LiverHope Consortium Investigators. Endpoints and design of clinical trials in patients with decompensated cirrhosis: Position paper of the LiverHope Consortium. J Hepatol 2021;74:200-19. [PMID: 32896580 DOI: 10.1016/j.jhep.2020.08.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
665 Mohan BP, Chandan S, Khan SR, Kotagiri R, Kassab LL, Olaiya B, Ponnada S, Ofosu A, Adler DG. Self-expanding metal stents versus TIPS in treatment of refractory bleeding esophageal varices: a systematic review and meta-analysis. Endosc Int Open 2020;8:E291-300. [PMID: 32118103 DOI: 10.1055/a-1067-4563] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
666 Marasco G, Dajti E, Ravaioli F, Alemanni LV, Capuano F, Gjini K, Colecchia L, Puppini G, Cusumano C, Renzulli M, Golfieri R, Festi D, Colecchia A. Spleen stiffness measurement for assessing the response to β-blockers therapy for high-risk esophageal varices patients. Hepatol Int 2020;14:850-7. [PMID: 32557193 DOI: 10.1007/s12072-020-10062-w] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
667 Berzigotti A. Non-invasive evaluation of portal hypertension using ultrasound elastography. J Hepatol. 2017;67:399-411. [PMID: 28223101 DOI: 10.1016/j.jhep.2017.02.003] [Cited by in Crossref: 110] [Cited by in F6Publishing: 96] [Article Influence: 22.0] [Reference Citation Analysis]
668 Naymagon L. Venous thrombosis of the liver: current and emerging concepts in management. Transl Res 2020;225:54-69. [PMID: 32407789 DOI: 10.1016/j.trsl.2020.04.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
669 Freeman AJ, Ng VL, Harpavat S, Hrycko A, Apted Z, Bulut P, Leong T, Karpen SJ. Level of γ-glutamyltransferase in 2-Year-old Children With Biliary Atresia Associates With Progression of Portal Hypertension. Clin Gastroenterol Hepatol 2017;15:1133-5. [PMID: 28259742 DOI: 10.1016/j.cgh.2017.02.025] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
670 Lee EW, Shahrouki P, Alanis L, Ding P, Kee ST. Management Options for Gastric Variceal Hemorrhage. JAMA Surg. 2019;154:540-548. [PMID: 30942880 DOI: 10.1001/jamasurg.2019.0407] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
671 Graupera I, Solà E, Fabrellas N, Moreira R, Solé C, Huelin P, de la Prada G, Pose E, Ariza X, Risso A, Albertos S, Morales-Ruiz M, Jiménez W, Ginès P. Urine Monocyte Chemoattractant Protein-1 Is an Independent Predictive Factor of Hospital Readmission and Survival in Cirrhosis. PLoS One 2016;11:e0157371. [PMID: 27359339 DOI: 10.1371/journal.pone.0157371] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
672 Zakeri N, Tsochatzis EA. Bleeding Risk with Invasive Procedures in Patients with Cirrhosis and Coagulopathy. Curr Gastroenterol Rep. 2017;19:45. [PMID: 28752476 DOI: 10.1007/s11894-017-0585-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
673 Chen PH, Hsieh WY, Su CW, Hou MC, Wang YP, Hsin IF, Yang TC, Liao WC, Lin HC, Lee FY, Wu JC. Combination of albumin-bilirubin grade and platelets to predict a compensated patient with hepatocellular carcinoma who does not require endoscopic screening for esophageal varices. Gastrointest Endosc. 2018;88:230-239.e2. [PMID: 29317268 DOI: 10.1016/j.gie.2017.12.023] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
674 Castro Filho EC, Perazzo H, Guimaraes RAP, Machado L, Fernandes FF, Perez RM. Reliability and safety of transnasal compared to conventional endoscopy for detecting oesophageal varices in cirrhotic patients. Liver Int. 2018;38:1418-1426. [PMID: 29323459 DOI: 10.1111/liv.13692] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
675 Huang Y, Huang F, Yang L, Hu W, Liu Y, Lin Z, Meng X, Zeng M, He C, Xu Q, Xie G, Liu C, Liang M, Li X, Kang N, Xu D, Wang J, Zhang L, Mao X, Yang C, Xu M, Qi X, Mao H. Development and validation of a radiomics signature as a non-invasive complementary predictor of gastroesophageal varices and high-risk varices in compensated advanced chronic liver disease: A multicenter study. J Gastroenterol Hepatol 2021;36:1562-70. [PMID: 33074566 DOI: 10.1111/jgh.15306] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
676 Peeraphatdit TB, Kamath PS, Shah VH. Beta-blockers in patients with advanced cirrhosis: Red light, green light, yellow light…. Liver Transpl 2017;23:725-6. [PMID: 28452116 DOI: 10.1002/lt.24780] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
677 Turco L, Garcia-Tsao G, Magnani I, Bianchini M, Costetti M, Caporali C, Colopi S, Simonini E, De Maria N, Banchelli F, Rossi R, Villa E, Schepis F. Cardiopulmonary hemodynamics and C-reactive protein as prognostic indicators in compensated and decompensated cirrhosis. J Hepatol. 2018;68:949-958. [PMID: 29331339 DOI: 10.1016/j.jhep.2017.12.027] [Cited by in Crossref: 60] [Cited by in F6Publishing: 50] [Article Influence: 15.0] [Reference Citation Analysis]
678 Kim SG, Larson JJ, Lee JS, Therneau TM, Kim WR. Beneficial and harmful effects of nonselective beta blockade on acute kidney injury in liver transplant candidates. Liver Transpl. 2017;23:733-740. [PMID: 28187503 DOI: 10.1002/lt.24744] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
679 Teng F, Sun KY, Fu ZR. Tailored classification of portal vein thrombosis for liver transplantation: Focus on strategies for portal vein inflow reconstruction. World J Gastroenterol 2020; 26(21): 2691-2701 [PMID: 32550747 DOI: 10.3748/wjg.v26.i21.2691] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
680 Armstrong MJ, Gohar F, Dhaliwal A, Nightingale P, Baker G, Greaves D, Mangat K, Zia Z, Karkhanis S, Olliff S, Mehrzad H, Steeds RP, Tripathi D. Diastolic dysfunction on echocardiography does not predict survival after transjugular intrahepatic portosystemic stent-shunt in patients with cirrhosis. Aliment Pharmacol Ther 2019;49:797-806. [DOI: 10.1111/apt.15164] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
681 Sutton H, Fitzpatrick E, Davenport M, Burford C, Alexander E, Dhawan A, Grammatikopoulos T. Transient Elastography Measurements of Spleen Stiffness as a Predictor of Clinically Significant Varices in Children. Journal of Pediatric Gastroenterology & Nutrition 2018;67:446-51. [DOI: 10.1097/mpg.0000000000002069] [Cited by in Crossref: 12] [Article Influence: 3.0] [Reference Citation Analysis]
682 Wu W, Liu Q, Li W, Kan J, Wang Q, Wang L. Ligation-occluded endoscopic injection sclerotherapy: a novel retrograde strategy for gastroesophageal varices obliteration. Endoscopy 2021;53:E328-9. [PMID: 33096574 DOI: 10.1055/a-1275-9674] [Reference Citation Analysis]
683 Wiles R, Patanwala I, Hankinson B, Healey P, Farrell C, Griffin C, Bonnett L, Richardson P. Can acoustic radiation force imaging of the liver and spleen predict the presence of gastroesophageal varices? Clin Radiol. 2018;73:1046-1051. [PMID: 30245070 DOI: 10.1016/j.crad.2018.07.199] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
684 Dong TS, Kalani A, Aby ES, Le L, Luu K, Hauer M, Kamath R, Lindor KD, Tabibian JH. Machine Learning-based Development and Validation of a Scoring System for Screening High-Risk Esophageal Varices. Clin Gastroenterol Hepatol 2019; 17: 1894-1901. e1. [PMID: 30708109 DOI: 10.1016/j.cgh.2019.01.025] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 5.7] [Reference Citation Analysis]
685 Iogna Prat L, Wilson P, Freeman SC, Sutton AJ, Cooper NJ, Roccarina D, Benmassaoud A, Plaz Torres MC, Hawkins N, Cowlin M, Milne EJ, Thorburn D, Pavlov CS, Davidson BR, Tsochatzis E, Gurusamy KS. Antibiotic treatment for spontaneous bacterial peritonitis in people with decompensated liver cirrhosis: a network meta-analysis. Cochrane Database Syst Rev 2019;9:CD013120. [PMID: 31524949 DOI: 10.1002/14651858.CD013120.pub2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
686 Wang B, Zhou J, Wu X, Sun Y, Li L, Li P, Li M, Jiang W, Xu M, Feng B, Xu X, Cheng J, Xie W, Han T, Wang X, Li H, Piao H, Wu S, Shi Y, Chen S, Kong Y, Ma H, Ou X, Jia J, You H. Screening varices in patients with HBV-related cirrhosis on antiviral therapy: Platelet alone or together with LSM. Liver Int 2021;41:369-77. [PMID: 33277803 DOI: 10.1111/liv.14752] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
687 Elkrief L, Ronot M, Andrade F, Dioguardi Burgio M, Issoufaly T, Zappa M, Roux O, Bissonnette J, Payancé A, Lebrec D, Francoz C, Soubrane O, Valla D, Durand F, Vilgrain V, Castera L, Rautou PE. Non-invasive evaluation of portal hypertension using shear-wave elastography: analysis of two algorithms combining liver and spleen stiffness in 191 patients with cirrhosis. Aliment Pharmacol Ther 2018;47:621-30. [PMID: 29322599 DOI: 10.1111/apt.14488] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 6.5] [Reference Citation Analysis]
688 Matsui N, Imajo K, Yoneda M, Kessoku T, Honda Y, Ogawa Y, Tomeno W, Fujisawa N, Misumi T, Kazumi K, Saito S, Nakajima A. Magnetic resonance elastography increases usefulness and safety of non-invasive screening for esophageal varices. J Gastroenterol Hepatol. 2018;33:2022-2028. [PMID: 29869419 DOI: 10.1111/jgh.14298] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
689 Kjærgaard M, Thiele M, Jansen C, Stæhr Madsen B, Görtzen J, Strassburg C, Trebicka J, Krag A. High risk of misinterpreting liver and spleen stiffness using 2D shear-wave and transient elastography after a moderate or high calorie meal. PLoS One 2017;12:e0173992. [PMID: 28376114 DOI: 10.1371/journal.pone.0173992] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 5.8] [Reference Citation Analysis]
690 Valla DC. Budd-Chiari syndrome/hepatic venous outflow tract obstruction. Hepatol Int. 2018;12:168-180. [PMID: 28685257 DOI: 10.1007/s12072-017-9810-5] [Cited by in Crossref: 46] [Cited by in F6Publishing: 32] [Article Influence: 9.2] [Reference Citation Analysis]
691 Thiele M, Rausch V, Fluhr G, Kjærgaard M, Piecha F, Mueller J, Straub BK, Lupșor-platon M, De-ledinghen V, Seitz HK, Detlefsen S, Madsen B, Krag A, Mueller S. Controlled attenuation parameter and alcoholic hepatic steatosis: Diagnostic accuracy and role of alcohol detoxification. Journal of Hepatology 2018;68:1025-32. [DOI: 10.1016/j.jhep.2017.12.029] [Cited by in Crossref: 46] [Cited by in F6Publishing: 37] [Article Influence: 11.5] [Reference Citation Analysis]
692 Roccarina D, Best LM, Freeman SC, Roberts D, Cooper NJ, Sutton AJ, Benmassaoud A, Plaz Torres MC, Iogna Prat L, Csenar M, Arunan S, Begum T, Milne EJ, Tapp M, Pavlov CS, Davidson BR, Tsochatzis E, Williams NR, Gurusamy KS. Primary prevention of variceal bleeding in people with oesophageal varices due to liver cirrhosis: a network meta-analysis. Cochrane Database Syst Rev 2021;4:CD013121. [PMID: 33822357 DOI: 10.1002/14651858.CD013121.pub2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
693 Hedenstierna M, Nangarhari A, El-Sabini A, Weiland O, Aleman S. Cirrhosis, high age and high body mass index are risk factors for persisting advanced fibrosis after sustained virological response in chronic hepatitis C. J Viral Hepat 2018;25:802-10. [PMID: 29406590 DOI: 10.1111/jvh.12879] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
694 Iwakiri Y, Trebicka J. Portal hypertension in cirrhosis: Pathophysiological mechanisms and therapy. JHEP Rep 2021;3:100316. [PMID: 34337369 DOI: 10.1016/j.jhepr.2021.100316] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
695 Waguri N, Osaki A, Watanabe Y. Balloon-occluded retrograde transvenous obliteration for treatment of gastric varices. World J Hepatol 2021; 13(6): 650-661 [PMID: 34239700 DOI: 10.4254/wjh.v13.i6.650] [Reference Citation Analysis]
696 Ippolito AM, Iacobellis A, Milella M, Conti F, Messina V, Valvano MR, Niro GA, Morisco F, Barone M, Termite AP, Brancaccio G, Andriulli A. Hepatitis C Virus Clearance in Older Adults. J Am Geriatr Soc 2018;66:85-91. [PMID: 29135030 DOI: 10.1111/jgs.15140] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
697 De Vos N, Sartoris R, Cauchy F, Rautou P, Vilgrain V, Ronot M. Performance of liver surface nodularity quantification for the diagnosis of portal hypertension in patients with cirrhosis: comparison between MRI with hepatobiliary phase sequences and CT. Abdom Radiol 2020;45:365-72. [DOI: 10.1007/s00261-019-02355-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
698 Angelico R, Pietrobattista A, Candusso M, Tomarchio S, Pellicciaro M, Liccardo D, Basso MS, Grimaldi C, Saffioti MC, Torroni F, Dall'Oglio L, Torre G, Spada M. Primary Prophylaxis for Gastrointestinal Bleeding in Children With Biliary Atresia and Portal Hypertension Candidates for Liver Transplantation: A Single-Center Experience. Transplant Proc 2019;51:171-8. [PMID: 30655149 DOI: 10.1016/j.transproceed.2018.04.074] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
699 Qi X, Li Y, Wang R, Lin L, Li J, Wang L, Zheng S, Sun Y, Zhao L, Fu X, Wang M, Qiu X, Deng H, Hong C, Li Q, Li H, Guo X. Liaoning Score for Prediction of Esophageal Varices in Cirrhotic Patients Who Had Never Undergone Endoscopy: A Multicenter Cross-Sectional Study in Liaoning Province, China. Adv Ther 2019;36:2167-78. [PMID: 31093864 DOI: 10.1007/s12325-019-00967-w] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
700 Majumdar A, Campos S, Gurusamy K, Pinzani M, Tsochatzis EA. Defining the Minimum Acceptable Diagnostic Accuracy of Noninvasive Fibrosis Testing in Cirrhosis: A Decision Analytic Modeling Study. Hepatology 2020;71:627-42. [PMID: 31297832 DOI: 10.1002/hep.30846] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
701 Fouad R, Hamza I, Khairy M, Elsharkawy M, Helmy AA. Role of Serum Soluble CD163 in the Diagnosis, Risk of Bleeding, and Prognosis of Gastro-Esophageal Varices in Cirrhotic Patients. Journal of Interferon & Cytokine Research 2017;37:112-8. [DOI: 10.1089/jir.2016.0098] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
702 Han X, Li J, Yang JM, Gao M, Wang L. A retrospective analysis of hyponatremia during terlipressin treatment in patients with esophageal or gastric variceal bleeding due to portal hypertension. JGH Open 2020;4:368-70. [PMID: 32514438 DOI: 10.1002/jgh3.12254] [Reference Citation Analysis]
703 Eqbal A, Wickremeratne T, Turner S, Higgins SE, Sloss A, Mitchell J, O'Beirne J. One-stop shop for variceal surveillance: integration of unsedated ultrathin endoscopy into the routine clinic visit. Frontline Gastroenterol 2021;12:545-9. [PMID: 34925746 DOI: 10.1136/flgastro-2020-101680] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
704 Luoto TT, Koivusalo AI, Pakarinen MP. Long-term Outcomes and Health Perceptions in Pediatric-onset Portal Hypertension Complicated by Varices. J Pediatr Gastroenterol Nutr 2020;70:628-34. [PMID: 31990868 DOI: 10.1097/MPG.0000000000002643] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
705 Reiberger T, Püspök A, Schoder M, Baumann-Durchschein F, Bucsics T, Datz C, Dolak W, Ferlitsch A, Finkenstedt A, Graziadei I, Hametner S, Karnel F, Krones E, Maieron A, Mandorfer M, Peck-Radosavljevic M, Rainer F, Schwabl P, Stadlbauer V, Stauber R, Tilg H, Trauner M, Zoller H, Schöfl R, Fickert P. Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III). Wien Klin Wochenschr 2017;129:135-58. [PMID: 29063233 DOI: 10.1007/s00508-017-1262-3] [Cited by in Crossref: 62] [Cited by in F6Publishing: 49] [Article Influence: 12.4] [Reference Citation Analysis]
706 Unger LW, Berlakovich GA, Trauner M, Reiberger T. Management of portal hypertension before and after liver transplantation. Liver Transpl. 2018;24:112-121. [PMID: 28752925 DOI: 10.1002/lt.24830] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
707 Zhao H, Yue Z, Wang L, Fan Z, He F, Dong X, Liu F. Benefits of Early Treatment for Patients with Hepatic Myelopathy Secondary to TIPS: A Retrospective Study in Northern China. Sci Rep 2018;8:15184. [PMID: 30315180 DOI: 10.1038/s41598-018-33216-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
708 Lv Y, Wang Z, Li K, Wang Q, Bai W, Yuan X, Yu T, Niu J, Yang Z, Zhu X, Zhao J, Xue H, Jiang Z, Zhuge Y, Zhang C, Sun J, Ding P, Ren W, Li Y, Zhang K, Zhang W, Guo W, Luo B, Li X, Yuan J, Han N, Zhu Y, He C, Yin Z, Fan D, Han G. Risk Stratification Based on Chronic Liver Failure Consortium Acute Decompensation Score in Patients With Child‐Pugh B Cirrhosis and Acute Variceal Bleeding. Hepatology 2021;73:1478-93. [DOI: 10.1002/hep.31478] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
709 Brusilovskaya K, Simbrunner B, Lee S, Eichelberger B, Bauer D, Zinober K, Schwabl P, Mandorfer M, Panzer S, Reiberger T, Gremmel T. Peripheral versus central venous blood sampling does not influence the assessment of platelet activation in cirrhosis. Platelets. [DOI: 10.1080/09537104.2021.2007868] [Reference Citation Analysis]
710 Frenette C, Kayali Z, Mena E, Mantry PS, Lucas KJ, Neff G, Rodriguez M, Thuluvath PJ, Weinberg E, Bhandari BR, Robinson J, Wedick N, Chan JL, Hagerty DT, Kowdley KV; IDN-6556-17 Study Investigators. Emricasan to prevent new decompensation in patients with NASH-related decompensated cirrhosis. J Hepatol 2021;74:274-82. [PMID: 33038432 DOI: 10.1016/j.jhep.2020.09.029] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
711 Berzigotti A. Advances and challenges in cirrhosis and portal hypertension. BMC Med. 2017;15:200. [PMID: 29121925 DOI: 10.1186/s12916-017-0966-6] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 5.4] [Reference Citation Analysis]
712 Peagu R, Săraru R, Necula A, Moldoveanu A, Petrişor A, Fierbinţeanu-Braticevici C. The role of spleen stiffness using ARFI in predicting esophageal varices in patients with Hepatitis B and C virus-related cirrhosis. Rom J Intern Med 2019;57:334-40. [PMID: 31301679 DOI: 10.2478/rjim-2019-0017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
713 Costa D, Simbrunner B, Jachs M, Hartl L, Bauer D, Paternostro R, Schwabl P, Scheiner B, Stättermayer AF, Pinter M, Trauner M, Mandorfer M, Reiberger T. Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality.J Hepatol. 2021;74:819-828. [PMID: 33075344 DOI: 10.1016/j.jhep.2020.10.004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
714 Praktiknjo M, Simón-talero M, Römer J, Roccarina D, Martínez J, Lampichler K, Baiges A, Low G, Llop E, Maurer MH, Zipprich A, Triolo M, Maleux G, Fialla AD, Dam C, Vidal-gonzález J, Majumdar A, Picón C, Toth D, Darnell A, Abraldes JG, López M, Jansen C, Chang J, Schierwagen R, Uschner F, Kukuk G, Meyer C, Thomas D, Wolter K, Strassburg CP, Laleman W, La Mura V, Ripoll C, Berzigotti A, Calleja JL, Tandon